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Abstract
Few satisfactory protocols exist for primary culture of postnatal brainstem neurons, and
commonly used procedures often give poor survival rates in older foetal (>El6) and early
postnatal brainstem cultures. The present study describes the first reliable method for
establishing stable in vitro cultures of foetal and postnatal brainstem neurons up to six days
postnatal age in a defined, serum-free culture medium. This novel culture method was used
to study opioid receptor expression and distribution in developing brainstem cells. Opioids
play an important role in brainstem functions, being involved in respiratory and
cardiovascular modulation and pain control (Olsen et al., 1995; Olson et al., 1997;
Vaccarino et al., 1999; Vaccarino and Kastin, 2001). These brainstem functions are
particularly important for survival at binh, and opioid receptor distribution patterns and
sensitivities to opioid ligands change during development. Using cultured cells and frozen
sections of brainstem tissue, mu (MOR) and delta (DOR) opioid receptor localisation in
neuronal and glial cells at different stages of foetal and postnatal development in the rat
were examined by immunocytochemistry and confocal microscopy. Bipolar and
multipolar neurons showed similar immunoreactivities; whereas, glial cells were more
lightly stained than neurons. Developmentally advanced stages were more intensely
stained for MOR (P<0.006, Mann-Whitney test); whereas, DOR immunoreactivity did not
change during development. These developmental expression patterns observed in culture
for MOR were similar to those obtained from Western blots of electrophoreses brainstern
lysates. DOR, however, decreased in expression in brainstem lysates with increased
developmental age, even though there was no difference in DOR expression in cultured
cells. MOR and DOR were colocalised in specific brainstem regions and in the cerebellum
of foetal and postnatal animals, although the distribution of both opioid receptors in the
foetal brain was more diffuse than in the older animals. The intracellular distributions of
MOR and DOR were investigated by confocal microscopy. In addition to plasma
membrane staining, a population of internalised cytoplasmic receptors was present in
neurons. MOR was down-regulated after exposure of either cultured brainstem cells or
transfected or non-transfected SH-SYSY neuroblastoma cells to the MOR agonist
DAMGO. From the above investigation, it was concluded that opioid receptors are
developmentally regulated during maturation of the brainstem of the rat, and that primary
I
cell culture, immunocytochemistry, and immunoblotting of cell lysates are suitable
techniques for investigating opioid systems in the foetal, postnatal, and adult rat.
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CHAPTER 1
1 Introduction and Literature Review
This chapter summarises the physiological function of opioids in the central nervous
system (CNS), their localisation and that of their receptors, their regulation and expression
during mammalian development, the functional implications of differential distributions oi
opioid receptors within the rat brainstem during development and the overall role the
opioid system plays in health and disease.
I..I. OPIOIDS
Opioid signalling is coupled to many physiological processes within the body (Olsen et al.,
1989; Olsen et al., 1995; Olson et al., 1997;Yaccarino et al., 1999; Vaccarino and Kastin,
2001). Opioids modulate respiratory, cardiovascular, and gastrointestinal systems and are
implicated in body temperature regulation (Adler and Geller, 1988; Takita et al., 1998),
analgesia (Paul et al., 1989; Pasternak, 1993), antinociception @elds and Heinricher,
1985; Porreca et al., 1992; Gutstein et al., 1998; Commons et al., 2001) immune cell
signalling (Bidlack,2000; Tefano et a1.,2000; Kraus et a1.,2001; Sun, 2002; Suzuki et al.,
2002), cognitive functions (Olsen et al., 1989), locomotion (Vaccarino et al., 1999), and
the central control of endocrine function (Olson et al., 1997; Vaccarino et al., 1999;
Vaccarino and Kastin, 2001). Opioid peptides bind to receptors on the plasma membrane
and exert their effects on the cell through G-protein signalling pathways (l-efkowitz, 1998;
Wang et al., 1999; Remmers et al., 2000; Wang et al., 2000; Tsao et al., 2001) (for revierv
see) (Standifer and Pasternak, 1997).
There are three main groups of endogenous opioid peptides: enkephalins, p-endorphins,
and dynorphins. These peptides are derived from proteolysis of their larger precursor
proteins, pro-enkephalin, pro-opiomelanocortin (POMC), and pro-dynorphin, respectively.
Pro-enkephalin is the precursor for several active peptides, all of which have opioid
activity. Within its structure, it contains 7 peptides with the [Met]- or [ru]-enkephalin
active core. POMC has at its carboxyl terminus the 3l amino acid p-endorphin and its 91
amino acid precursor beta-lipotropin. POMC is also the precursor for adrenocorticotropic
hormone. p-endorphin is the only peptide from this precursor to have opioid functions.
Pro-dynorphin produces three main [Iru]-enkephalin-containing peptides, including
dynorphin-A and 
-B. All endogenous opioid peptides contain the opioid core Tyr-Gly-
Gly-Phe-Met (or Leu). Endomorphin-l and endomorphin-2 are proposed endogenous
ligands for mu opioid receptors, although they are the product of an as yet unidentified
precursor. For a review on endogenous opioids, ses Akil et al. (198a) (Akil et al., 1984).
Opioid peptides bind with different affinities to the five main classes of opioid receptors:
mu receptor (MOR), delta receptor (DOR), kappa receptor (KOR) (Martin et al., 1976;
Barnard and Demoliou-Mason, 1983; Kieffer et al., 1992; Pasternak, 1993; Minami and
M., 1995; Reisine, 1995; Satoh and Minami, 1995; Standifer and Pasternak,1997; Law and
Loh, 1999), opioid receptor-like receptor (ORL-1) (Pan et al., 1998; Meunier et al., 2000;
Mollereau and Mouledous, 2000; Slowe et al., 2001), and opioid gowth factor receptor
(OGFr) (Zagon et al., 1999;Zagon et al., 2002), all of which have been cloned. Each class
of opioid receptor (OpR) has distinct expression and functional profiles within the bodl',
especially within the brain, where they are developmentally and spatially regulated (Liu et
al., 1999). The distributions of opioid peptides and their receptors in the adult brain and
within the foetal brain during early development are functionally important. To better
understand opioid action at the cellular level, Xenopus oocyte expression systems
(Appleyard et al., 1999; Koch et al., 2000), transfected cells (Cvejic and Devi, 1997:
Martin and PL., 2001; McVey et al., 2001; He et al., 2002), and cells endogenously
expressing opioid receptors (Prathert et al., 1994; Kramer and Simon, 1999) have been
studied.
1.1.1 TTIE HISTORY OF OPIOIDS
Opiates are alkaloid compounds that have been used for over 4000 years in religious rituals
because of their ability to evoke euphoria. The first active substance was isolated in 1806
from opium extracted from poppy seeds (Papaver somniferum) and was named morphine,
after Morpheus, the god of dreams. In the 1850s, morphine was introduced into medicine
for the treatment of acute pain during surgery and for the relief of chronic pain. It was also
used as a cough suppressant and for the treatment of diarrhoea. Since this time, research
efforts have sought molecules that mimic the action of morphine without causing the
unwanted side effects of nausea, constipation, respiratory depression, immune suppression,
addiction, and tolerance (Olson et al., 1997; Y accarino et al., 1999; Vaccarino and Kastin,
2001). In 1898, heroin, a diacetylated derivative of morphine, was synthesised for this
purpose but later discovered to be even more addictive than morphine because it crosses
the blood-brain barrier more readily. OpR antagonists are often used in drug therapy to
block the effects of opioids (Gonzalez and Brogden, 1988). Opioids are now one of the
most dangerous and costly drugs of abuse and are estimated to cost the USA over 100
billion US dollars/pa in lost earnings, medical expenses and crime associated with drug
abuse [www.nida. nih. gov/EconomicCosts].
The development of cellular and molecular techniques with which to study OpRs has
dramatically increased the knowledge of how the opioid system works, although the exact
cellular mechanisms that lead to desensitisation and addiction still remain unknown.
Unfortunately, little progress has been made in separating the desired anti-pain effects of
opioids with their unwanted side effects.
I.I.2 ENDOGENOUS OPIOIDS
The term opioid refers to all drugs with morphine-like actions, regardless of their
molecular structure. Endogenous opioid ligands were first identified by Hughes et al.
(1975), who isolated met-enkephalin and leu-enkephalin from the pig brain (Hughes et al.,
1975). Two other classes of endogenous opioid peptides, dynorphins and p-endorphin,
were discovered soon after from porcine and camel pituitary glands, respectively (Li and
Chang, 1976; Goldstein et al., l98l). The endorphins tend to have a peripheral site of
action; whereas, the enkephalins and dynorphins are widely distributed in the central
nervous system and are considered to be the predominant central opioid peptide
neurotransmitters (for reviews see (Carr, 1988; Lutz and Pfister, 1992; Dhawan et al.,
1996; Vaccarino et al., 1999; Vaccarino and Kastin, 2001)). Opioid receptors were first
identified in the mammalian brain in the 1970's by autoradiography of binding sites of
radiolabelled opioid peptides (Pert et al., 1973). Multiple OpRs were characterised by the
different effects of different OpR agonists or partial agonists in the morphine-dependent
and nondependent chronic spinal dog (Martin et al., 1976).
1.1.3 SELECTIVITY OF LIGANDS FOR OPIOID RECEPTORS
Binding experiments have shown that DOR preferentially binds enkephalin, KOR
preferentially binds dynorphin, and MOR shows high affinity for endomorphins, [i-
endorphin and enkephalin. Endogenous opioid peptides have only moderate selectivity for
one OpR type over another and it is likely that they activate more than one OpR. The
interaction between opioid peptides and OpRs involves both the binding selectivity of the
ligands and receptor availability in the vicinity of peptide release. The pharmacological
profiles of each opioid receptor have been well characterised (for reviews see (Iwamoto
and Martin, 1981; Smith and Low, 1981)). Most of the opiates used clinically such as
morphine, codeine, and methadone, selectively interact with MOR. The pharmacology of
the three groups of classical opioid receptors is distinct and well characterised. OpR
ligands have been synthesised with varying specificities for each class of opioid receptor,
summarised in Table I.l. [D-Ala2,N-methyl-Pheo,G]yt-ollenkephalin (DAMGO) and
dermorphin have a high selectivity and affinity for MOR (Goldstein 'and Naidu, 1989;
Negn et al., 1992; Attila et al., 1993). The DOR agonists [D-Ser2]I-eu-enkephalin-Thr
(DSI-ET) and fD-Ala2,D-Irutlenkephalin (DALDE) have only slight selectivity for DOR;
whereas, [D-Pen2'5]enkephalin (DPDPE) is highly selective. DSLET has been reported to
have 20- to 600-fold selectivity for DOR over MOR (Gacel et al., 1980); whereas, DALDE
has a 2- to 20-fold selectivity for DOR over MOR (James and Goldstein, 1984). DPDPE is
100- to 1000-times morc potent at DOR than MOR (Mossberg et al., 1983; Toth et al.,
1990) and is the preferred DOR agonist for use in binding studies. The specificity of the
ligands has been mapped to specific regions of the opioid receptor, using chimeric or
mutated OpRs (Meng et al., 1996; Capeyrou et al.,1997; Gouldson et al., 1998; Chaturvedi
et al., 2000; El Kouhen et al., 2000).
Table 1.1 Selectivity of ligandsfor opioid receptoro
Natural Transmitter
MOR
Morphine-f- glucuronide
DAMCiO
klorph ne
Derrnorphin
CTOP
Naloxonazine
P.PNA
sNc 80
Endomorphin-1
Elrdomorphin-2
Enlcephalin
Endorphin
DOR, DPDPE Naltrindole Enkepialin
DAIDE NTB EndorPhin
DSLET BNTX
Deltorphin I ICIL74864
Deltorphin tr
U50,4818
u69,593
Enadoline
no-r-BM Dynorphin A
DynorphinB
KOR
I.2 OPIOID RECEPTORS
I.2.I TYPES OF RECEPTORS
In the 1970s, the three main classes of OpR, F, 6, and K, were identified (Martin et al.,
1976). These three classes were further subdivided according to their pharmacological
properties into p1/p2lpg, 6r/62, and rr/rzlK3 receptors. Although these eight isoforms of
opioid receptors (OpRs) have been recognised pharmacologically, only three OpR genes
have been cloned. DOR is located on chromosome 1, MOR on chromosome 6, and KOR
on chromosome 8 (Befort et al., 1994; Wang et al., 1994; Yasuda et al., 1994). The seven
MOR, DOR, and KOR isoforms are all products of these three cloned genes. This has
recently been confirmed by production of knockout mice in which the pharmacological
responses are lost for each particular OpR gene deleted (Matthes et al., 1996; Kieffer,
1999; Chen et al., 2000; Kieffer and Gavdriaux-Ruff, 2002). The correlation between the
biological activity of the encoded proteins and the pharmacological subtypes remains to be
established.
Recent studies have shown that some pharmacological heterogeneity arises from the three
known MOR, DOR and KOR genes by alternative splicing mechanisms. At present fifteen
different C- and N- terminal splice variants have been reported for the MOR-I receptor in
rodents (Koch et al., 1998; Pan et al., 1999; Koch et al., 2001; Pan et al., 2001). These
splice variants, classified as MOR-I and MOR-IA to MOR-IN, are differentially
distributed in the brain and undergo region-specific processing (Schulz et al., 1998;
Abbadie et al., 2000b; Abbadie et al., 2000a). For example, MOR-IC is absent or sparse in
the nucleus ambiguous (NA), locus coeruleus, and striatum, regions where MOR-I is
expressed at high levels. MOR-IC and MOR-I are both found in the periaqueductal gray
(PAG) and laminae I and II of the spinal cord (SpC); whereas, MOR-IC expression is
higher in the hypothalamus than MOR-l (Abbadie et al., 2000a). MOR-lD is expressed at
high levels in the nucleus of the solitary tract (NTS), area postrema, inferior olive (IO),
NA, and spinal trigeminal nucleus; whereas, it is absent from the striatum and loecus
coeruleus (Abbadie et al., 2000b). In the mouse, five splice variants of KOR have been
described, and each of these splice variants has distinct expression patterns within the brarn
(Pan et al., 1998). KOR-3A is expressed at high levels in the striatum, a region wherc
KOR-3 is absent. KOR-3C is found in the PAG and hypothalamus in the same regions as
KOR-3. KOR-3B levels were low throughout the brain. KOR-3D was most predominant
in the cerebellum; whereas, the brainstem had similar expression levels of KOR-3, KOR-
3,{, and KOR-3D (Pan et al., 1998). Two DOR splice variants have also been identified in
mouse brain by RT-PCR. The DOR splice variants are present at low levels
(approximately SVo) when compared to total DOR-I expression levels (Gavdriaux-Ruff et
al., 1997). Most of the splice variants express a truncated form of the receptor protein, and
in the case of the KOR and DOR splice variants, the receptors are unlikely to couple with
G-proteins. The precise biological functions of these splice variants remains to be
determined.
I.2.2 OPIOID RECEPTOR STRUCTURE
A major breakthrough in the understanding of OpR structure and function was achieved
with the cloning of the different OpRs @vans et al., 1992; Kieffer et al., 1992; Chen et al.,
1993b; Fukuda et al., 1993; Li et al., 1993; Thompson et al., 1993; Abood et al., 1994;
Zimprich et al., 1995; Akil et al., 1996; Zagon et al., 1999; Meunier et al., 2000). The
sequence of the cloned genes indicated that opioid receptors belonged to the superfamily of
G-protein coupled receptors (GPCR), Iying within the subfamily of rhodopsin receptors.
The three classical OpRs share about 6OVo sequence identity (Knapp et al., 1995; Satoh and
Minami, 1995), and each OpR is approximately 90Vo identical to its counterpart in other
mammalian species (Befort and Kieffer, 1997). The N-terminus shares the least homology
(around lOVo), with the transmembrane regions and intracellular loops showing the greatest
homology (Blake et al., 1996) for review see (Satoh and Minami, 1995).
OpRs have seven transmembrane helices (Figure l.l) connected by three intracellular and
three extracellular loops, a cytoplasmic C-terminus, which has a highly conserved potential
palmitoylation site, and an extracellular N-terminus that contains multiple glycosylation
sites. Two cysteine residues located in the first and second extracellular loops are highly
conserved between different OpRs and form a disulfide bond in the properly folded,
functional protein. Multiple sites exist for protein kinase phosphorylation, and these sites
are present in the 2od and 3'd intracellular loops and in the C-terminal domain (Chen et al.,
1993a), (for review, see (Minami and M., 1995)). Mutation analysis of the OpRs has been
carried out by construction of opioid receptor chimeras (Befort and Kieffer, 1997:'
Gouldson et al., 1998; Law and Loh, 1999; Law et al,, 2000a) and site-directed
mutagenesis. (Meng et al., 1996; Capeyrou et al.,1997; Chaturvedi et al., 2000; El Kouhen
et al., 2000). Mutation analysis has increased the understanding of ligand binding
selectivity and identified the receptor regions responsible for activation and regulation of
the receptors. For example, the C-terminal of DOR and MOR appears to be involved in
receptor trafficking, since loss of the C-terminal prevents polarised insertion of the
receptor in the plasma membrane (Trapaidze et al., 1996; Trapaidze et al., 2000). KORs
require the C-terminal region for agonist-induced receptor down-regulation (Appleyard et
al., 1999). A summary of opioid receptor regions important for binding and regulation is
shown in Figure l.l (Minami and M., 1995; Satoh and Minami, 1995; Wang et al., 1995;
Blake et al., 1996; Meng et al., 1996; Trapaidze et al., 1996; Befort and Kieffer, 199'l;
Koch et al., 2000; Law et al., 2000a; Wang et al., 2000). Extracellular loops have a role in
determining ligand selectivity. These extracellular loops probably do not form the actual
binding pocket for the peptide, but act as filters for the ligands, regulating the ability of the
ligands to interact with the binding pocket within the core of the receptor. The orientation
of the amino acid side chains greatly affects the ability of the extracellular loop to filter
opioid selective ligands, since mutation of a single amino acid can alter the tertiary
structure of the receptor protein. For example, when an OpR agonist binds to its receptor,
a small conformational change exposes the intracellular loop, allowing its interaction with
G-proteins (Javitch et al., 1997).
The resolution of the atomic structure of GPCRs has not yet been carried out, but several
models have been presented in the literature (Knapp et al., 1995; Wess, 1998). In one
proposed model, the seven transmembrane helices are tightly packed and arranged in a
sequential clockwise order in a tight bundle. The position of the transmembrane helices is
important in determining the interaction of the side chains. A schematic diagram of the
organisation of the transmembrane helices has been presented (Law et al., 2000a). The
structure of the OpR in the membrane has been modelled in detail for rat MOR (Minami
and M., 1995; Satoh and Minami, 1995) and DOR (Law et al., 1999).
I.2.3 OPIOD RECEPTOR REGULATION
The OpR signalling pathways described in this section are summarised in Figure 1.2. The
cloning of DOR in 1992 by Evans et al. (1992) (Evans et al., 1992) and Kiefer etal. (L992)
(Kieffer et al., L992) dramatically increased the understanding of OpR regulation.
Regulation has now been extensively studied using cell lines (Elliott et al., 1994; Prathert
et al., 1994; Gies et al., 1997: Yabaluri and Medzihradsky, 1997; Kramer and Simon, 1999:
Law et al., 2000c; Remmers et al., 2000; Jenab and Inturrisi, 2002), brain membrane
preparations (Satoh and Minami, 1995; Gray et al., 2001), Xenopus oocyte expression
systems (Appleyard et al., 1999; Koch et al., 2000), and yeast expression systems (Lagane
et al., 2000). Cloning and transfection techniques have allowed the function of individual
OpR amino acid sequences to be determined by selective mutation (Meng et al., 1996),
thus, permitting identification of the receptor domains responsible for opioid ligand
selectivity, agonist activation, and receptor regulation. Transfected cells and cells
endogenously expressing OpRs are often used to study receptor regulation because thel'
consist of homogeneous populations of cells that are more easily characterised than the
heterogeneous population of cells within the brain that express OpRs. Studies of OpR
function within the brain are further complicated by differences in regional distribution,
function, and regulatory mechanisms (Mansour et al., 1987, 1988). These regional
differences are fufther complicated by species differences that exist in the type,
localisation, and expression levels of different OpRs. Species variability is described in
detail later in this chapter.
Activation of OpRs causes a reduction in pre- and postsynaptic neuronal excitability.
OpRs, through GPCR signalling pathways, inhibit adenylyl cyclase activity. The resultant
decrease in cAMP in the cells, through alteration of numerous protein kinase activities,
leads to changes in receptor phosphorylation, activation of inward-rectifying K* channels,
and inhibition of voltage-gated Caz*channels. (Xiang et al., ; Fan and Crain, 1995; Kovoor
et al., 1995; Belcheva et al., 1996; Trapaidze et al., 1996; Blake et al., 1997:' Chen et al.,
L997: Chu et al., 1997; Gaudriault et &1., L99'l; Pak et al., 1997; Yabaluri and
Medzihradsky, 1997; Yu et al., 1997; Koch et al., 1998; Zhang et al., 1998; Kramer and
Simon, L999; Law and Loh, 1999; Liu et al., 1999; Pak et al., 1999; Bohn et a1.,2000;
Kramer and Simon, 2000; Pet?ija-Repo et al., 2000; Remmers et al., 2000; Tryoen-Toth et
al., 2000; Wang et al., 2000; Yoshikawa et al., 2000; Wei and Low, 2002). Exposure of
cultured cells that express OpRs, or cells transfected with OpRs, to opioid agonists causes
an inhibition of adenylyl cyclase activity, similar to that seen in vivo (Law et al., 1983;
Kieffer et al., 1992; Chan et al., 1995). Chronic exposure causes a decrease in the ability
of the OpR to regulate adenylyl cyclase activity (receptor desensitisation) and a decrease in
receptor density (receptor down-regulation) (Law et al., 1983; Law et al., 2000b).
Exposure of OpRs to opioid antagonists in cultures of spinal cord dorsal root ganglion
causes an up-regulation of receptors to the plasma membrane (up to a 4OVo increase);
whereas, incubation with OpR agonists causes a down-regulation of OpR function (up to a
70Vo reduction in function) (Chen et al., 1997).
l0
Figure 1.1 Opioid Receptor Structure, Binding and Regulation Properties
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Figure 1.2
Opioid Receptor Activation
Binding of opioid peptides (OP) at opioid receptors (OpR) causes G-protein mediated inhibition
of adenylyl cyclase (AC) which causes a decrease in intracellular cAMP levels. The K' channel
is activated and the Ca2' channel inhibited. causing hyperpolarisation of the cell membrane.
Decreased cAMP levels causes a decrease in protein kinase activity (PKA) which modulates
numerous cellular processes. including reduced OpR transcription and changes in channel
activities. Modified from Nestler ( 1996) and Kandel et al. (2000).
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Opioid receptors, through coupling to G-proteins, inhibit (Chen et ill., 1993b) or activate
(Chan et al., 1995) different isoforms of adenylyl cyclases (Standit'er and Pastemak, 1997).
There ile many different types of G-proteins, and there are diff'erences in subunit
conformation between these G-proteins. Each of the 19 diff-erent cr subunits. the -5 p
subunits, and the 6 y subunits described in the literature has unique functional properties
(reviewed by Harrison, 1998 and Conner 1999) (Harrison et al., 1998; Connor and
Christie, 1999). G- protein coupling ditl'ers between ditferent brain regions; cell lines,
transt'ected cells, and between OpR subtypes (Chan et al., 1995; Appleyard et al., 1999).
There are also differences in the sensitivity of G-proteins to toxins (Standifer and
Pasternak, 1997). For example, in SH-SY5Y cells, MOR couples to the G-protein Gcqr:
whereas, DOR couples to the G-protein Guir. suggesting that G-protein specificity exists
for different OpRs (Remmers et al.. 2000) (reviewed in Standif'er and Pasternak (1997)
(Standifer and Pasternak. 1997). The dill'er"ent types of adenylyl cyclases, of which eight
have been described (Standifer and Pasternak, 1997), vary in their sensitivity to
calcium/calmodulin and the different G-protein subunits (Han'ison et al., 1998: Connor and
Christie, 1999), as well as their regulation by different protein kinases (Xiang et al., ; Koch
et al., 1997; Wilson, 1997; Zhang et al., 1998: Appleyard et al., 1999; Kramer and Simon,
1999, 2000; Tso et al., 2000: Wang et al., 2000). All these factors affect the overall
regulation of OpRs in neuronal cells.
Receptors within the GPCR class share similarities in their regulatory properties
(Dohlman, l99l: Lcfkowitz, 1998; Jordan and Devi, t999; Tsao and von Zastro,2000),
and G-protein signalling has been well descnbed in the literature. Briefly. when GPCRs
are not stimulated by agonists, the G-protein exists as a heterotrimer with u, p, and
y subunits. GDP is bound to the cr subunit. When the ligand binds to the receptor, the
receptor associates with the G-protein, and GDP is exchanged for GTP. The G-protein cr
and By subunits separate, and the OpR dissociates fiom tlre G-protein subunits. The cr G-
protein subunit then acts on adenylyl cyclase, GTP is hydrolysed to GDP, and the a
subunit reassociates with the $y subunit (Connor and Christie, 1999).
Activation of OpRs causes a reduction in cellular excitability and neurotransmitter release.
This can occur by several different mechanisms that are described below and illustrated in
Figure l-2. The OpR, on exposure to an agonist. inhibits voltage-dependent Ca2* channels,
t4
including N-type (Tallent et al., 1994) and L-type Ca2* channels (Piros et al., 2000). OpR
stimulation reduces neuronal excitability by hyperpolarising the plasma membrane by
increasing K* conductance out of the cell, ancl inhibiting Cal+ entry into the cell (Piros et
al., 2000). This has been confirmed by studies in Xe.nopus oocytes that coexpress either
MOR or KOR along with the G-protein activated K* channel (GIRKI) (Kovoor et al.,
1995). In the brain, MOR also couples to the G-protein-activated, inward-rectifying K*
channel (Bausch et al., 1995b). The presence of coupling between MOR and GIRKI has
been directly supported by studies that demonstrate that MOR and K* channels colocalise
in some regions of the brain, including the olfactory nucleus, cerebral coftex, thalamus,
locus coemleus, and the dorsal raphe nucleus (Bausch et al., 1995b).
Agonist-induced receptor phosphorylation is critical in the regulation of GPCRs (Arden et
al., 1995; Yu et al., 1997: El Kouhen et al., 2001) and involves phosphorylation of the C-
terminal of MOR (Pak et al., 1997). Several ditferent protein kinases are involved in OpR
phosphorylation, including protein kinase C (Xiang et al., ; Kramer and Simon, 1999),
Ca2*/calmoclulin (CaM)-dependent protein kinases (Koch et al., L997), G-protein-coupled
receptor kinases (Zhanget al., 1998; Appleyard et al., 1999), and mitogen-activated protein
kinases (MAPK) such as Erk-l and Erk-2. Activation of MAPK occurs via the G-protein
By subunit (Wilson, 1997; Kramer and Simon, 2000; Tso et al., 2000; Wang et al., 2000).
GPCR regulation by phosphorylation has been recently reviewed by Law (2000) (Law et
al., 2000a). A G-protein independent, tyrosine-kinase-dependent pathway may also be
involved in MOR down-regulation (Pak et al., 1999). DOR may also be partially regulated
by G-protein independent and phosphorylation independent mechanisms. For example,
mutant C-terminal truncated DOR, in the absence of phosphorylation, showed down-
regulation on exposure to DOR agonist DALDE. The DOR internalisation observed in this
study was via a dynamin-dependent mechanism involving clathrin-coated pits (Murray et
al., 1998). The study of DOR down-regulation canied out by Murray et al. (1998) was the
first to show GPCR down-regulation that does not require phosphorylation to undergo
dynami n-dependent endocytosi s.
1.2.4 RAPID RECEPTOR DOWN.REGULATION AND INTERNALISATION
Opioid rcceptor signal transduction is closely associated with receptor down-regulation or
desensitisation, a phenomenon characterised by a rapid loss of rcceptor function upon
l5
sustained exposure to an opioid agonist. Several cellular systems, including cell lines
endogenously expressing these receptors and transfected cell lines, provide useful models
to study these f'unctions in vitro. In viyo systems are complicated further by long-term
adaptive changes, tolerance, and addiction (Nestler and Aghajanian, 1997: White and
Irvine, 1999). Recent findings suggest that MOR down-regulation during agonist
stimulation is the sum of both accelerated receptor degradation and decreased receptor
biosynthesis (Afify, 2002). Numerous mechanisms operate at the transcriptional,
translational, and protein levels to lead to the desensitisation of opioid receptors.
The curent model for OpR desensitisation (summarised in Figure 1.3) follows the same
model as for other GPCRs (recently reviewed by (Tsao et al.. 2001)). Brief-ly, the receptor
is phosphorylated by protein kinases on exposure to its agonist, allowing B-arrestin to bind
to the receptor. The binding of B-arrestin competes with G-protein binding for the
attachment sites, resulting in termination of receptor function. Addition of G-protein
receptor kinase and B-arrestin to t Xenopus oocyte KOR expression system showed
increased KOR down-regulation on exposure to KOR agonists (Appleyard et al., 1999).
The internalisation of the receptor is also p-arrestin-dependent, and therefore
phosphorylation-dependent, and occurs via endocytosis mediated by clathrin-coated pits
(Xiang et al., I Chu et al., 1997). The internalised receptor is resensitised by
dephosphorylation and is then recycled to the membrane, or, alternatively, the receptor is
degraded within lysosomes (Ko et al.. 1999; Shapira et a1.,2001; Tanowitz and von
Zastrow, 2007). The endocytosis of GPCRs usually requires ubiquitination. Cytoplasmic
lysine residues are covalently modified by ubiquitin to signal MOR and DOR removal
from the membrane to endosomes (Chaturvedi et al., 2001). Another study, however, has
described ubiquitination-independent trafficking of DOR to lysosomes (Tanowitz and von
Zastrow, 20OZ). Several pathways for down-regulation of OpRs probably exist. Recently,
a G-protein-coupled receptor-associated sorting protein (GASP) has been implicated in the
moduf ation of lysosomal sorting (Whistler et al., ?002).
l6
Figure 1.3 Opioid Rcceptor Regulation
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Whistler et al. (2001) using a C-terminal truncated DOR suggested that phosphorylation
was required for wild-type DOR intemalisation. but not fbr internalisation of the truncated
DOR. This suggests that the DOR C-terminal region acts as a brake for receptor
internalisation and that the break is removed by receptor phosphorylation (Whistler et al.,
2001). Another protein, dynamin, has also been implicated in OpR internalisation in
addition to B-arrestin (Chu et al., 1997). There ere differences in the specific pathways of
down-regulation and internalisation tor diflferent types of receptor. For example.
Gauderiault et al. (1997), using cells transf'ected with MOR and DOR showed that OpRs
were down-regulated and internalised through partially distinct endocytotic pathways
(directly visualised by confocal micrcscopy) (Gaudriault et ul., 1997). This suggests that
each receptor interacts with distinct proteins that mediate intracellular tmfficking and
sorting. OpR splice variants also display diffcrent patterns of insertion and rcmoval from
the membrane, and the rates of down-regulation with dift-erent agonists vary (Koch et al.,
1998; Koch et al., 2000; Abbadie and Pasternak. 2001; Koch et al., 2001).
Despite all this direct experimental evidence ol'OpR down-regulation and desensitisation,
some studies indicate that other tactors may be involved. since inhibition of phosphatase
activity does not enhance OpR desensitisation and internalisation, and protein kinase
activation, or over-expression of p-arrestin, does not enhance phosphorylation (El Kouhen
et al., 1999). Numerous factors may therefore be involved in regulation, and regulatory
pathways may be unique for each OpR subtype, splice variant, G-protein subtype, or
adenylyl cyclase isoform (Pak et al., 1999; Tso et al., 2000). Indeed, not all OpR
regulation directly involves G-protein-rnediatcd pathways. To complicate matters further,
opioids are not always inhibitory. lt has becn shown, fbr example, that KOR acts in an
excitatory manner to oppose the actions of MOR (summarised in a review by Pan 1998)
(Pan, 1998). KOR was recently fbund to reduce K* currents via activation of stimulatory
G, proteins in cultured hippocampal neurons, supporting the concept of an excitatory
opioid system (Fan et al., 1992: Fan and Crain, 1995; Hampson et al., 2000). In addition, it
has been proposed that morphine, which does not cause rapid internalisation of MOR, may
have a different mechanism for down-regulation that leads to opioid tolerance (Keith et al.,
1996: Keith et al., 1998).
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In summary, activation of OpRs generally results in hyperpolarisation of the membrane via
altered ion channel activity and G-protein-mediated inhibition of adenylyl cyclase activity.
Afier activation, receptor phosphorylation causes OpR desensitisation (reduced coupling to
signaling pathways) or down-regulation (removtl of OpRs fr-om the membrane), processes
mediated by protein kinases and B-anestin. Opioid receptor regulation is complicated by
the invofvement of different isoforms of adenylyl cyclase (Standif'er and Pastemak, 1997)
as well as G-protein subunits (Harrison et al., 1998; Connor and Christie, 1999), and the
interactions they have with each subtype of receptor are unique.
1.2.5 OLIGOMERISATION
GPCRs fbrm oligomers in a tissue. regional. and species-specific fashion (Rios et al., 2001;
Salim et al., 2002). The formation of oligomers alters the function of individual receptors
and influences signal amplification. Oligomerisation has therefore been postulated to be a
mechanism for increasing the functional repeftoire of G-protein coupled receptors
(Gouldson et al., 1998). OpRs, as members of the family of GPCRs, also fbrm oligomers.
Using time-resolved fluorescence resonance energy transfer (FRET) techniques (Cvejic
and Devi, 1997; Lrvac et al., 2001), DOR has been shown to form homo-oligomers when
transf'ected into HEK 293. CHO, or COS cells. The structural basis for this association
remains uncleal but may involve the fbrmation of disulfide honds, hydrophobic
interactions, and intracellular coiled-coil interactions (Bouvier, 2001). The presence of the
DOR C-tail is reported to be necessary for receptor dimerisation (Cvejic, 1997). Indirect
evidence also exists for MOR homodimer tbrmation. In a study of mouse brain tissue,
MOR homodimers were observed by protein coimmunoprecipitation techniques (Garz6n et
al., 1995), and Western blots of electrophoretic extracts of the pedaqueductal grey from
mouse brain demonstrated the presence of low (50-58 kD) and high molecular weight
(100-l14 kD) MOR bands. The high molecular weight bands were twice the size of the
MOR monomers (Garz6n et al., 1995).
Hetero-oligomerisation has been reponed between MOR-DOR (George et al., 2000;
Gomes et al., 2000; Martin and PL.. 2001) and DOR-KOR (Jordan and Devi, 1999;
Ramsay et al., 2002) and between DOR and KOR with p2-adrenoceptors (another GPCR)
(Jordan and Devi,200l; McVey et a1.,2001; Ramsay et a1.,2002). MOR-I also forms
heterodinrers with the GPCR, somatostatin-2a (Pfeiffer et al., 2002). Recently, MOR,
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DOR, and KOR werc found to oligomerise with the chemokine receptor CCR5, and the
heterodimers were postulated to have a role in modulating immune responses (Suzuki et
al., 2002). The DOR-KOR heterodimer displays differences in ligand binding profiles
when exposed to the KOR selective agonis(s dynorphin A and U69593 and the DOR
selective agonist DPDPE. In the case o[ DPDPE, a decreased affinity for the heterodimer
was seen relative to the DOR monomer. On the other hand. the non-specific opioid
antagonists naloxone and diprenorphine showed an increased affinity for the DOR-KOR
heterodimer rcceptor complex (Jordan and Devi. 1999).
lnteractions between MOR and DOR have been postulated for years (Traynor and Elliott,
1993), although direct interactions have only been discovered recently (George et al.,
2000). Like the DOR-KOR heterodimer, the l-50 kD MOR-DOR heterodimer has novel
binding sites compared with the MOR and DOR monomers, showing reduced binding
affinity for some agonists (DALDE, DPDPE, DAMGO, and morphine), and increased
affinity for some endogenous opioid peptides (endomorphin-l and leu-enkephalin).
Differences in OpR regulation, desensitisation. and receptor internalisation were also seen
with heterodimers (Gomes et al., 2000; Martin and PL., 2001). An intact MOR C-terminal
region is not required for MOR-DOR hetero-oligomerisation to occur (Gomes et al., 2000).
The functional relevance of OpR hetero-oligomerisation is still being investigated. MOR-
DOR hetero-oligomers do not closely match any MOR or DOR pharmacological subtype.
At present, hetero-oligomerisation has only been seen in vitro, mainly in OpR transfected
cell lines that grossly over-express OpRs. It still remains to be established if hetero-
oligomers are present in vivo, although some indirect evidence exists for their formation.
For example, in studies using knockout mice, MOR is needed to obtain full DOR-mediated
analgesia of the tail withdrawal response (Matthes et al., 19961 Matthes et al., 1998). MOR
knockout mice also do not display place preference, a test designed to measure rcward and
drug seeking behaviour in response to a selective DOR agonist such as deltorphin II
(Hutcheson et al., 2001). MOR knockout mice are unresponsive to morphine, including
the effects of morphine on pain reliel', addiction, and tolerance. The expected functional
consequences of OpR knockout are not always observed. The maintenance of normal
function in these mice is not a result of increases in expression of the remaining OpRs,
since their expression and distribution rcmarn unchanged (Kitchen et al., 1997). For
example, OpRs are believed to have a role in developmental maturation and in the
modulation of respiration. OpR knockout mice, however, seem to develop and mature
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normally and have normal breathing rhythms. MOR and DOR have some overlapping
functions irt t,it,ct and act synergistically to increase the response to MOR and DOR
agonists (Cahill et al., 2001a; Mafiin and PL., 2001). Recent investigations have indirectly
linked these enhancements of function to heterodimer formation (Levac et al., 2001).
Both MOR and DOR homodimers on their own cause adenylyl cyclase inhibition, MAPK
activation via pertussis toxin-sensitive GPCRs, and undergo agonist-dependent
internalisation and desensitisation. The MOR-DOR heterodimer, however, is coupled via
pertussis toxin-insensitive G-proteins. Inhibition of adenylyl cyclase and MAPK
activation in the MOR-DOR heterodimer orrly occurs if both MOR and DOR selective
ligands are added together. In the MOR-DOR heterodimer no desensitisation was seen
with the MOR-selective agonist DAMGO or the DOR-selective agonist DPDPE. As stated
earlier, the MOR-DOR heterodimer has increased affinity fbr endomorphim-l and leu-
enkephalin. The DOR-KOR heterodimer shows an increased affinity for non-selective
agonists. The properties of OpR dimers have been recently reviewed by Levuc et al.
(2001) (Levac et a1.,2001).
1.3 OPIOID RECEPTOR EXPRESSION
The anatomical distribution and expression levels of specific OpRs within the brain can
provide important clues on the sites of action and functional significance of the different
opioid systems within the brain. For example, OpRs located in par-ts of the limbic system
and cerebral cortex have been implicated in modulating the opioid effects of euphoria and
drowsiness (Wamsley, 1983); whereas. activartion ol'OpRs within the spinal cord leads to
spinal analgesia and desensitisation to pain (Fields and Heinricher, 1985; Gamboa-Esteves
et a|.,2001). OpRs in brainstem areas modulate cardiovascular and respiratory functions
(Denavit-Saubfe et al., 1978; Pastemak et al.. 1980; Hassen et al., 1982; Sessle and Henry,
1985; Yeadon and Kitchen. 1989; Shook et al.. 1990: Gray et al., 1999r Liu et al., 2000;
Moss and Laferridre,2000; Aiclrer et a1.,2001: Stornetta et a1.,2001). These regional
distributions show species variations in lroth receptor expression levels and in the specific
sites of localisation within the brain (Yoburn et al., l99l: George et al., 1994). Differences
can also be seen in receptor expression and localisation patterns at different stages of
development (Beland and Fitzgerald, 2001) and in disease states (Delay-Goyet et al., 1987;
Barg et al.. 1993b).
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The distribution of OpRs generally matches the pharmacological site of action and
production of opioid peptides. For example. met-enkephalin immunoreactivity is found in
the medulla (Ceccatelli et al., 1989) and dorsal horn of the rat spinal cord (SpC) where it is
colocalised within the same SpC regions as DOR (Cheng et al., 1995b). Leu-enkephalin is
also fbund in the rat NTS where it is fbund closely associated with MOR-positive neurons
(Cheng et al., 1996). Radioimmunoassay expedments have shown that met-enkephalin, p-
endorphin, and dynorphin are present in brainstem respiratory regions of the piglet (Zhang
and Moss, 1995). Met-enkephalin is also present in tlre NTS and medulla of newborn
rabbits (Gingras-Leatherman et al., 1986) and human foetal brain tissue (Yew et al., 1990).
These regions all express high levels of both MOR and DOR receptors (Delfs et al., 1994,
Arvidsson et al.. 1995a; Arvidsson et al., 1995b; Bausch et al., I99-5a; Ding et al., 1996a).
No single OpR, however, exists in the same brain regions as a single opioid peptide, More
often, several opioid peptides are tbund in the same regions along with multiple OpRs
(Loughlin et al., 1985). It is difficult to compare or con'elate the distributions of peptides
and receptors reported in the literature. because of the dif'ferences in techniques used in
each study and the fact that opioid peptides can diffuse away from their site o1'production.
Zadinia et al. (1997) showed that endomorphin had a high affinity for MOR (Zadina et al.,
1997) and was fbund in the CNS in regions of high MOR density (Zadina et al., 1999).
Both the level of expression and receptor distribution can help investigators gain better
insight into opioid functions, interactions. and regulation in vivo since the physiological
function of any neuromodulatory system depends on the ratio of active receptors to
available ligands.
The distribution of endogenous opioid peptides (Olson et al., 1997; Vaccarino et al., 1999;
Vacceuino and Kastin,200l) and the OpRs they interact with (Xia and Haddad, l99l) are
developmentally regulated and spatially distdbuted in the brain. The anatomical
distribution of OpRs in the rodent brain has been examined by radioligand binding in the
foetal (Tsang et al., 1982), postnatal (Tsang et al., 1982; Kornblum et al., 1987; Xia and
Haddad, l99l), and adult rat (Kornblum et al., 1987; Mansour et al., 1988; Xia and
Haddad, l99l; Bunzow et al., 199-5). and in the adult mouse (Matthes et al., 1998;
Goodman et al., I999; Chen et aI.,2000). lnrmunocytochemistry (ICC) has been used to
investigate OpR populations in the adult rat (Dado et al., 1993; Elde et al., 1995, Ding et
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al., 1996b; Kalyuzhny et al., 1996; Cheng et al., 1997; Gutstein et al., 1998; Schulz et al.,
1998; Abbadie et al., 2000b; Abbadie et al., 2000a; Cahill et al., 200lbl Wessendorf and
Dooyema, 2001; Abeyta et al., 2002', Wang and Wessendorf, 2A02) and adult mouse (Pan
et al., 1998; Abbadie et al., 2000b). The ICC studies have been limited, until recently, by
the unavailability of suitable antibodies against OpRs (Elde et al., 1995). With the cloning
of the OpR genes, mRNA expression has also been examined in various regions of the
CNS and SpC of foetal rats (Georges et al., 1998) and mice (Zhu et al., 1998), postnatal
rats (Georges et al., 1998; Gulled-ee et al.. 2000), and adult rats (Mansour et al., 1988;
George et al., 1994; Maekawa et al., 1994: Zastawny et al., 1994; Mansour et al., 1995;
Witterr et al., 19961 Georges et al., 1998; Bouret et al., 2000; Tong et al., 2000; Cahill et
al., 2001b; Wang and Pickel, 2001; Wang and Wessendorf, 2002) and adult mice (Pan et
al., 1998; Pan et al., 1999). In all these in situ hybridisation studies, radiolabelled, rather
than fluorescent probes, werc used for visualisation of receptor binding sites. The
resolution and specificity of radiolabelled probes are not as good as those obtained with
fluorescent or colourimetric antibody or nucleic acid probe labelling techniques.
OpR expression is primarily regulated by transcription. OpR expression levels are
controlled by both proximal and distal promoters (Kraus et al., 1995; Andria and Simon,
1999; Liu et al., 1999), and several transcriptional regulatory factors have been discovered
(Kraus et al.. 2001; Sun and Loh, 2001). For example, DOR is regulated by both
transcription promoters and suppressors (Andda, 2001). An example of this is Ets-1, a
DOR transcriptional activation factor (Sun and Loh, 2001). Transcriptional regulation is
known to vary during development (Ko et a[., 2002). OpR expression and spatial
distributions in the adult rat brain are summarised in Table 1.2.
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Table 1.2 Distrihution of Opioid Receptors in the Brain
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Animal Ral Rat Rat Mouse Rat Rat RAT RAT
Reference numbgr 8 7 o 7 4 THE 'RESENTSruDY
llethod tHc IHC tHc tHc mRNA ARB tHc rHc
CDiold Recoptor ooR DOR DOR DOR DOR KOR moR DOR
falencsohalon
rlfactorv bulb P +++ +++
llfdctory tubercle P +++ +
:ORTEX
Ant cinqulat€ +++ ++ ++ i
fionlal parieta ++ +
piribrr P ++ + +
Striatum P ++ ++
\lucleus accumbens
HIPPOCAMPUS P + +
cAl P
cA2 P
cA3 P
Dendate gyrus P i
Amygdala P
Globus pallidus +
Daencephalon
Hypothalamus P +++
TtIiCLAMUS P
Anterior group
Medial group ++
MidlirE group
Lateral qrouo
Ventral qroup
Lateral geniculale
Medial geniculate
llesencsphalon
Substantia nigra +f+ P +++ +
vental teqmental area +++ ++t +
nterDeduncular nucleus +++ P +++ +++
iuoerior colliculus ++ ++ ++
nbrior colliculus +++ +++ ++
f,eriqueductal gray P ++
;erebellum P ++ ++
Rhombencephalon
rontine reticular nucleus ++ r + ++++
-ocus coeruleus o P 0 0
:acial motor nucleus P P
)arabrachial nucleus ++ P ++ ++ ++
3iqantocellular nucleus +++ P +++ +++ + + +
Intermediate reticular nucleus
)anocellular reticular nucleus
Vledullary relicular nucleus
laohe nuclei + P + + +
Nucleus ambiguus P ++++ ++++
lucleus of tlrc solitarv tract P +++ ++++ ++++
3racile + +
luneate + +
Extemal cuneate i +
Soinal triqeminal nucleus ++ P +++ P ++++ ++ +++ +++
-lvooalossal Nuclei P P +++ +++
Vaoal nuclei P P ++ ++
nbrior oli\E P +++ +++
Medial reticular furmation ++ P +++ +++
Lateral reticular nuclei P + ++ ++
qrea postrema +++ +++
Data from Table l -2 has been collected fiom the following re ference; ( I ) Delfs et al. ( | 994);
(2) Morwaki et al. ( 1996); (3) Diaz et al. (2000X (4) Mansour et al. ( 1995); (5) Zastawny et al'
(1994); (6) Delay-Goyet et al. ( 1990); (7) Cahill et al. (200l ); (8) Arvidson et al. ( | 995); (9)
Bausch et al (1995); (10) Goody et al. (2002): (l l) Ding et al. (1996).
26
I.3.I OPIOID RECEP''TOR COLOCALISA'TION WITH OTHER RECEPTORS
AND NBUROTRANSMITTERS
OpRs colocalise with opioid peptides. other neurotransmitters, and ion channels (Bausch et
al., 1995b; Ding et al., 1995; Gracy et al., 1997b Gray et al., 1999; Aicher et al., 2000a;
Huang et al., 2000; Stasinopoulos et al.. 2000; Taki et al., 2000; Barry et al., 2001).
Colocalisation in specific brain regions helps to elucidate the specific functions of OpRs in
these areas. For example, in the cerebral cortex. olfactory nucleus, nucleus accumbens,
substantia nigra, hippocampus, thalamus, locus coeruleus, reticular nucleus, vestibular
nucleus, and trigeminal nucleus, MOR is colocalised with Kn channels (Bausch et al.,
1995b) and acts on postsynaptic sites to inhibit neuronal fidng through the opening of
these channels (Hampson et al., 2000). Recently, GIRK knockout mice were shown to
have impaired morphine-induced analgesia (Ikeda et al., 2002). Knowledge of the spatial
distribution and regulatory properties of OpRs may contribute to the development ol'an
opioid analgesic with fewer adverse side effects, provided that opioid peptides can be
targeted to specific regions.
MOR is also often colocalised with neurokinin I (or substance P) receptors (NKIr) in the
dorsal horn of the Spc (Ding et al., l'99-5; Aicher et al., 2000a) where the dorsal horn
receives input from the PAG (Fields and Heinricher, 198-5). This input modulates
antinociception and plays an important role in opioid-mediated analgesia (Kalvuzhny et al.,
1996). Brainstem regions showing colocalisation of NKlr and MOR include the spinal
trigeminal tract (STT) (Aicher et al., 2000a), nucleus of the solitary tract (NTS) (Laferridre
et al., 2003), and the pre-Bdtzinger complex (preBOtC) of the brainstem (Gray et al., 1999),
the latter a region believed to be responsible for generating respiratory rhythm (for review
see)(Rekling and Feldman, 1998; St. John, 1998; Lipski et al., 2002). Usually, NKlr and
MOR are cotocalised at postsynaptic sites on dendrites. Opioids have also been implicated
in the release of substance P from cultured dorsul root ganglion neurons (Suarez-Roca and
Maixner, 1995). MOR colocalises with N-methyl-D-aspartate (NMDA)-type glutamate
receptors in the rat NTS (Huang et al., 2000) and in other brain regions (Gracy et al.,
1997a) and is believed to have a role in the presynaptic modulation of 
-qlutamate release in
these areas (Aicher et al,, 2000b). The colocalisation of MOR with glutamate receptol's
may be involved in the decrease in arterial pressure and heart rate produced on exposure to
opioid ligands (Miyawaki et al., 2002). In the cerebral conex of the rat, MOR is expressed
on GABAergic neurons (Taki et al., 2000), and MOR is present in the NTS in areas where
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ercetylcholinesterase-positive neurons are located (Barry et al., 2001). In the rostral
ventrolateral medulla (RVLM) of the rat. DOR immunoreactive boutons appose
catecholaminergic neurons (Stasinopoulos et al., 2000).
In addition to colocalising with other rcceptors and neurotransmitters, OpRs also colocalise
with sites of opioid peptide synthesis in many brain regions. In the periaqueductal gray
(PAG) of the rat SpC, DOR is present in enkephalin-positive neurons (Commons et al.,
2001) and is postulated to act as a presynaptic autoreceptor. ln the caudate putaman
nucleus of the basal ganglion, MOR colocalises with leu-enkephalin in both axons and
dendrites (Wang et al., 1996). In the cerebral cortex, it colocalises with preproenkephalin-
producing neurons (Taki et al., 2000).
1.3.2 DEVELOPMENTAL OPIOID RECEPTOR EXPRESSION AND
DISTRIBUTION
OpRs are expressed in different regions of the brain and at different expression levels
during growth and maturation. Opioid receptors appear first in the brainstem and later in
the striatum, midbrain and cortex (Coyle and Peft, 1976). Studies of OpR expression in the
foetus and early postnatal rodent have shown that MOR and KOR first appear around El I
to El5. DOR appears later, not normally being detected until early postnatal development
(Spain et al., 1985; Tavani et al., 1985; Petrillo et al., 1987), although in one study in the
mouse, DOR was first detected at El3 (Zhu et al., 1998). Detection of OpR expression
varies with the sensitivity of the techniques used (Tsang et al., 1982; Villiger et al., 1982;
Kornblum et al.. 1987; Attali et al., 1990; Xia and Haddad, l99l; Zhu et al., 1998). More
recent techniques that make use of specific antibody binding and nucleic acid hybridisation
are more sensitive and can pick up lower expression levels than radioligand binding
techniques. 'fhese distinct and repeutable ontogenic profiles of OpR expression in
different brain regions suggest that opioids are important in the development of neural
pathways. A naloxone-reversible B-endorphin effect on circulating growth hormone has
been described in the foetal ovine brain, suggesting the presence of functional opioid
receptors in the foetus that control release of growth hotmone (Gluckman et al., 1980).
Opioids are expressed in the CNS of all mammals at birth, and administration of opioid
agonists in neonates causes marked et'fbcts on respiratory and cardiovascular activities
(Moss et al., 1993a, b: Murphey and Olsen, 1994; Grcer et al., 1995; Takita et al., 1998;
Colman and Miller,200l; Colman and Miller, 2002). This suggests that OpR modulation
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is present and tunctional at birth. Opioid agonist exposure befbre birth has important
implications in cardiorespiratory function with regard to the increased risk of respiratory
arrest in newborns (Chavez et al., 1979: Kandall et al.. 1993). Variations in OpR
sensitivities to particular agonists and antagonists occur during development, especially in
the first few weeks after birth (Spain et al., 1985). These variations in sensitivity may be
related to OpR expression levels and neuronal maturation of brainstem nuclei. The
detailed effect that opioids have on respiration during development is discussed later in this
chapter,
1.3.3 DEVELOPMENT OF THE RAT BRAINSTEM
At birth, the rat brain is very similar in morphology to that of the adult rat, and nearly all
structures can be recognised from a familiarity with the adult rat brain. In the foetal brain,
however, fewer nuclei are distinguishable, and the boundaries of the nuclei are less
distinguishable in stained sections. Figure 1.4 compares brainstem structures of the rat at
El6 with the adult (Paxinos and Watson. 1986: Paxinos et al., 1994). In the medullary
raphe nucleus, a region that shows OpR expression in the adult (Delfs et al., 1994,
Mansour et al., 1995; Moriwaki et al., 1996: Cahill et al., 2001b; Diaz et al', 2002), 5-HT-
positive neurons synthesise neurotransmitter at El3 and receive synaptic contacts by E20
(Lidov and Molliver, 1982). At El2, the posterior neuropore closes and several brainstem
regions, including the reticular formation and medullary regions, send projections to the
SpC (de Boer-van Huizen and ten Donkelaar, 1999). ln intact brainstem preparations from
El2 foetuses, spontaneous action potentials can be detected in the medial and lateral
brainstem regions. These action potentials are believed to arise from motorneuronal
responses in the dorsal motor nucleus of the vagus and sensory nerve inputs from the NTS
(Momose-Sato et al., 2001).
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Figure 1.4
Anatomy of brainstem nuclei
Schematic pictures of El6 (A), and adult (B) coronal sections of the rat brainstem. showing
locations of specific brainstem regions. Scals Bars : 1.3 mm (A) and 4 mm (B). Abbreviations:
nucleus of the solitary nact (NTS): dorsal motor nucleus of the vagus (12); medial longitudinal
fasiculus (mlf); raphe nucleus (R); gigantocellular reticular nuclei (Gi); pyramidal tract (Py);
inferior olive (lO); lateral para-gigantocellular nuclei (LPCi); spinal nigeminal tract and nuclei
(STT): nucleus ambiguus (NA): spinat vestibular nuclei (SpVe); external cuneate nucleus (ECu):
rostral ventrolateral medulla (RVLM); and medial vestibular nucleus (MVe).
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Most neurons in the NTS and vagal nucleus undergo their final mitotic division between
E10 and El5 (Altman and Bayer, 19801 Phelps et al., 1990; Lakke, 1997) with a peak at
813: whereas, neurons in the NA finish dividing at El5. The acquisition of neuronal
properties during development is described by Momose-Sato et al. (2001) (Momose-Sato
et al., 2001). As El3 and E14 neurons mature, more multipolar cells appear and the cells
become larger in size (de Boer-van Huizen and ten Donkelaar, 1999). At developmental
age Et5 in the rat, the neural tube undergoes a marked increase in thickness, especially in
the rostral brainstem, and neural migration is apparent. At El5, several nuclei are easily
identifiable, including the hypoglossal and tngeminal nuclei. There is also a marked daily
incrcase in cell volume and cell number. At El6. more brainstem nuclei can be identified
in the spinal trigeminal tract and nucleus (STT), inferior olive, NA, NTS, and facial
nucleus, although the characteristic shapes and boundaries of these brainstem nuclei do not
become apparent until El9 (Lidov and Molliver, 1982). The caudal medullary regions are
more highly innervated early in development than the more rostral brainstem regions, such
as the pons, although the STT and reticular areas appear to be devoid of terminals at El6
(Lidov and Molliver, 1982).
In late embryonic development there is an increase in growth of neuronal processes.
Brainstem projections can be seen in the lurnbar SpC of the El7 to E2l rat, emanating
from many brainstem nuclei, including the NA and NTS (Lakke, 1997). After E19, there
is an increase in dendritic growth and a decrease in cellular packing density (Lidov and
Molliver, 1982). In the neonate there are postnatal changes in neurotransmitter and
receptor densities that influence neuronal lunctions (Bayliss et al., 1997; Moss and
Lafenidre, 2002). At birth it is necessary tbr many brainstem nuclei to be functional for
survival, including the brainstem nuclei responsible for breathing (Mitchel and Berger,
1975), swallowing, and suckling (Sessle,1973: Nakamura et al., 1999). The rat at bifth is
relatively immature; hence, other functions such as eye and limb movements develop later
in postnatal development (Vinay et al.,2000; Freeman and Nicholson,200l). The
development and maturation of breathing and the respiratory system will be discussed later
in this chapter.
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1.3.4 FUNCTION OF OPIOIDS IN THE BRAINSTEM
The brainstem has an important role in the integration and control of numerous essential
physiological functions, including control of the somatic and autonomic nervous systems.
These functions are modulated by endogenous opioid peptides but can also be affected by
administration of exogenous opioids (Denavit-Saubie et al., 1978; Harlan et al., 1987).
Brainstem functions that are affected by the opioid system include the generation and
modulation of respiratory movements and chemoreception, cardiovascular activity,
gastrointestinal tract motility and digestion, transmission of pain, modulation o[ arousal
and consciousness, modulation of sensory motol pathways, control of reflexes mediated by
cranial nerves, taste, hearing and maintenance of balance, temperature regulation, and
swaflowing and control of the face and neck muscles (Sessle, 1973: Feuerstein, 1985;
Fields and Heinricher, 1985; Punnen and Sapuru, 1986: Adler and Geller, 1988; Wang and
Li, 1988; Shook et al., 1990; Wind and Kuhin, 199-5; Sz.ilagyi. 1998; Llewellyn-Smith,
2000; Tershner and Helmstetter,2000; Vanderah et al.,2001). For rcviews on the
functional role of opioids in these physiological systems, see Vaccarino (1999;2001) and
Olson (1995; 1997) (Olsen et al., 1995; Olson et al., 1997; Vaccarino et al., 1999;
Vaccarino and Kastin, 2001 ).
Studying brainstem areas that express OpRs helps in the understanding of the functional
implications of these receptors and their peptides and provides a rationale for the
differential distribution of receptors and their peptides in different brain regions. Further
information on the role OpRs play in regulating function carn be gained from genetically
modifled mice that lack specific OpRs (knockout mice). Genes encoding all the
components of the opioid system have been disrupted in mice by homologous
rccombination (Matthes et al., 1998; Kieffer, 1999: Chen et al., 2000; Kieffer and
Gavddaux-Ruff, 2002). All these mutated mice, including double-knockouts as well, reach
adulthood with no obvious abnormalities, suggesting that OpRs are not essential for
normal development. tt is possible that redundancy is built into opioid functions itt t,ivo,
such that the action of one receptor type can be taken over by another. As described
earlier, in the single-knockout mouse, the remaining OpR expression levels remain
unchanged, suggesting that the absence of one OpR is not compensated tbr by an increuse
in expression levels of other OpR types (Kitchen et al., 19971 Simonin et a1.,2001).
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Increased receptor coupling of the other OpRs (Matthes et al., 1998), or enhanced ligand
expression levels, also appear not to be involvcd (Matthes et al., 1996).
Respiratory function in mice lacking MOR showed no significant dift-erences in respiratory
rhythm generation, ventilatory pattern. or chemosensitivity control when compared with
wild-type mice (Matthes et al., 1998: Morin-Surun et a|.,2001). These results suggest that
MOR does not play a direct or essentinl role in the development and maturation of the
neural respiratory pathways. Respiratory parameters, however, have not been evaluated in
DOR or KOR knockouts or in double-knockouts. Another possibility is that gene
knockout can lead to a compensatory upregulation of other genes that can maintain the
function normally associated with the gene of interest. MOR and KOR action are known
to influence analgesia, and, as expected, both MOR and KOR single-knockout mice show a
reduced threshold to pain (Matthes et al., 1996; Matthes et al., 1998; Park et al., 2001). In
a study of MOR knockout mice, Matthes et al. (1996) tound that morphine was unable to
induce analgesia, reward, or physical dependence (Matthes et al., 1996). The effects of
morphine on respiratory depression and immunosuppression were also absent in these
mice, demonstrating that these ef'fects of morphine are encoded for by the MOR gene
(Matthes et al., 1996). In these same mice, it was also shown that the response of mice to
KOR agonist-induced analgesia and KOR adenylyl cyclase inhibition were maintained in
the MOR knockout mouse. Reduced DOR analgesia and the absence of DOR-mediated
respiratory depression, however, were observed in the MOR knockout mouse, suggesting a
link between the actions of MOR and DOR; rvhereas, MOR and KOR act independently of
each other in vivo (Matthes et al., 1998).
Brainstem areas with high expression pattems for both MOR and DOR include the NTS
(Atweh and Kuhar, 1977; Mansouret al., l9t)4; Mansouret al., 1995; Cheng et al., 1996;
Gamboa-Esteves et a1.,2001), NA (Atweh and Kuhar, 1977; Nomura et al., 1996;
Stasinopoulos et al., 2000), rostral ventrolateral medulla (RVLM) (Gray et al., 1999;
Stasinopoulos et al., 2000; Aicher et al.. 2001; Guyenet et al., 2002; Wang and
Wessendorf ,2002), and STT (Kandel et al., 2000; Stasinopoulos et al., 2000), as described
earlier in this chapter and summarised in Table 1.2. The functions of these brainstem
regions and the implications of OpR localisation are discussed below, with emphasis on
opioid systems involved in cardiorespiratory rnodulation and pain control, The SpC shows
high levels of MOR and DOR in the dorsal horn (Cheng et al., 1997), which sends
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projections to brainstem ilreas. The outer layer of the STT contains fibre tracts that are a
continuation of the superficial laminae of the dorsal horn extended into the medulla. The
spinal trigeminal nucleus receives sensory fibres from all of the cranial nerves of the head,
including the facial nerve, glossopharyngeal nerve, and vagal nerve (Kandel et al., 2000),
and in these areas opioids may be involved in modulation of such functions as taste, tongue
movements and swallowing (Sessel et al., l98l; Sessle and Henry, 1989).
1.3.4,1 Opioid Receptor Function in the RVLM and NA
The RVLM is located around the NA and contains a pool of mixed motor neurons that
have functions in respiration, vocalisation, and vomiting. This brainstem region contains
the decrementing expiratory neurons of the Bcltzinger complex (BOIC). When these
neurons are labelled with neurobiotin in the ventral respiratory group of the rat, they show
axonaf proiections to other respiratory areas in the medulla and SpC (Saito et al., 2002),
supporting the findings of previous electrophysiological and morphological studies (Bryant
et al., 1993). The central control of breathing has been extensively reviewed (Mitchel and
Berger, 1975; Loeschcke, 1982; Yeadon and Kitchen, 1989; Bianchi et al., 1995; Bonham,
199-5: Rekling and Feldman, 1998: St. John, 1998; Butera et al., 1999; Ballantyne and
Scheid, 2000; Lipski et al., 2002). Opiltes like morphine. commonly used in the relief of
pain, often cause nausea and vomiting as unwanted side effects (Olson et al., 1997:
Vaccarino et al., 1999; Vaccarino and Kastin.200l), and it is possible these opioid eft-ects
are modulated by neurons in these brainstem areas. The NA contains motorneurons that
innervate pharyngeal muscles through branches of the vagus nerve and the larynx via
laryngeal nerves (lscoe, 1988); whercas, hypoglossal motorneurons are involved in tongue
protrusion during inspiration (Iscoe, 1988). Axons from the NA motorneurons typically
run dorsally toward the vagus nerve (No. l0) and hypoglossal nerve (No. 12) before
turning and heading ventrally (Saito et al., 2002). The vagus and hypoglossal nuclei in the
brainstem express MOR (Delfs et al., 1994; Nomura et al., 1996) and DOR (Arvidsson et
al., 1995a; Bausch et al., 1995a) and may be a site for opioid effects on swallowing (Sessle
and Henry, 1989).
1.3.4.2 Function of Opioids in the NTS
The NTS shows marked opioid peptide (Ceccatelli et al., 1992; Cheng et al., 1996) and
OpR immunoreactivity (Mansour et al., 1987, 1988; Ceccatelli et al., 1989; Cheng et al.,
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1996). The NTS is part of the dorsal respiratory group and rec,eives projections from
spinal cord fibers of the dorsal horn (Gamboa-Esteves et al.,2001). The NTS is a sensory
nucleus dedicated to processing visceral inpirt trom all the major organs, including the
heart, lungs, and abdominal visera (Lau'rence and Jan'ott,1996). The peripheral afferent
information from baroreceptors and chemoreceptors, together with inputs fiom higher
brain centers, is integrated in the NTS, and the final reflex response is determined and
directed to medullary neurons that rcgulate sympathetic and parasympathetic outflow. The
NTS is also involved in descending pain control via neurons that send projections to the
NA (Lewis, 1998). OpRs in the NTS aff-ect cardiopulmonary, gastrointestinal, and cortical
arousal activities (Cheng et al., 1996), and these functions are mainly modulated via the
MOR receptor (Ruegg et al., 1994). In the NTS, immunogold-labelling experiments
showed that MOR was present in both presynaptic vagal afferent axon tetminals and
postsynaptic dendrites but was rarely lbund in both sites in the same neuron (Aicher et al.,
2000b). These results suggest that MOR ligands modulate either the presynaptic release
from or the postsynaptic response to vagal aff'erents in the NTS. The vagal afferents ale
likely to include the inhibitory neurolls and gastric and cardiorespiratory afferents that
terminate in regions of the NTS that have MOR immunoreactivity (Cheng et al., 1996).
Electron microscope studies indicate that MOR is colocalised with NMDA receptors in the
rostral NTS where MOR acts postsynaptically to modulate excitation via these NMDA
receptors (Huang et al., 2000). In the intermediate NTS, MOR activation inhibits
presynaptic release of glutamate from visceral afferents, thus, reducing neuron excitability
(Huang et al., 2000). Opioid administration reduces the urge to cough (Rutherford et al.,
2002), causes vomiting (Fl6rez and Hurld. t993), and influences taste and f'eeding
responses in rats via MOR activation in the NTS (Kotz et al., 1997). These opioid effects
possibly occur via sensory fibres in the throat that terminate in the NTS, as well as via
connections to the vomiting centre in the hypothalamus.
1.3.5 EFFECTS OF OPIOIDS ON THE CARDIOVASCULAR SYSTEM
1.3.5.1 Cardiovascular Effects of Opioids in the RVLM and NA
The opioid signalling system in the brainstem plays a role in the medullospinal network
that controls sympathetic tone and arterial pressure. In the RVLM, this occurs via both
pre- and postsynaptic modulation of neurons on exposure to MOR agonists (Huang et al.,
2000), and presynaptic modulations on exposure to DOR agonists (Guyenet et al., 2002).
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The presynaptic OpR effects are inhibitory, causing a reduction in glutamate release that
leads to reduced neuronal firing. DOR activation in the RVLM modulates cardiovascular
reflexes by inhibiting neurotransmitter release from axon terminals of neurons that synapse
with presympathetic neurons. Microiniection of various opioid receptor agonists into the
RVLM produces hypotension (Punnen and Sapuru, 1986), and the overall action of opioids
in this area is to inhibit presynaptic sites, causing a fall in blood pressure (Feuerstein, 1985;
Punnen and Sapuru, 1986: Miyawaki et al., 2002: Pugsley, 2002). A recent study by
Miyawaki et al. (2002) has shown that microinjection of a MOR-selective agonist
(DAMGO) into the RVLM selectively blocks baroreceptor reflexes. DOR activation with
a selective agonist (DPDPE) in some cells inhibits respiratory-related neuronal burst
patterns; whereas, no effect on baroreceptor or chemoreceptor reflexes was seen in other
cells (Miyawaki et a1.,2002). These results suggest that opioid peptides in the RVLM act
on distinct OpR populations at presynaptic sites.
1.3.5.2 Cardiovascular Effects of Opioids in the NTS
Opioid peptides in the NTS mediate complex cardiovascular events. Almost all visceral
aft'erent projections that relay information to the brain about the status of peripheral
cardiovascular functions terminate in the NTS (Brody, 1986). Met-enkephalin, when
injected into the NTS, causes bradycardia and a decrease in blood pressure (Rabkin, l99l).
In this brainstem region there seems to be opposing actions of KOR and MOR on the
control of the baroreceptor heart rate reflex when selective agonists are microinjected into
the NTS. Agonist activation of DOR causes a vagus-dependent bradycardia (Randich et
al., 1992); whereas, the MOR selective agonist. DAMGO, when injected into the NTS
produces hypertension and tachycardia (Hassen et al., 1982). In whole cell patch clamp
experiments, MOR agonists were shown to cause hyperpolarisation of NTS neurons by
acting at presynaptic sites, leading to a depression of glutamate-mediated excitatory post-
synaptic potentials (Rhim et al., l993Xtbr review see) (Lawrence and Jarrott, 1996).
1.3.6 EFFECT OF OPIOIDS ON RESPIRATION
OpRs are highly exprcssed in certain brainstem regions responsible for the generation
and/or modulation of respiratory rhythm (for review, see (Bianchi et al., 1995)).
Exogenous administration of opioids directly al'l'ects the rate of respiration in all mammals
studied [Gray, 1999 #321; Liu, 2000 #567: Moss, 2000 #568; Shook, 1990 #7 43; (Denavit-
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Saubfe et al., 1978; Ling et al., 1985: Sessle and Henry, 1985; Neubauer et al., 1987;
Yeadon and Kitchen, 1989; Paakkari et al.. 1990; Moss et al., 1993a, b; Murphey and
Olsen, 1994; Kato, 1998: Laferridre et al.. 19991 Colman and Miller,200l;Morin-Surun et
a|.,2001). The specific effects opioids have on respiration depended on the OpR subtype
activated (Yeadon and Kitchen, 1989). KORs appear to be devoid of respiratory
depressant activity, DOR exerts modest respiratory depressant effects, and MOR exefts a
strong inhibitory influence on ventilation. Studies have shown that administration of
opioids in neonatal, juvenile and adult rats causes a decrcase in the rate of respiration and a
f all in tidal volume via activation of both p1 and p2 rcceptors (Colman and Miller, 2001).
1.3.6.1 Respiratory Rhythm Generation
The pons and medulla of the brainstem contains several areas with respiratory function.
The medullary respiratory regions can be further divided into the dorsal respiratory group
(DRG) and ventral respiratory group (VRG). For a review, see (St. John, 1998). The DRG
gloup is made up of the ventrolateral NTS and adjacent parts of the reticular formation
including the nuclei of the cranial nerves and contains neurons that display an inspiratory
discharge pattern. The VRG. shown in sagittal section in Figure 1.5, is made up of the NA,
RVLM, preBdtC, BdtC, and facial nuclei and contains neurons with mixed discharge
patterns (St. John, 1996). The BdtC is a group of neurons located near the rostral end of
rhe NA in the VRG, and motorneurons and interneurons within this region are active
during expiration (Bryant et al., 1993). The pleBritC is located in the ventrolateral medulla
(VLM) caudal to the BdtC and is the postulated site of the respiratory rhythm generator in
mammals (Smith et al., l99l). Others, however, suggest that the discharge pattern from
this area more closely resembles gasping (St. John, 1996, t998). An alternative theory of
respiratory rhythm generation, the network theory, suggests that a network of
interconnecting, pre-sympathetic RVLM neurons are involved. [t is possible that a
combination of these two systems may generate the respiratory rhythm. Respiratory
rhythm generation has been reviewed by Funk and Feldman (1995) and Lipski et al. (2002)
(Funk irnd Feldman, 1995; Lipski et al., 2002). A recent study by Del Negro et al. (2002)
shows that abolishing pacenraker neurons with low doses (less than 20 pM) of riluzole (a
sodium channel antagonist used to abolish bursting activity) has no effect on the
respiratory rhythm in neonatal slice preparations of the mouse and rat, thus, suggesting an
emergent network property (Del Negro et al., 2002). The preBdtC, in tissue slice
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preparations taken from neonatal rats, generates respiratory-related motor nerve output
(Smith et al., l99l). Excitatory interneurons also show intrinsic pacemaker-like properties
(Rekling and Feldman, 1998). Respiratory related areas, especially the preBOtC, do not
have precise anatomical boundaries. A study by Gray et al. (1999) reported that preBotC
neurons responsible for rhythmogenesis were immunoreactive for both MOR and
neurokinin-l receptors (NKlr). This finding has helped to anatomically define the location
of the preBdtC (Gray et al., 1999). MOR agonists applied to the preBdtC in tissue slice
preparations cause a decrease in rcspiratory t'requency (Johnson et al., 1996) by
hyperpolarising the membrane via an incrcasc in K" conductance (Gray et al., 1999) in a
similar way to that observed in the intact animal (Bonham, 199-5). MOR and NKlr
positive neurons in the preBcitC are depolarised by substance P and thyrotrophic hotmone
(Rekling et al., 1996) and hyperpolarized by MOR agonists such as DAMGO. These
neurons are believed to be responsible for both rhythm generation and respiratory
frequency control (Rekling and Feldman, 1998).
1.3.6.2 Modulation of Respiration
The endogenous opioid peptides, cnkephalin and dynorphin, have been implicated in
central respiratory control (Rutherfurd and Gundlach, 1993). The NTS is part of the dorsal
respiratory group (DRG), which has for a long time been implicated in respiration.
Different types of respiratory neurons in this region have been classified according to their
firing properties (Berger, 1977; Berger et al., 1984). Discrete areas lvithin the brainstem
are linked via neural processes, and modulation of neurons in one arca transmits signals to
modulate neuronal activity in other areas. This is especially apparent in the brainstem
areas involved in respiratory and cardiovascular control. In the rat, inspiratory neurons in
the VRG project to the NTS (Lipski et al., 1994), Respiratory related neurons in the NA
receive chemorcceptor inputs from other VRG nuclei, the NTS, and the caudal raphe
nucleus (Smith et al., 1989; lrwis, 1998; Wang et al., 1998), and have been implicated in
NA-mediated respiratory modulation. Both the NTS and the raphe nuclei also provide
OpR inputs to the RVLM (Stasinopoulos et ul., 2000).
The primary muscle of inspiration is the diaphragm. a flat sheet of muscle that forms the
lower boundary of the thorax and is innervated by the phrenic nerves. Motorneurons
projectin-e to muscles of the chest wall and abdomen are located in the SpC and are
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controlled by respiratory centers in the brainstem. Ventilatory aotivjty can be modulated in
multiple regions of the brainstem. O.ne group of regions havtng nenrons with respiratory-
modulated discharge patterns are *il-e nucloi of the cranial nerves V, VII, D(, X, and XII.
These cranial nerves innervate r1usele.s of the upper airway and larynx (for review see)
(Iscoe, l98S). Some of the cranial Rulclei, as nrentioned above, also express OpRs,
including the faEial nuclci (Vil), vagus (X) and hypoglossal nr,rclei (KI) (Delfs el al.,
1994; Arvidsson et al." 1995a; Baueeh et al., 1995a), thus, pnoviding more putative
locations for p.ossible OpR modulation of brainstem functi@.
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Brainstem Reopirdo,qy'Contcrc of tte Venr*I Rospiratory Group
,sehernatie diagram ofuur* rat brainstem in sagittal seetion, showing the
location of resp.iratory areas. Modified trom Gray er al, ( 1999L
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1.3.6.3 Chemosensitivity
The respiratory system is extremely responsive to acid/base changes in the plasma and
cerebrospinal fluid (CSF). Chemosensitivity arises at the cellular level from the activity of
specialised glomus cells in the carotid body and via central chemoreceptors located within
brainstem nuclei and in the ventral floor ol' the medulla. These peripheral and central
chemoreceptors can communicate with each other. For example, efferent fibres in the
carotid nerve innervnte glomus cells within the carotid body, and sensory afferents synapse
with relay neurons in the NTS and nuclei within the VRG (Finley and Katz, 1992). Irt
vitro exper"iments using brainstem slices have identified neurons within many brainstem
nuclei that increase their firing rate when exposed to acidosis. These neurons are found in
the NTS, locus coeruleus, medullary raphe nucleus, and the NA (Rigatto et al., 1992). This
arrangement suggests that central respiratory chemoreception is a distributed ploperty of
the respiratory network; although, in some cases, CO2 changes needed to elicit a response
have been outside the concentration range expected to occur in vivo (Wang et al., 1998).
Chemosensitive neurons show unique molphologies. with neurons stimulated by CO2
having large multipolar somas, whereas, CO:-inhibited neurons having small fusiform
somas. Only neurons in a limited number of brainstem regions respond to the small
changes in CO: that typically occur under physiological conditions. These findings
suggest that not all chemoreceptors play an equal role in respiratory chemoreception
(Wang et al., 1998).
Medull:uy raphe nuclei contain putative central respiratory chemoreceptors and also
express OpRs (Delfs et al., 1994; Mansouret al., 1994; Moriwaki et al., 1996;Diaz et al..
2000; Cahill et al.,200lb). Medullary raphe neurons project to several respiratory nuclei.
includin-e the NTS, NA, and RVLM, and all these regions express MOR and DOR. It
seems likely, therefore, that OpRs modulate the chemosensitivity of neurons within the
brainstem. Abnormalities in the hunran homologue of the medullary raphe have been
reported in infants who died of sudden infant death syndrome (Kinney et al., 1995). These
findings have been linked to a decrease in respiratory drive and/or arousal in response to a
hypercapnic stimulation during sleep. A decrease in respiratory drive and response tc
hypoxia is ulso a characteristic of OpR activation, su-sgesting a possible link between the
two systems. For example, OpR activation by morphine in awake, unrestrained rats causes
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a decrease in sensitivity of the COz controller. This was observed as a blunted respiratory
response to a hypercapnic stimulus (Van Den Hoogen and Colpaert, 1996).
In the rostral pons and medulla oblongata, MOR activation causes respiratory depression
by decreasing chemoreceptor sensitivity to hypercapnia (Murphey and Olsen, 1994).
Long-term exposurc to hypoxia can also cause alterations in OpR expression patterns. For
example, rats exposed to hypoxia for 7 days show decreased DOR expression in the brain.
This finding suggests that DOR agonists play a protective role in chronic hypoxia
(Mayfield et al., 1996). A significant role lbr endogenous opioids in the modulation of
respiration is also supported by studies in the piglet by Moss et al. (1981) who showed that
p-endorphin caused a naloxone-reversible decrease in respiratory drive and reduces the
sensitivity of breathing to hypercapnic stimuli (Moss and Scarpelli, l98l ).
I.3.7 EFFECT OF OPIOIDS DURING DEVELOPMENT
The respiratory neural network in the brainstem undergoes maturation after birth (Funk and
Feldman, 1995), but the circuitry for generating respiration is established before birth (St.
John, 1998). Spinal and brainstem motomeurons are coupled in the NA in early
development of the newborn mouse (Rekling and Feldman, 1997) in a similar way to the
adult, suggesting that this circuitry develops early.
Centrally administered morphine at low doses stimulates, and at high doses decreases,
foetal breathing movements (Szeto et al., 1988). At birth, breathing must become
continuous, and several mechanisms have been postulated to be involved in this process,
including the loss of a placental inhibitor of respiration at birth or a sudden alteration in
blood/gas levels. The individual imponance of these two factors remains controversial
(Rigatto, 1996; Kuipers et al., 1997). Respiratory output patterns are irregular at birth, and
regular rhythmicity is not established until days or weeks after birth, depending on the
species under investigation (Mortola. 1984).
Both MOR and DOR help maintain nonnal foetal (Cheng et al., 1993a) and neonatal
(Grunstein and Grunstein, 1982) breathing movements, although the panicular receptor
sub-types involved in stimulatory and depressant ef'fects are controversial (Moss anc;
Scarpelli, 1979; Cheng et al., l99l; Cheng er al., 1992; Cheng et al., 1993b). In neonates
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opioids are associated with respiratory depression, mainly via MOR, although some DOR
modulation has also been repofied, similarly to that seen in adult animals. For example, in
conscious neonatal rabbits the DOR agonist DALDE reduces ventilation (Grunstein and
Grunstein, 1982). Similar DOR effects were shown in conscious neonatal rats in one study
(Greer et al., 1995) but were not seen in conscious neonatal rats in another study (Atalie
Colman, unpublished observations). MOR respiratory effects in young mamnrals are more
clearly established. In conscious neonatal dogs. the MOR-selective agonist fentanyl
caused a decrease in the frequency of breathing (Brage et al., 1995). In conscious,
unanaesthetised, neonatal rats, fentanyl administration led to a tiequency change that
resembled a gasping response, and this change was shown to involve p1 receptorsi
whereas, a general reduction in tidal volume occured via [r: receptors. A blunted response
to hypoxia was also seen in consci<lus rat pups (Colman and Miller, 2002). The OpR
antagonist, naloxone, when administered to conscious neonatal rats, caused an
enhancement in breathing at rest (Hazinski et al., 1981); whereas, the DOR-specific
antagonist, naltrindole, had no effect in neonatal piglets (Moss et al., 1993a), suggesting
that endogenous MOR-selective agonists arc modulating breathing shorrly after birth in the
pig.
The magnitude of the effects of opioids on respiration is increased durin-e hypoxia. This
was demonstrated in a study by Moss et al. (1993), who showed that naltrexone enhanced
the respiratory response to hypoxia in piglets (Moss et al., 1993a). Endogenous opioid
levels, both in the CNS and peripherally, are increased in neonates exposed to hypoxia
(Moss and Inman, 1989: Armstead, 1995: Yan et al., 1995). Long-term hypoxic treatment
(7 days) of adult mice also alters OpR expression levels. DOR expression (but not MOR
or KOR) decreased by down-regulation of receptors us u result of release of endogenous
DOR agonists (Mayfield et al., 1996). Evidence has accumulated that opioids have a
major role in breathing during hypoxia during neonatal development. This hypoxic
modulation presumably occurs via the OpR-expressing regions of the DRG and VRG in a
manner similar to adults. OpR expression changes during development, and modulation ol
OpR functions during development may reflect these changes. Exposure to morphine
dudng fbetal or early neonatal rat development causes a decrease in OpR expression in the
brain. Tolerance to the analgesic efl'ects of morphine appears similarly to that seen in the
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adult, suggesting that the mechanisms for OpR down-regulation are present and functional
at birth (Temple et al., 1988).
I.4 ROLE OF OPIOIDS IN HEALTH AND DISEASB
I.4.I RESPIRATORY RELATED DISEASIIS
The effects of opioids on the respiratory system, although known for a long time, are only
currently being linked to specific physiological rcsponses and pathological conditions. As
stated above, endogenous opioid peptides are involved in the modulation of normal
breathing (Yeadon and Kitchen, 1989: Shook et al., 1990; Morin-Surun et al., 1992:Fl6rez
and Hurl6, 1993) but have also been linked to stress responses in diseases such as sudden
infant death syndrome (SIDS) (Chavez et al., 1979; McMillen, t986; Coqueral et al., 1992;
Storm et al., 1994), sleep apnoea (Ferber er al., 1988; Myer et al., 1990; Shook et al.,
1990), asthma (Rogers and Barnes, 1989), and other chronic obstructive pulmonary
disorders (Fl6rez and Hurld, 1993), Opioids have also been studied in relation to
cardiovascular diseases; in particular, haemorrhage (Bedell et al., 1998; Vaccarino et al.,
1999; Cavun et al., 2001; Henderson et al.. 2002).
1.4.1.1 SrDS
The risk of SIDS increases when infants are unable to, or have compromised ability to,
respond to a stressful stimulus, such as hypoxia. These risks increase with exposure to
opioids and nicotine. A postulated cause of SIDS is the abnormal regulation of opioid
transmission (Morin-Surun et al., 1992). Evidence suppofting the role of opioids in SIDS
includes a study on infants at risk for SIDS. These infants have a reduced central
chemosensitivity and display alveolar hypoventilation (Shannon and Kelly, 1977). During
the first day of life, partially asphyxiated prcterm infants have higher plasma p-endorphin
levels than nonasphyxiated pretem infants. An elevated B-endorphin concentration in the
CSF may be responsible for an incrcased risk of infant apnoea syndrome and its associated
SIDS (Shook et al., 1990; Pokela, 1993; Storm et al., 1994). B-endorphin injected into the
CSF of dogs' causes a respiratory depression that is mediated by central vagal pathways,
shown to be important in the timing of respiration (Moss and Scarpelli, l98l). It has been
suggested that incidences of SIDS may he rclated to exposure to opiates in breast milk,
either arising from opiates prescribed for the mother, or possibly from naturally occurring
opioids present in breast milk (Shook et al., 1990). Foetal bradycardia may also arise fiom
intrathecal opioids prescribed for labour analgesia (Mardirosoff et al., 2002), and this may
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turther complicate the opioid induction of SIDS symptoms. Prenatal methadone or heroin
exposure also increases SIDS risk (Chavez et al., 1979; Kandall et al., 1993). The true role
of opioids in increasing the risk of SIDS is unknown. OpR distributions within the
brainstem cardiorespiratory nuclei of victims of SIDS appear to be normal, suggesting that
OpR dysfunction itself does not play a role (Kinney er al., 1998).
1.4.1.2 Sleep Apnoea
A disease related to SIDS, infant apnoea, is otien refemed to as near-miss SIDS. There arc
many forms of infant apnoea syndrome that can be attributed to abnormally high endorphin
levels, and prenatal exposure to methadone is generally associated with a depressed
response to COz afier birth in human inlhnts (Olsen and Less, 1980). In adult sleep apnoea
sufferers. a rcduction in number, duration, and intensity of hypoxic events occurs if the
patients are given the opioid antagonist naltrexone, suggesting that clpioids play some role
in the development of sleep apnoea (Ferber er al., 1988).
1.4.1.3 Asthma
Opioids are believed to influence responses to asthma, although the mechanism and extent
of their role in this disease remains lalgely unknown. For rccent reviews of opioids and
asthma, see Mazzone and Canning (2OO2) and Groneberg and Fischer (2001) (Groneberg
and Fischer,200l'.Maazone and Canning,2002). Opioids can be detected in the healthy
lung. For example, met-enkephalin immunoreactivity exists in the rat and guinea pig lung
in nerve fibres in the trachea and bronchi (Shimosegawa et al., 1990). In asthma sufferers,
there is damage to the epithelial lining of airways that exposes C-fibres in the bronchial
mucosa. Stimulation of these C-fibres by intlammatory mediators may subsequently lead
to bronchoconstriction and inflammation (Barnes, 1986). In animal models, inhalation of a
MOR agonist inhibits C-fiber activation, although this agonist was not effective in humans
(Pavord et al., 1994). Opioid eff'ects on tlre airways also include inhibition of smooth
muscle contraction and inhibition of neurally-mediated mucous secretion in human bronchi
(Rogers and Barnes, 1989). New studies r.vith the non-classical opioid receptor ORL-l
have shown that activation of this receptor prevents airway constriction; however, eff-ective
therapeutic strategies employing ORL-l drugs have not yet been developed (Groneberg
and Fischer,200l). Chronic exposur€ to opioids by pharmaceutical workers increases the
incidence of bronchial asthma, probably as a result of effects of opioids on the immune
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system (G6rski and Ulinski, 1996). Thus, opioids may influence the progression of asthma
by directly altering mucous secretion and airway responsiveness, or they may indirectly
affect asthma through their ef'fects on immune responses.
I.4.2 HAEMORRHAGE
In addition to their involvement in respiratory disease, endogenous opioids may also play a
role in cardiovascular disease. Opioid receptors are found in the heart, vessels, and areas of
the CNS that regulate cardiovascular function (Hassen et al., 1982; Pfeiff'er et al., 1984;
Feuerstein, 1985; Lawrence and Jarrott, 1996: Miyawaki et al., 2002: Pugsley, 2002). For
example, severe haemorrhage reduces blood volume (direct effect) and suppresses the
activity of the sympathetic nervous system leading to a marked bradycardia
(decompensatory response) and a fall in blood pressure. The exact central mechanism for
the decompensatory response is not understood, although opioids are believed to play a
role. Opioid involvement in haemon'hage wels first observed by Faden and Holaday (1979)
who discovered that intravenous injection of naloxone inhibited the fall in arterial blood
pressure caused by haemorrhage in rats (Faden and Holaday,1979). In the periaqueductal
gray of the SpC, this response is mediated by DOR (Cavun et al., 2001). Fentanyl, a MOR
agonist, when infused into a cat with brain trauma injuries, also produces a decrease in
blood pressure (Bedell et al., 1998; Vaccarino et al., 1999). Another study has shown that
KOR activity in the medulla inhibits sympathetic activity in severe haemorrhage
(Henderson et al., 2OO2). Thus, all three classical receptors, MOR, DOR, and KOR, can
influence the sympathetic control of the cardiovascular system, particularly affecting its
response to haemorrhage. These effects are clinically important with regard to
haemorrhage during surgery because opioids are often used in anaesthesia and for reducing
postoperative pain.
I.4.3 DRUG ADDICTION
Opioids are often used as drugs of abuse because of their ability to produce euphoria.
Chronic use, however, results in tolerance and addiction, and opioid overdose often results
in death from severe respiratory depression (White and Irvine, 1999). OpR down-
regulation and desensitisation on exposure to opioids have been discussed earlier in this
chapter. Briefly, chronic exposure to opioids causes down-regulation and rcduced OpR
density (Prathert et al., 1994; Trapaidze et al.. 1996; Gaudriault et al., 1997' Standifer and
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Pasternak, 1997t Massotte and Kieffer, 19981 Law and Loh, 1999). There is also a
decrease in the synthesis of endogenous opioids [Fang, 1998 #1120, suggesting a negative
f'eedback system, as well as alterations in gene regulation. Behaviourally, chronic opioid
administration produces tolerance through the action of N-methyl-D-aspartate (NMDA)
receptors and serotonergic systems (Vaccarino et al., 1999). Chronic opioid administration
also results in dependence and addiction. as observed by opiate withdrawal symptoms that
include aches and pains, changes in respiration, sweating, and tremors. MOR mediates
most of the analgesic effects of morphine, although DOR also plays a role (Quock et al.,
1999). The exact mechanism of addiction and tolerance are not well understood and
involve both cellular and behavioural changes (Koob and Moal, 1997; Nestler and
Aghajanian , 1997', Vaccarino e[ al., 1999: Vaccarino and Kastin, 2001).
There appears to be a genetic predisposition fbr drug abuse. People who show a
predisposition to drug abuse sometimes have polymorphisms in genes for the opioid
peptides and receptors (Bond et al., 1998t Mayer and Hcillt, 2001). In a study by Bond et
al. (1998) five single nucleotide polymorphisms (SNPs) in the MOR coding region were
found in heroin addicts. One of the SNPs in the MOR gene showed enhanced responses to
B-endorphin when the mutated protein was expressed in cell lines, due to increased binding
affinity of B-endorphin for MOR (Bond et al.. 1998; Mayer and Hdllt. 2001).
1.4.4 THE ROLE OF THE BRAINSTE]VT AND OPIOIDS IN PAIN CONTROL
Opioids play an important role in stress-induced analgesia, being implicated in childbirth,
exercise, and conflict or threat (Olson et al., 1997; Vaccarino et al., 1999; Vaccarino and
Kastin, 2001). In a study in which mice rvere exposed to biting flies, opioid-mediated
analgesia (measured by naloxone sensitivity) developed within 30 min (Kavaliers et al.,
1998), although not all stress-induced analgesia was reversible by naloxone (Fields and
Heinricher, 1985). The degree of opioid-mediated analgesia varied with the sex of the
subject, being greaterin males than f'emales (Kavaliers et al., 1998). The neural pathways
by which stress-induced analgesia occurs have been extensively studied, although the exact
mechanisms rcmain unknown. Several brain regions and OpR subtypes have been
implicated in pain control (Vaccarino et al., 1999; Vaccarino and Kastin,200l).
Stimulation of the PAG, an area that expresses high levels of MOR. DOR and KOR
(Gutstein et al., 1998: Commons et al.,2001) reduces the severity of clinical pain in
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humans (Fields and Heinricher, 1985). The PAG receives input from the cortex and sends
projections to the RVLM, which in turn sends projections to the dorsal hom of the SpC.
At each of these integrative levels. there are enkephalin-containing interneurons that
express MOR and DOR (Commons et a1.,2001). SpC neurons also project rostrally to
terminate at medullary and midbrain regions and play an imponant role in analgesia. The
SpC is the point of entrance of nociceptive sensory information and is an important site for
antinociception by MOR and DOR agonists (Cheng et al., 1995b). Clinically, morphine is
one of the most widely used drugs fbr the relief of pain, and is often used for pain relief
after surgery, during labour, and for cancer sufferers. Opioids modulate analgesia by their
actions on MOR, DOR, and KOR subtypes, Within these receptor classifications, rl, 12,
K3, and 6l receptors mediate supraspinal morphine analgesia and p2,61, and xl receptors
are responsible for spinal analgesia (Pasternak, 1993). The use of opioids in controlling
pain is problematic, due to the effect of opioids on other systems, including respiratory,
gastrointestinal, and cardiovascular systems. As previously stated, opioids injected into the
CSF of women in labour causes foetal bradycardia (see review by Mardirosoff et a|.2002)
(Mardirosoff et al., 2002\, and such treatment mav therefore be undesirable because of this
adverse effect on the late-term foetus.
1.5 Aims of Thesis
The aim of the present study was to establish a primary culture model for investigating rat
brainstem cells isolated from late foetal and early postnatal developmental stages. This
culture method will be used, along with studies on frozen sections from rat brain, to
examine developmental changes in MOR and DOR OpR expression and distribution in the
rat brainstem.
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Chapter 2
2 Primary Culture Of Brainstem Cells
2.I AIM
The aim of this study was to develop a method tor growing primary brainstem neurons
fiom rats at different stages of foetal and early postnatal development. The development of
a method for culturing postnatal brainstem neurons was important because it would allow
study of cultured brainstem neurons at Iater developmental ages than had previously been
possible. This method could then be used to investigate opioid receptor expression during
development (Chapter 3).
2.2 INTRODUCTION
2.2.1 USE OF PRIMARY CULTURE IN INVESTIGATION OF BRAINSTEM
FUNCTION
Primary cultures of brainstem neurons tiom foetal and postnatal rats are uselul models for
itt ,,,ilro studies of brainstem function. because they more closely mimic the normal
situation than cultures of established cell lines. In both primary cultures and established
cell cultures, more control exists over the cell environment. Greater experimental control
is beneflcial because it allows single components of the medium to be changed and their
eff'ects evaluated. The use of a chemically defined, serum-free medium is recommended
for studies in which complete control of the environment in the nutrient medium is desired.
for example, studies involving electrophysiological recordings (Rigatto et al., 1994),
immunocytochemical staining (Fitzgerald et al., 1992), neurotransmitter release (Shimoda
et af ., 1992), and growth factor responses (Copray and Leim, 1993; Miller and Azmitia,
1999). Culture in a defined mediurn provides a more stable and consistent environmenl
because it removes the variability between difl'erent batches of serum. The advantages of
studying receptor expression in culture, as opposed to whole brain slices, is the ability to
trace individual neuronal processes and observe interactions with other cells. The
diszrdvanta-qes of using a cell culture ntodel may include the formation of abnormal cell
architecture, changes in gene expression, and the formation of abnormal glial-neuronal.
neuronal-neuronal. and neuronal-elial communication.
49
The brainstem integrates many functions of the somatic and autonomic nervous systems.
For example, the brainstem plays a role in the suckling response, swallowing, respiration,
cardiovascular control, the maintenance of the arousal state, and the mediation of stress
responses [Vaccarino, 1999 #877; de Boer-van Huizen, 1999 #549: lrhnert, 1998 #548:
(Pilowsky et al., 1990a; Rigatto et al., 199?). The brainstem is composed of many
heterogeneous neurons having different morphologies and functional properties. Neutons
from the brainstem send projections to wide arcas of the brain and spinal cord, and the
specilic morphology of cells relates to their functional propefties (Berger et al., 1984:
Pilowsky et al., 1990b; Pilowsky et arl.. 1993). Rostral brain regions are relatively easily
maintained in culture because they are at ln earlier developmental stage than caudal
regions; and thus fewer connections are broken during tissue dissociation (Brewer, 1997).
No satisfactory protocols for primary culturc of postnatal brainstem neurons in defined
medium have been reported. Even with serum. commonly used procedures often give poor
survival rates in older foetal (>El6) and postnatal brainstem cultures (Azmitia, 1990;
Minamoto et al., l99l). Only two papers. Masuko et al. (Masuko et al., 1986), and
Ternaux and Por-talier (Ternaux and Porralier. 1993) have reported the successful culture of
brainstem neurons from the postnatal rat. Masuko et al. (1986) cultured brainstem cells
from neonatal mice up to P5 using a glial feeder layer and FCS. Neurons were not labelled
by neuron-specific markers but were identificd solely on morphology, a criterion shown to
be unreliable (Raff et al., 1979). Some brainstem cultures from neonatal rats were also
used, although no actual data were presented for these cultures. The study by Ternaux and
Portalier (1993) provided more comprehensive culture data; however, their culture medium
generally contained serum and was therefore undefined (Ternaux and Portalier, 1993).
Although some of their cultures were maintained without serum, detailed results in defined
medium were not reported.
The present study describes the first reliable method for establishing stable in vito cultures
of foetal and early postnatal brainstem neurons in a defined culture medium. Optimal
neuron survival of both late foetal and early postnatal brainstem cultures was achieved
with a commercially available, serum-free culture medium specifically designed for
support of neurons in culture. This medium consisted of Neurobasalru, a medium from
Gibco (Invitrogen, Gathersburg, MD. USA) for foetal cultures, and NeurobasalrM-A for
postnatal cultures. Both of these were used with a defined supplement (827) high in
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anfioxidants, also' from Gibco" Neursn and glial cells ,present in the. cultures wrere
idbntified usng irnrurnoey-toc-hemical staining wittl antibodies against rnicrotu,bule-
associated proteirn-2 (MAPA) or gli:al fibrillary acidic prot€in (GfAP), respectively,
Neur n populations were stabie for up to 9 days in culture and showed significant newite
outgrowth with time. This culture systern wilt be useful f.or studying u-rai.nsterrl neuron
function in vitro @t la'ter develroprnental ages than previously possible, thus providing a
rnore golnplete picture of neuronal maturafion during development of the rat braiilsEm.
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2.3 METHODS
2.3.I PRIMARY CELL CULTURE
2.3.1.1 Animals
All procedures werc approved by the Victorit University of Wellington Animal Ethics
Committee (JM95R2, JM98R2 and JM2000R4).
Foetal brainstem neurons were cultured from pooled embryos of time-mated Wistar rats.
Pro-oestrous rats were mated overnight. Successful mating was confirmed by the presence
of sperm in vaginal smears the next moming and termed E0 according to Paxinos et al.
(1994). Smears were taken using damp cotton wool wrapped around curved forceps.
Smears were dabbed onto microscope slides and stained for several minutes with a drop of
toluidine blue (0.05Vn in water) (The General Chemical Company Ltd, Budbury,
Middlesex, UK). Excess toluidine blue was removed by blotting the edge of the slide with
a paper towel. Vaginal epithelial cells were observed using a compound microscope
(Zeiss, Oberkochen, Germany).
Neonatal Wistar rats aged 0 to 6 days postnatal (P0 to P6) were anaesthetised with
Nembutal (-50 mg/kg; Virbac, Otahuhu. Auckland) intraperitoneal (ip) injection, and then
sacrificed by cervical dislocation. The external surface of the animal was sprayed with
70Vo ethanol before aseptic removal of the brain.
2.3.1.2 Culture Reagents and Equipment
Pasteur pipettes were siliconised by aspirating Siliclad solution (Sigma, St Louis, MO,
USA), into the barrel of the pipette, then expelling it once. The pipettes were allowed to
air dry before autoclaving at 120'C for l5 rnin. Circular 13 mm diameter coverslips
(BDH, Palmerston North, NZ) were cleaned tor 10 min in a sonicator bath (L&R. Kearney,
NJ, USA) with warm water containing a small amount of detergent. The coverslips were
then washed in 7 changes of dH2O and two changes of 7O7o ethanol, and stored in a sealed
container in 7O%, ethanol until needed. The day prior to setting up the cultures, the
coverslips were flame-sterilised, and lbur coverslips were placed in each 35 mm diameter
cell culture dish (Nunc; Invitrogen). Each coverslip rvas coated with 
-50 pL of l0 prg/ml
poly-o-lysine (PDL) (Sigma) by incubation at room temperature for 5 min. Excess coating
solution was removed, and the coverslips were allowed to dry overnight. Coated
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coverslips could be stored at 4"C tor up to one week. On the day of plating, the coverslips
were washed 3x in sterile dH2O and pre-treated with lOVo heat-inactivated foetal calf
serum (FCS) (lnvitrogen) for at least 2 h at 37'C to assist cell attachment. The FCS
solution was removed prior to plating the cells.
2.3.1.3 Foetal Brainstem Culture
Primary brainstem cultures were established l}om E14, E16, El8 and E20 rat foetuses by a
modification of the method of Cheung et al. ( 1997) (Cheung et al., 1997) who used serum-
free conditions to culture El4-El6 tbetal rat mesencephalic neurons. Pregnant rats were
anaesthetised by ip injection of Nembutal (Virbac). Foetuses were removed from the
uterus and placed in sterile ice-cold balanced salt solution (BSS) (pH 7.a) (Appendix 2:
Section l). All dissections were performed with sterile instruments, and solutions were
kept on ice in a laminar flow cabinet (Gelman Sciences, Australia). Foetal rat brains were
removed and placed in Hibernate-E medium (Invitrogen), a medium that allows prolonged
storage of tissue without loss of viability. Both Hibernate-E (for foetal tissue) and
Hibernate-A (for postnatal tissue) media are no longer commercially available through
Invitrogen. The appropriate Hibernate formulae are given in Appendix l. Recently.
Hibernate medium has been made commercially available again through the original
designer of the medium, Dr Gregory Brewer (email:gbrewer@simed.edu, Springfield IL,
USA) at a cost of approximately $60 (USA) lbr 500 mL.
Brainstems were dissected from the whole brain with the aid of a dissecting microscope
(Olympus, Tokyo, Japan), and blood vessels. meninges, and the cerebellum were carefully
removed using fine-tipped, sterile watchmaker's forceps. Detailed foetal brain dissections
complete with photographs and diagrams are described in the fbllowing refercnces,
(Brewer and Cotman, 1989; Azmitia. 1990: Fitzgerald et al., 1992: Copray and teim,
1993). Brainstem regions taken for culture included the rostral brainstem region, consisting
of the pons and medulla, extending posteriorly to approximately 2mm caudal to the obex
(Figure 2.1).
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Figure 2.1
Diagram of El6 Foetal Rat Showing the Brainstem Region
Taken for Culture
I'he area shown in red is the area taken tbr prirnary brainstem cultures. This region
includes the pons. medulla. nuclcus of'thc solitalv tract (NTS), and nucleus anrbiguus
(NA). From Paxinos et. al. (1994). Scale bar - mm.
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Pooled brainstems f'rom a single litter (8-15 feluses) were transfened to fresh Hibernate'rM-
E medium. The tissue pieces (approx 2 mm3) could be left at this stage for up to a week at
4'C without loss of viability although for all experiments discussed in this thesis, they
were never stored tbr more than 30 h. The tissue was then transferred to a sterile 15 mL
centdfuge tube and mechanically clissociated by triteration using a fire-polished.
siliconised, long-stem Pasteur pipette. Trituration involved aspirating the tissue suspension
in and out of the pipette approximately l0x. Tissue pieces were allowed to settle, and the
supernatant containing the dissociated cells rvas removed and retained. This procedure
was repeated 3x, and the combinecl supematants wete centrifuged in a non-refrigerated
hench-top cenrrifuge (300 g, 5 min, Clements. GS200, Sydney, Australia) and resuspended
in complete growth meclium. The complete growth medium consisted of Neurobasal
medium with |Va B-27 supplement (lnvitrogen), 0.2-5 mM L-glutamine (Sigma). 0.25 mM
GlutaMax I (lnvitrogen), penicillin G (50 U/mL) (lnvitrogen), and streptomycin sulphate
(50 pglml-) (lnvitrogen). A mixture of glutamine and GlutaMax I was used initially due to
the cells' inability to metabolise GlutaMax I when first seeded (personal communication,
Dr Stephanie Hughes), although when the culture medium was changed (every 5-7 days)
-50 mM GlutaMax I was used instead of the glutamine/glutaMax mixture. This complete
medium, rvith an osmolality of 240 mosm/k,e H2O, was used for El4 and El6 cultures.
Osmolality was determined in a Fiske OSlv osmometer (Fiske Associates, Needham
Heights, MA, USA). To enhance neuron survival in E20 cultures, a mixture of 50Vo
Neurobasal medium and 50Vo Neurobasal-A nredium containing identical supplements as
for the E14 and Et6 cultures wals used. The osmolality of this modified medium rvas 26(
mosm/kg H2O.
The percentage of viable cells was determined by trypan blue dye exclusion. A 50 pL
sampte of suspended cells was diluted in .150 ptl- of 0.0?Vo trypan blue in BSS. Th:
percentage of viable cells was determinecl microscopically using a haemocytometer. Th:
cells were seede{ onto prcviously cleaned coverslips that had been treated with poly-D-
lysine and serum at a density of 0.5- 1.0x106 viable cells/cm2 in a total of 2 mL complete
growth medium per 35 mm clish. Cells were incubated in a controlled atmosphere of 95(zo
air, 59o CO2 and 917o hun'idity at 37'C lor up to 3 weeks. To keep cellular debris to a
minimum in the cultures, half the medium was replaced after I day in culture with fresl,
.i-5
pre-warmed culture medium. Following this, cultures were fed every 5-7 days with half
changes of medium.
2.3.1.4 Postnatal Brainstem Culture
Neonatal Wistar rats aged up to 6 days (P0 to P6) were anaesthetised with pentobarbital by
ip injection (50 mglkg), and then sacdficed by cervical dislocation. The animals were
sprayed with 707o ethanol before aseptic removal of the brain. Whole brains from rats of
the same litter were removed and placecl in a 100 mm diameter culture dish containing l0
mL of Hibernate-A medium (Invitrogen) on ice. The meninges and blood vessels were
carefully removed with the aid of a dissecting microscope. A separate 60 mm culture dish
containing Hibernate-A medium was used for every two animals. Brainstems were
identified using the same criteria as for foetuses (Figure 2.2), removed, pooled and placed
in petri dishes containing Hibernater.Nr-A medium. The tissue was cut into 2 mm cubes and
the tissue matrix loosened by treating with trypsin stock (lnvitrogen) to give a final
concentration of O.05Vo trypsin in Hibernate-A medium. Tissue was then incubatedfor l5
min at 37"C in a shaking waterbath. Alternatively, the tissue pieces could be stored
overnight in Hibernate-A medium containing B-27 supplement (without trypsin), as
described fbr embryonic tissue. The tissue pieces were allowed to settle for 5 min and the
supematant removed. The pellet was resuspended in Hybernate-A medium containing
l0% FCS (to inhibit trypsin activity) and 0.01 mg/ml DNase (Sigma). The tissue was
then mechanically dissociated in the sante way as for tbetal cultures, substituting
Hibernate-A medium and Neurobasal-A medium for the embryonic medta, Hibernate-F
ancl Neurobasal. The supernatant containing the dissociated cells was centrifuged at 300 g
for 5 min, and the cell pellet resuspencled in Neurobasal-A medium containing ZVo B-2-,
supplement, 0.25 mM L-glutamine, 0.25 mM GlutaMax l, penicillin G (50 U/mL). antl
streptomycin sulphate (50 p.g/ml). The osmolality of this medium was 280 mosn/k13
HzO. Cell viability was cletermined by trypan blue dye exclusion as described above .
Cells in 2 mL complete growth medium were seeded onto prepared coverslips in 35 mrn
culture clishes at a density of 0.5-1.0 x106 viable cells/cm2.
2.3.2 CELL.SPECIFICMARKERS
Immunocytochemistry (see below fbr methods) was used to identify and characterise the
cell types present in the cultures. GFAP rvas used to specifically label astrocytes (Raff et
t6
al., lg7g), and MAP2 was used to specifically label neurons (Sarnat et al., 1991)'
Cholinergic neurons in some cultures werc labelled using antibodies to choline
acetyltranst'erase (ChAT) (Knusel ancl Hefii. 1988; Burton et al., 1995; Chen et al., 2001)'
2.3.2,1 Fixation of Cultured Cells
Coverslips with their attachecl cells were removecl fiom the culture medium and washed 3x
in phosphate buffered saline (PBS) (pH 7.4) (Appendix 2: Section 2) before being fixed in
a mixture of 507o acetone: 50% methanol for 8 min at -20"C. The coverslips were washed
3x in colcl PBS (5 min each) and stored at 4oC (fbr up to 3 weeks before staining) in PBS
containing 0.l7rr sodium azide in a culture dish sealed with Parafilm (American National
Can'rN{ Chicago, tL, USA).
2.3.2.2 Permeabilisation and Removal of Endogenous Peroxidase Activity
Prior to immunostaining, cells were permeabilised fbr 30 min at room temperature in PBS
containing 0.?Vo Tnton X100. Endogenous peroxide activity was removed by incubation
in}.lvo H202,507o methanol in dH20 (Appendix 2: Section 3) for 15 min, and washed 3x 5
min in PBS.
2.3.2.3 Colourmetric Visualisation with DAB
DAB colourmetnc visualisation of immunostaining was used as an alternative to
fluorescence signal amplification. The colourmetric method was used to obtain permanenl
mounted samples that permitted a comparison to be made between samples of different
developmental ages after varying times in culture, without the problems of photobleachinS:
generally associated with fluorescence. DAB visualisation used secondary antibodier;
conjugated to Horseradish peroxidase (HRP), as described above.
2.3.2.4 MAP2 Immunocytochemistry
To identify neurons, microtubule-associated protein-2 (MAP2) immunostaining wi's
capied out using a modification of the method of Hsu et al. (1981) (Hsu et al., l98l).
Biotin/avidin amplification was performed, l'ollowed by visualisation using 3,3'-
diaminobenzidine (DAB) (Volsen. 1984). Briefly, cells were fixed, permeabilise,l'
endogenous peroxidase activity was removed and coverslips were washed. Non-specific
binding sites werc then blocked at room temperature for 30 min in PBS containing 27o
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normal goar serum (NGS) (Invitrogen), 4Vo bovine serum albumin (BSA), 0.27o Triton,
and 0.017o sodium azide. Coverslips were inculrated with mouse monoclonal anti-MAP2
primary antibody (specific for MAP2a, b and c) (l:250; Sigma) in PBS containing 0.27c
Triton. l7a NGS, and,ZVo BSA, at 4"C overnight. Coverslips were then washed 3x in PBS
containing O.2VaTriton, incubated with biotin-labelled goat anti-mouse IgG (l:250 in PBS
containing O.ZVo Titon; Sigma) for 2 h at room temperatute, washed 3x in cold PBS (5
min each), and then incubated for 2 h at room temperature in ExtrAvidin Peroxidase (1:500
in PBS; Sigma). After incubation. the coverslips were washed 3x as before.
lmmunostaining was visualised with DAB developing solution (0.5 mdml-; Sigma),0.1 M
phosphate buff'er, and 0.0lVo H202. Coverslips were washed 3x in cold PBS and mounted
on microscope slides with glycerin jelly. Negative controls werc incubated identically but
without primary antibody. Some coverslips were counterstained with 37<, toluidine blue or
Delafield's haematoxylin to improve visualisation of non-immunostained, non-neuronal
cells. Cells were observed using a compound microscope (Zeiss, Oberkochen, Germany)
at 400X magnification by phase contrast or hri,ehtfield optics. Cell types were identified
according to immunostaining characteristics and morphology.
2.3.2.5 GFAP Immunocytochemistry
Astrocytes were positively identified using a rabbit primary antibody to GFAP (l:100;
Sigma) and a sheep anti-rabbit secondary antibody conjugated to FITC (l:100: Sigma).
Non-specific binding sites were blocked and the coverslips washed between antibody
treatments as describecl above for MAP2. Fixed cells were incubated in primary and
seconclary antibodies for t h each at room temperature in the dark. The coverslips were
mounted in Antifade (Molecular Probes, Eugene, OR, USA) and examined fbl
fluorescence on a confocal microscope (TCS 4D, Leica Lasertechnik Gmbh, Germany). Ir;
some cases, cells were double-labelled with antibodies against MAP2 and GFAP usingr
secondary antibodies conjugated to Rhodamine Red and FITC, respectively.
2.3.2.6 Choline Acetyltransferase (ChA'I' ) Immunocytochemistry
Some primary brainstem cultures were immunostained for the presence of cholinergi:
neurons using antibodies specific for ChAT (Knusel and Hefti, 1988; Burton et al., 199-';
Chen et aI.,2001). ChAT antibody was kindly donated by DrGregory Funk (Departmerrt
of Physiology, University of Auckland, NZ). Cell culture samples were fixe,i,
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permeabilised, endogenous peloxidase activity removed, and non-specific binding sites
blocked as described previously. Primary antihody (rabbit anti-ChAT) (l:500; Sigma) was
incubated overnight at 4"C followed by goat anti- rabbit IgG Biotin (l:500, Sigma).
Samples were washed 3x 5 min, then incubated with ExtrAvidin HRP (l:500, Sigma) for
DAB visualisation, or ExtrAvidin-FITC ( l: I000, Sigma) for detection by flttorescence.
2.3.2.7 Colour Development and Mounting
Antibody-labelled cells werc washes 3x 
-5 rnin. then incubated in DAB colour development
reagent (Appendix 2: Section 4) for l-20 min until the colour had developed. They were
then washed 3x 5 min in PBS and mounted onto glass slides using glycerin jelly mounting
medium (3.8Vo gelatin (Sigma), 507r' pure glycerin (Sigma), and 0.27o phenol crystals
(BDH) in dH2O (Appendix 2: Section 6)).
2.3.2.8 Cell Type Classification
Neurons, positively stainecl for MAP2, were classified as either bipolar or multipolar
according to the number of processes extending out from the soma (Figure 2.4C & D).
Glial cells were classified by morphotogy as eitlrer type I astrocytes (large flat cells with an
epitheloid shape and a prominent nucleus) or type [I astrocytes (smaller stellate-shaped
cells morphologically similar to neurons)(Raff et al., 1983) (Figure 2.4A & B). Cells not
titting within these categories four were classified as 'other' and presumably consisted of
fi broblasts, macrophages, oli godendroc ytes, and endotheli al ce I ls.
2.3.2.9 MorphometricAnalysis
Morphometric analysis was canied out on MAP2 immunoreactive neurons, using the
Semper 6 image acquiring software program (Synoptics, Cambridge, UK). Coverslipr
werc counterstained with toluidine blue to identify cell nuclei. Measurements of cell bod"
length were obtained using lmage Pro soliware (Media Cybernetics, Silver Spring, MD,
USA). Fifteen cell bocly diameters and total neurite length fbr each cell were analyse,l
from foetal (El6) and postnatal (P6) cultures after 4 and 7 days in culture. Only nerv:
cells in sparsely populated areas of the coverslip were morphometrically analysed because
of the difficulty in distinguishing cell and neurite boundaries in densely populated regiors
(Figure 2.3).
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232JA Shtistical Analysis
Distributions of cell types from different develop,mental ages (814, El6, E20' P3 and P6)
and after different times in culttire (4, 7 and 9 days) were analysod using the nonpararnetric
Kruskal-Wallis test (llarraway, L997), Values are presenrcd as the mean t SEtrvl
Frequency histograms: from the morphornetric analyse$ were, analysed for differenees in
somal length and nzurite length by the nonparametric Mann-Whitney test (Harraway,
wn\.
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Figure 2.2
Postnatal Brain Structure
Three-day-old postnatal rat brain (P3), showing lower brainstem
regions taken for culture (highlighted by arrows). Scale bar divisions
equal I mm.
t*i
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Figure 2.3
Cell Morphometry Measu rements
A MAP2-positive neuron (n) showing cell body length (red) and neuronal
process measuren'lents (blackl. f'otal neurite length from black outlined
neuronal processes was calculated using Image Pro software. Note the
presence of toluidine blue stained glial cells (g). Scale bar: 20 p m.
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2.4 RESULTS
2.4.I PRIMARY BRAINSTEM CULTURE
During the development of the brainstem culture method a number of variations in culture
conditions were tried. The results of these experiments are descdbed below.
2.4.1,1 Brainstem Cell Dissociation
Brainstem tissue was dissociated in Hibernate.ru medium/827, which is high in
antioxidants and contains Caz* and Mgt' ions (Brewer and Price, 1996). In the present
study HibernaterM mediumlB2T increased celt viability during dissection ancl dissociation
(60-8OE('viability) compared with (Car., Mgr- tiee) BSS (40-607o viability). Cell viability,
immediately before plating, was typically between 65-8OVo, with younger foetal cultures
having the highest proportion of viable cells.
2.4,1.2 Establishment of Primary Cultures
Dissociated brainstem cells attached to the coverslip within I day in culture and nerve cells
began to produce neurites within the I'irst l'ew days. After 4 days in culture, neurons
visualised by phase contrast optics, had a phase-bright soma (Figure 2.5A-D) and stained
positively for MAP2 (Figure 2.58 & F). Neurons were often seen growing on top of type I
astrocytes, although a small proportion of neurons were not directly associated with glial
cells.
2.4.1.3 Cell Attachment in Culture
In addition to serum pre-treatment of coverslips, several cell attachment substrates werr:
tested for their ability to promote neuron survival. In the absence of added substrate, cell
attachment was very poor. Coverslips treated with poly-D-lysine showed better attachment
than those treated with poly-L-lysine. Polyethyenimine (PEI) (507o w/v) (Sigrna) gav:
good neuron attachment, survival and process outgrowth initially, but the PEI solution
obtained from Sigma proved to be unstable, and therefore results were inconsistent. Poh.
D-lysine gave the most successful and consistent cell attachment and neurite outgrowth ('f
the three substrates tested. In some cultures poly-D-lysine-treated coverslips were not prc-
treated with serum, and this prevented most neurons from attaching to the surface.
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Figure 2.4
Classilication of Different Cell Types in Culture
The main cell fypes observed in brainstem cultures were type I astrocyte (A) and type II astrocyte (B).
staining positively for GFAP (FIl'C) and observed by confocal microscopy. Scale bar: l0 pm. Bipolar
neurons (C) ana multipolar neurons (D), staining positively for MAP2 (DAB) were observed using
brightfield microscopy. Note the absence of staining of type I glial cells by anti-MAP2 antibody (g).
Scale bar: 20 pm.
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Figure 2.5
Morphology of Primary cultures of Brainstem Neurons from Different
Developmental Ages of Foetal and Postnatal Rats.
Brainstem cultures from El4 (a) and El6 (b) rats were grown in Neurobasal medium/B27 supplement.
Cultures from 3-day old postnatal rats @. and 6-day old postnatal rats (d), were grown in Neurobasal-A
medium/B27 supplement. All cultures were seeded at 0.5-l.0xl06cells/cm2. Photomicrographs were
taken after 7 days in culture using phase contrast microscopy. Some phase bright neurons are shown
with arrows. Brainstem cultures stained for MAP2 from 6-day old postnatal rats are shown after 4 days
in culture (e) and after 7 days in culture (l). Note the increased neurite length at 7 days (f) compared
with 4 days (e). Scale bars :20 pm.
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2.4.1.4 Effect of Different Culture Media on Cells
Several variations of culture media were tested to determine the optimal conditions for
culturing brainstem neurons. In postnatal cultules. qualitative estimates of neuron survival
were made. Quantitative comparisons between neurons cultured in DMEM medium and
DMEM-FI2 medium, or Neurobasal medium have been reported previously by Brewer et
al. (1993) (Brewer et al., 1993). In our study DMEM-FIZ with l07o FCS gave poor
neuron survival: whereas, DMEM-FI2 with B27 supplement gave moderate neuron
survivttl. Neurobasal/Bz7 supplement for fbetal cultures and Neurobasal-A/B27 for
postnatal cultures gave the best neuron survival and were chosen as the standard culture
media for brainstem neurons.
2.4.1.5 GlutaMax I Replacement of Glutamine
Glutamine and GlutaMax I supplements rverc directly compared in Pl cultures. Cultures
were seeded at lxl05 cells/cm2 with either 0.5 mM L-glutamine or with 0.25 mM
GfutaMax V0.25 mM L-glutamine. The density of the cultures was estimated using a
compound microscope equipped with phase contrast optics ilt l60x magnification.
Cultures were scored on a scale of I to 3 according to cell density, without regard to the
type ol'cells. A score of 3 was given when cells covered >85Vo of a typical field of view, a
score of 2 when 50-85Vo of the field of view wits covered, and a score of I when <5OVo of
the field of view was covered. After 6 and l2 days in culture there were significantly more
cells in cultures containing GlutaMax I supplement (mean score = 2.1) than in cultures
containing glutamine only (mean score = 1..5) (P < 0.03, Mann-Whitney test. n = 33 fields
of view for glutamine: n = l-59 fields o1'vierv for GlutaMax I liom counts of two coverslipr,
and six coverslips, respectively). Others have reported similar results with GlutaMax I ilr
neuronal cultures (Minamoto et al.. l99l). Neither the replacement of glutamine witlr
GlutaMax I nor the seeding density had any obvious effect on the percentage of neurons irr
the cultures relative to the total number of cells.
2.4.2 EFFECTS OF SEEDING DENSITY ON NEURONAL SURVIVAL
In preliminary experiments il range of seecling densities from lxl05 to lx106 cells/cnr2
were tested. Good neuron survival was observed at each density within this range. In one
culture, l3 poolecl brainstems from Pl rat pups were seeded at either lxl05 cells/cm? (n = 8
coverslips) or 5xl0s cells/cm'(n = 6 coverslips). There wils no statistically signitrcart
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difference in the percentage of neurons staining positively for MAP2 after 6 or 12 days in
culture relative to the total number of cells present in the cultures (50-100 cells were
counted on each coverslip and classified as being either bipolar or multipolar neurons, or
type I or type II astrocyres).
All other cultures were initially seeded at the same density of 5x105 cells/cm2. Neuron
density was not directly measured over time in culture, although neuron survival appeared
to be reduced in cultures established from older developmental ages, as evidenced by a
decrease in overall cell density with time and an increase in the number of unattached cells
and debris after one day in culture. Some cell divisions could be seen in the cultures. One
older postnatal culture (Pl5) was attempted; however, few neurons survived more than one
day in culture.
2.4.3 CELL MORPHOLOGY AND IMMI.JNOREACTIVITY IN CULTURE
Celfs classifled as bipolar and multipolar neurons (Figure 2.4C & D) were confirmed to be
neurons by their positive MAP2 immunoreactivity (Figure 2.6). It was necessary to use a
specific marker to identify neurons since their morphology was very similar to the stellate-
shaped type II astrocytes that stained positive fbr GFAP (Figure 2.4A &. B), but negative
for MAP2 (Figure zAC & D). The negative control for MAP2 (no primary antibody)
showed no staining (Figure. 2.6F). In a single experiment, a culture of brainstem neurons
and glial cells was double-labelled using antibodies against GFAP (FITC-Iabelled) and
MAP2 (Rhodamine Red-labelled). No cells stained with both GFAP and MAPZ when
observed by confocal microscopy, thus ensuring that MAP2-stained multipolar neuronr
were not incorrectly identitied as type II astrocytes, and vice versa. This immunostaining
distinction has been well-established in other culture systems (Marriott et al., 1995).
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EFigure 2.6
Cultured Brainstem Neurons Positively Stained for MAP2
El4 nernpus aftet 7 days in sulture (a); El6 neurons after 9 days in cutture O); E20 neuron-s after
Tdays in culturc (b); p: neurons aftet 7 days in culture (d); P6 n€urions after 9 days in culture (e);
Negative MAP2 control f,or P6 neurons after 7 days in cuftue (no MAP2 antibody) (f;. Note the
absence of MAI2 staining in the cell body and nucleus in a-e. Brighffield microscopy. Scale bar:
20 pn.
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2.4.4 DISTRIBUTION OF CELL TYPES
Cell type distributions on coverslips fronr each developmental age, embryonic El4, El6,
E20 and postnatal P3 and P6, were counted after 4, 7, and 9 days in culture (Figure. 2.7).
Between 
-50 and 250 cells on each coverslip were counted and classified into one of the
five groups. The ratio of neurons to glial cells remained constant with time in culture in
El6, E20, P3 and P6 cultures, Type I astrocytes made up a greater proporlion of the total
cells (50-72Vo) in more advanced developmental ages compared with the youngest El4
cultures (17-20qo). There was no significant change in tlre distributions of cell types with
time in culture from 4-9 days, suggesting good neuron survival and maintenance between 4
and 9 days in culture.
The more adherent, flattened type I astrocytes were more common than tlre neuronal like
type II astrocytes in both foetal and postnatal cultures. The marked difference in the
frequency distribution of cell types in E14 cultures comparcd with the developmentally
more advanced cultures was highly significant (P < 0.001, n = 5, Kruskal-Wallis).
Comparing cell types at dift'erent developmental ages (average value from the pooled 4, 7
and 9 day results of Figure. 2.7),814 cultures had a higher proportion of neurons than glial
cells (617o compared with 35Vo), and most of'the neurons were bipolar (40V0 of total cells)
rather than multipolar (Tl%o of total cells). Late embryonic (El6 and E20) and early
postnatal cultures (P3 and P6) had a higher proportion of astrocytes than neurons (61-73Vc
comparcd with 25-3lvo), and most of the neurons were multipolar (18-257o) rather thar
bipolar (5-97o) (range of values averaged l}om pooled results of El6, 820, P3 and P(
cultures after 4, 7 and 9 days in culture). There were significant differences between thr:
bipolar/multipolar neuron ratios in cultures l}om foetal El4, El6 and E20 and postnatal Pll
and P6 stages. More advanced cultures had disproportionately more multipolar neurons.
This difference was statistically significant between E14, El6, E20, P3 and P6 cultures at
4, 7 and 9 days in culture (P < 0.0019, n = 5, two-factor, Kruskal-Wallis test). Thus El l
culturcs showed significantly more neurons than glial cells; however, by Et6, type I glirrl
cells predominated in the cultures. El4 also showed more bipolar than multipolar neurons
compared with later stage cultures in which multipolar neurons were more common.
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Figure 2.7
Proportion of different cell types present in brainstem cultures of foetal and
postnatal rats
Proportion of dift'erent cell types in cultures liorn foetal and postnatal rat brainstenrs. Coverslips
were removed, stained. and cell type distributions determined after 4. 7. and 9 days in culture.
Mean + S.E.M of the percentage of total cells counted at each age vs. timc in culture. Multiple
cultures for each developmental age of rat were used. and the results were pooled (n : number of
pooled coverslips from two to fbLrr dift'erent culture preparations).
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2.4.5 CELL MORPHOMETRY MEASUREMENTS
Neuronal processes incrcased in length during culture (Figure 2.8 and Table 2.1) and made
connections with cell bodies or processes of other neurons, but more commonly with glial
cells. The mean cell body diameter was the same fbr foetal and postnatal cultures, with no
size difference over time in culture or between bipolar and multipolar neurons (Figure 2.9).
Neurite length increased in El6 foetal cultures between 4 and 7 days in culture (P < 0.005,
n =29, Mann-Whitney test). In P6 culturcs, neurite length incrcased fiom zero at day I to
162 + 20 pm by 7 days in culture: however. there was no significant increase in neurite
length between days 4 and 7 in these cultures. Total neurite length in foetal El6 cultures
was 45Vo greater than in P6 cultures after 7 days (P < 0.02, n = 31, Mann-Whitney test).
2,4.6 PRESENCE OF CHOLINERGIC NEURONS IN PRIMARY BRAINSTEM
CULTURES OF THE RAT
ChAT-positive cells were present in all developmental ages of primary brainstem cultures
from El6 to P6. All ChAT-positive cells showed neuronal morphology, and no staining
was observed on glial cells. The percentage of cells stained positive for ChAT was
determined by counting ChAT-positive cells as a percentage of total cell nuclei from 3
tields of view from 2 separate coverslips from developmental ages El6, E20, P3, and P6
primary brainstem cultures of the rat. Approximately 5Vo of cell nuclei were found to be
ChAT positive (not shown in Figure). Usually, ChAT-positive cells appealed in small
cf usters of 2-3 neighbouring ChAT-positive cells (Figure 2.lO). Staining was ditfuse in the
cytoplasm of some cells (Figure 2.10A) and punctate in others (Figure 2.108 & C). Cel
processes were also stained (Figure 2.10A).
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Figure 2.9
Frequency Histograms of Cell Body Diameter
Frequency histograms of MAP2 positive neurons showing cell body length for E16 and P6
cultures after 4 and 7 days in culture. El6C4 stands for El6 cells cultured for 4 days.
Table 2.1 Morphometric Data Summary
Average values of cell body diameter and total neunite length (mean t SEM) for the data of
Figure 2.8 and Figure 2.9. Cell body diameter was determined for the long axis of eltipsoid
cells. Total neurite length was calqulared as the sum of the lengths of individual neurites of a
single cell.
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Figure 2.10
ChAT-Labelled Cells
Cells labelled positive fbr ChA'f (green) fionr primary brainstem culrures tiom E16 (A). 820 (B).
and P3 (C) rats. counterstained with propidiunr iodide (red) to visualise cell nuclei. The negative
control cell line. LLC-PKl showed no ChA'l staining (D). Scale Bars:20 prm.
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2.5 DISCUSSTON
2.5.1 PRIMARY BRAINSTEM CEI,L CUI,TURE
This study describes the first successful nlethod for culture of late foetal and early
postnatal animals in defined medium, usin-e a commercially available neuronal medium
containing supplements high in antioxidants. Few satislactory protocols for pdmary
culture of postnaterl brainstem neurons have been reported, and commonly used procedures
often give poor survival rates in older foetal and early postnatal brainstem cultures, despite
the presence of serum (Azmitia. 1990; Miller and Azmitia, 1999). The use of primary
culture as a model tbr in vitro studies of hrainstem function is imporlant because it more
closely mimics the normal situation when compared with cultures of established cell lines.
In a culture system, it is possible to trace individual neurons and neuronal processes and
observe interactions between cells that would not be possible in brainstem slice studies.
This method has been used successfully to study the survival of neurons, outgrowth of
neurites, and to determine the proportion of different cell types in cultures from foetal and
postnatal rats of different ages (Kivell et al.. 2000, 2001). This culture system suppons
brainstem neuron survival in the absence ol' FCS, present only in the initial seeding to
promote cell attachment. Glial cell f-eeder layers are also not necessary, thus reducing the
amount of advance prcpafation required to set up the cultures. In addition, the use of
Hibernate medium removes the time constraints normally faced when establishing primary
cultures from brain tissue.
2.5.2 METHODDEVELOPMENT
2.5.2.1 Cell Dissociation
A problem that arises when culturing cells from various brain regions of the neonatal rat ir;
that some areas, such as the brainstem, are proportionally more mature than others, such a;
the more rostral cortex, and are theretbre ditficult to establish and maintain in culture.
Mature, developing neurons rcquire increased interactions with trophic factors release,l
from their target fields (Barde, 1989; Levi-Montalcini, 1995). These trophic facrors,
including nerve growth factor, brain-derived neurotrophic tactor, and basic and aciclic
fibroblast growth factor, tend to be selective for dift'erent types of neurons (Varon and
Adler, 1980; Barde, 1989; Barbacid. 199-5; Levi-Montalcini, 1995). One study, using
foetal (El8-19) rat cells cultures from the rostral ventrolateral meclulla (RVLM), tested tle
effect of trophic factors on neurons expressing tyrosine hyclroxylase. Glial derive,d
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neurotrophic factor, brain-derived neurotrophic factor, neurofophin 3, neurotrophin-4/5,
and ciliary neurotrophic factor increased the number of tyrosine hydroxylase positive cells
in culture. However, nerve growth factor, transforming growth factor-beta, and basic
fibroblast factor did not (Copray et al., 1999). The more immature a tissue is the more
easily it can be dissociated, thus yielding higher numbers of viable cells. In the prcsent
cultures, there was better cell survival at El-l than later developmental ages. This may
have been due to increased plasticity and immaturity of the younger neurons and their
reduced requirements for trophic support. It is also possible that some of the cells present
at El4 were either stem cells. progenitor or precursor cells that can give rise to neurons or
astrocytes, depending on culture conditions. The increased requirement tor trophic support
in developmentally older cultures may also explain why neuronal processes from P6
cultures were significantly shorter than those from El6 cultures (Table 2.1) (P < 0.02,
Mann-Whitney test), This may also be due to the fact that trypsin was not used in tissue
dissociation of foetal cultures, whereas trypsin was used in cultures prepared from
developmentally older brainstems,
2.5.2.2 Tissue Storage
Hibernate rv is a serum-free medium c<lntaining Ca2* and Mgt*. The use of Hibernate
medium was a significant improvement in the present culture system because it allowed
foetal tissue to be dissociated without the need for halmful exposure to Ca2*-Mg '*-ttee
conditions, as well as permitting lon-e-term storage of dissected tissue prior to culturinp
(Brewer and Price, 1996). Hibernate has been used for storage of living brain tissue for up'
to 4 weeks at 2-8 "C and ambient CO, (0.2%') (Brewer and Price, 1996). Using Hibernate,
the viability of dissociated cells was improved compared with use of the more common
Ca2*-Mg2*-free tissue dissociation solutions (Copray and Leim, 1993). It was noted in th,:
present study that undissociated foetal and postnatal brainstem tissue pieces (2 m63; coul,J
be maintained in this storage medium for several days at 4oC without noticeable loss cf
viability. This reduced the time constraints of setting up cultures. Literature reports
emphasise the necessity of rapid (l-2 h) tissue dissociation and plating procedures ro
obtain good neuron viability and attachment (Buse, 1985). The two variations of
Hibernate medium. E (embryonic) and A (adult), differ only in their osmolality (240 ar,d
280 mOsm/kg HrO, rcspectively). Neurons are particularly sensitive to changes n
osmolality, and the optimal osmolality lbr survival of mid-foetal neurons (El4-El8) is
"t5
lower than that of late foetal neurons (E20). Early postnatal neurons tend to swell at lower
osmolalities. Unforlunately, soon afier the present method was developed and published,
Hibernate medium was deleted from the Invitrogen range of cett culture reagents. It is now
necessary to either produce the medium lrom its individual components or purchase it from
its originator, Dr Gregory Brewer:
[gbrcrver@simed.educmailto:gbbrewer'@simcd.edul. The protocols for making
Hibernate-A, and -E are described in the Appendix of this thesis (Appendix I ).
2.5.2.3 Choice of Medium
Neurobasal'tt medium is a serum-f-ree, bicarbonate-buffered medium that was originally
developed for optimising growth of foetal rat hippocampal neurons (Brewer, 1997).
Neurobasal medium also supports neuron 
-erowth and differentiation in cultures of rat cells
derived from other brain regions, including cortex, cerebellum, dendate gyrus, stdatum,
and substantia nigra (Brewer, 1995). The composition of Neurobasal medium is based on
DMEM (Brewer et al., 1994). DMEM medium has a higher osmolality, however, than
other reported media that have been optimised fbr the culture of foetal neurons (Brewer.
1997). In the present study it was shown that Neurobasal medium effectively supported
the maintenance of El4-El8 rat brainstem neurons, and Neurobasal-A medium supportec.
the maintenance of more advanced E20 and postnatal rat brainstem regions, wherr
supplemented with 827. B27 is an antioxidant-rich, serum-free medium supplemen.
(Brewer et al., 1993). B27 supplement can replace the obligatory rcquirement for serum,
once neurons have attached to the substrate. ln Neurobasal/B27, our neuron survival ratr:
was higher than that in Neurobasal containing l07o FCS. Coverslips were coated with
poly-D-lysine and FCS to promote attachment, but no serum was added to the mediurr
itself during the actual culturcs. Thus, culture conditions were completely defined after
plating. Defined media are important fbr providing complete control over in vitrt
conditions. Studies that use FCS-containing medium, such as those ol Ternaux and
Porralier (1993) (Ternaux and Portalier. 1993) and Masuko et al. (1986) (Masuko et al.,
1986), repofi good neuron stability, however, FCS content is unknown and variable
between batches and FCS supports astrocyte division. In the present study, culture in a
defined medium without FCS shorved similar neuron survival without the inherelt
disadvantages of serunl use.
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2.5.2.4 Glutamine/Glutamate Toxicity
A major problem encountered when growing neutons in culture is their susceptibility to
glutamine toxicity, yet cultures without glutamine tend to grow poorly. L-glutamine
produces ammonia, a toxic breakdown prnduct (Minamoto et al., l99l). GlutaMax I (L-
alynyl-L-glutamine) does not produce ammonia and was used to replace half of the
glutamine to maximise neuronal survival. Neurotoxicity can also occur from glutamate,
which is thought to play a role in neurodegenerative clisorders, including Alzheimer's
disease (Arias et al., 1997). Glutamate excitotoxicity has been extensively studied in cell
culture (Kassof et al., 1995: MacManus et al., 1997). Using glutamate-free media
containing semm, Brcwer et al. (Brewer et al., 1994), have shown that DMEM-FI2
provides better neuronal survival than DMEM in cultures of some brain regions (brainstem
not reported). Neurobasal medium, although DMEM based, is glutamate-free. The present
study used a modification of the method of Clreung et al. ( 1997), originally developed for
mesencephalic culrures (Cheung et al., 1997). Neurobasal medium with 827 supplement
gave better neuron survival than glutarnate-containing DMEM-FI2 with 827 supplement.
This improved survival in Neurobasal compared with DMEM-Fl2 or DMEM has been
attributed to the omission of the excitatory amino acids, glutamate and aspartate, as well as
the lower osmolality of the culture medium (Brewer et al., 1994). The addition of 827
supplement to the medium during cell clissociation and culture also rcduces cell damage
caused by free radical production.
2.5.3 SEEDING DENSITY AND CELL A'TTACHMENT
Primary culture of post-mitotic neurons from distinct brain regions requires the use of largt:
numbers of animals in order to have enough cells to plate at high densities (lx106 cells/cmr
or higher) required for viable cultures (Azmitia, 1990). In the present study. survival wa;
excellent at seeding densities as low as lxl05cells/cm:. The seeding density used her,:
allowed between 4 to l0 culture dishes (35 mm diameter, each containing 4 coverslips) t,t
be seeded from one litter of rat pups.
Poly-D-lysine gave the most successful and consistent cell attachment and neurire
outgrowth in culture. This conclusion is supporled by the findings of Brewer and Cotmin
(1989) (Brewer and Cotman, 1989) who also found that poly-D-lysine reduces t|e
aggregation of neurons compared with poly-L-lysine. Other commonly describe,d
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attachment substrates include collagen and fibronectin (Mains and Patterson, 1973:
Masuko et al., 1986). These were nol tested in the present study. Failure to pre-treat the
coverslips with serum prevented most neurons from attaching to the coverslip surface,
indicating the need for attachment factors present in serum. A review by Barnes (Barnes
and Sato, 1980) describes the role ol' serum in providing specific attachment f'actors in
neuronal cultures. These attachment tactors include fibronectin-like molecules. cell
adhesion and spreading firctor, and cold-insoluble globulin.
2.5.4 CULTURB CHARACTERISTICS
2.5.4.1 Cell Specific Markers
In the present study, different types of cells in culture were identified using phase contrast
moryhology and staining profiles with antibodies against MAP2 and GFAP. GFAP is only
present in glial cells (Raff et al., 1979). MAP2 localisation is specific for neurons and
neural precursor cells (Sarnat et al.. 1997). Distributions of MAP2 during normal
development, (Cficercs et al., 1983; Binder et al., 1984; Matus, 1988: Chauhan ancl Siegel,
1997) and during development in culturc have been well established (De Lima et al.,
1997). In mature neurons in situ and in cultured cells afier several days in culture, MAP2
staining is found predominantly in dendrites, and the axons are unstained (Kadota et al..
1997). In the present study, all neurites, whether dendrites or axons, stainecl positively for
MAP2 for at least the first 9 davs in culture.
Neurite growth occurred by an increase in length as well as an increase in the number o'
branches with time in culture. This was observed for all developmental ages tested,
although at younger developmental stages, neurite growth tended to be faster, especiall.r
immediately after plating. Cultures could be successfully maintained for up to 3 week;
with little neuronal cell death. The number and type of neurons present in culturc were
unchanged between 3-9 days for all developmental ages tested. A few cultures werc als.r
observed for longer time periods with little differences seen. [n cultures established from
older developmental ages (P3 and P6), the neurons tended to be multipolar, whereas at
younger developmental ages (El4 and El6), the neurons were mostly bipolar. These
results support the findings of de Boer-Van Huisen et al. (de Boer-van Huizen and ten
Donkelaar, 1999) who showed that brain tissue tiom El4 foetuses contained more marurc
multipolar cells than tissue from El2 foetuses, sug-qesting that the number of neuri;e
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connections increases with age. Mature neurons require morc tlophic supporr from their
target tissues than immature neurons. The increased neurite complexity of
developmentally older neurons and the complex connections formed with other neurons
and glial cells may in part explain why postnatal and late foetal tissues are more difficult to
establish in culture.
2.5.4.2 Neural-Glial Associations
Many multipolar and bipolar neurons at all developmental ages tested and after 4,7 andg
days in culture tended to be associated with glial cells. Usually neurons were observed on
top of type I astrocytes, although there were always sr:me isolated neurons present in the
same cultures. This observation is consistent with findings in other culture systems
established from diff-erent brain rcgions (Trenkner, 1992). Miller and Azmitia (1999)
reported neuronal-glial connections in E14 and El6 cultures of cholinergic neurons from
ventral forebrain. Neurons connected to glial cells stained more intensely with ChAT
antibody than unconnected neurons (Miller and Azmitia, 1999). In the present study, the
proportion of glial cells from all developmental ages remained constant between days 4
and 9 in culture (Figure. 2.7). Since the proportion of astrocytes did not change with time
in culture, it is clear that this Neurobasll/B?7 medium inhibits the proliferation and
overgrorvth of astrocytes, altlrough astrocytes remained viable. It is well-established that
serum-free culture conditions inhibit astrocyte cell division (Marriott et al., 1995). The
lack of glial cell proliferation means that culturcs did not need to be treated with an agenr
such as 5-fluoro-2'-deoxyuridine (FDU) or p-D-cytosine arabinoside (Ara C) to inhibi
division of non-neuronal cells. This is advantageous for setting up healthy culturesr
because addition of Ara C has been shown to cause neuronal cell death (Wallace anrl
Johnson, 1989), and exposure to FDU for greater than 24 h can also be neurotoxic.
2.5.4.3 Presence of Cholinergic cells in primary brainstem cultures of the rat
ChAT-positive cells were present in cultur"es from the rat brainstem. The choline acetl,l
transl'erase (ChAT) antibody is commonly used as a marker for cholinergic neuror,s
(Knusel and Hefti, 1988; Burton et al., 1995; Chen et al., 2001). The presence of
cholinergic neurons was tested to help determine if brainstem neurotransmittr:r
characteristics were maintained in culture. ChAT-positive neurons are found in mar'y
brainstem areas including the NTS and spinal trigeminal tract (Barry et al., 1993; Barry et
79
a1.,2001). areas also shown to express opioid receptors (Delfs et al., 1994; Mansouret al.,
1994; Arvidsson et al., 1995a; Arvidsson et al., 1995b; Bausclr et al., 1995a; Mansour et
al., 1995; Moriwaki et al., 1996; Cahill et al., l00lb). In the present study ChAT-positive
neurons werc found in primary cultures of the rat brainstem at all stages of development
tested from El6 to P6.
2.6 CONCLUSIONS
A serum-free primary culture system was successfully developed for establishing and
maintaining foetal brainstem cells in culture. In addition, it was possible to culture
postnatal brainstem neurons up to age P6 in a completely defined medium. These studies
reinforce several key factors that must be considered when culturing late foetal and early
postnatal brainstem neurons: (l) optimal osmolalities must be provided for different
developmental ages of neurons: (2) antioxidant-rich medium supplements should be
included in culture media; (3) glutamine cytotoxicity should be controlled by partial
replacement with GlutaMax Il (4) culture media that do not include glutamate should be
used, and (5) Hibernate medium/B27 (lnvitro-een) should be considered to increase neulon
survival during tissue dissociation. Taking account of these factors, this study has
provided the first reliable method, using a defined culture medium, that supports the
culture of brainstem neurons from late foetul and early postnatal stages of the rat. A well-
characterised cell culture system allows developmental studies of the rat brainstem to be
carried out at a later developmental age than has previously been possible.
ri0
CHAPTER 3
3 Opioid Receptor Distribution In Cultured Cells
3.1 AIM
The aim of the present study was to charactcrise mu opioid receptor (MOR) and delta
opioid receptor (DOR) expression durin-t late lbetal and early postnatal development of the
rat using primary cultures of dissociated brainstem cells. Using the culture technique
described in Chapter 2, changes in the expression patterns of MOR and DOR during
development were investigated.
3.2 INTRODUCTION
3.2.I A NOVEL BRAINSTEM CELL CT]LTURE SYSTEM FOR STUDYING
OPIOID RECEPTOR EXPRESSION DURING DEVEI,OPMENT
Using the dissociated brainstem cell culture method previously developed (Chapter 2)
(Kivell et aI.,2000,2001), brainstem cclls from late foetal and early postnatal stages were
used to study opioid receptor expression during early development, a critical time when
neuronal control of cardiovascular and respiratory I'unction is established (Moss and
Laferridre, 200?). MOR and DOR action in the brainstem has been shown to modulate
cardiovascular and respiratory functions (Laf'erridre et al., 1999) (for reviews see (Guyenet
et al., 1994; Vaccarino and Kastin,2001: Pugsley,200?)). Primary cell cultures were usec
because they more closely resemble the irl ui lo brainstem than established neural cell lines
in part because of the heterogeneous population of neurons and astrocytes present in the,
cultures. A secondary advantage of using primary cultures is that established cell liner;
often have random loss or gain of 
-qenotypes and phenotypes. Thidly, an established cell
line that models brainstem cells does not exist. A better understanding of opioid receptor
expression during early brainstem dcvelopment is thus possible using primary culture
techniques coupled with immunocytochemistry (tCC) and confocal microscopy (Ojcius et
al., 1996).
3.2.2 OPIOID RECEPTOR IMMUNOCYTOCHEMISTRY
Several ditferent methods werc used in the present study to achieve optimal opio d
receptor visualisation in cultured cell lines and in primary brainstem cell cultures. Wht:n
rJl
this project was first started, there were t-ew commercially available opioid receptor
antibodies. The antibodies that were available lvere of questionable quality, presumably
due to the difflculty generally encountered in making good antibodies to G-protein-coupled
receptors. Problems with detection of antibody signal as a result of low expression levels
were also common. These ditficulties made it necessary to pre-test opioid receptor (OpR)
antibodies from different sources in order to choose the one with the highest specificity and
to evaluate that antibody with different signal amplitication strategies. One arnplification
method that was used was Tyramide Signal Amplification (TSATM) (Perkin Elmer Life
Sciences Inc., Boston, MA, USA). This reagent is available in a complete kit designed to
amplify weak signals [Buki, 2000 #893; Shindler, 1996 #93S]. TSA uses HRP enzyme to
catalyse the deposition and covalent cross-linking of haptens (FITC, Rhodamine, Biotin),
or other detection reagents to the HRP-conjugated antibody. TSA allows a lower
concentration of primary antibody to be used, thus, minimising non-specific primary
antibody binding that can occur at high concentrations, while generating the high signal
amplification that is necessary for the rcceptol's to be detected (De Haas et al., 1996;
Hunyady et al., 1996).
3.2.2.1 Opioid Receptor Localisation in SH-SYSY Cells
Previous studies have shown that SH-SY5Y human neuroblastoma cells endogenously
express MOR, DOR and KOR (Yu et al., 1986; Cheng et al., 1995a). The exact expression
level of opioid receptors on these cells varies according to the methods used to detect OpR
expression and whether the cells are dif'ferentiated or not. Kazmi and Mishra (1986) repor
a2ll ratio of MOR/DOR (Kazmi and Mishra, 1986): whereas, Yu et al. (1988) report ir
ratio of 
-5/l (Yu and Sad6e, 1988). When SH-SY5Y cells are differentiated with all-tran;
retinoic acid (RA), the neuroblastoma cells become more like mature neurons (Pihlman et
al., 1984). The density of MOR increases by 32-40 7o, whereas DOR density remains th,:
same (Yu and Sadde, 1988). The levels of MOR mRNA have also been shown to increase
on differentiation (Jenab and Intunisi, 2002). The amount of MOR protein at the SH-
SY5Y cell surface has been repofted to be in the range of 43 fmol/mg protein (Law et al.,
2000c). MOR expression on SH-SYSY cells has been further classified to be of the ;r2
subtype because the rcceptors reversibly bind naloxonazine (Elliott et al., 1994).
Naloxon:zine is known to ireversibly bind and block p; opioid receptors (Ling et a .,
1986: Pick et al., l99l); thus, reversible binding suggests that p2 receptors are present. Tlre
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SH-SY5Y cell line has become a well-characterised, reproducible cell model for studying
opioid receptor regulation and function (P&hlman et al., 1990; Gies et al., 1997) and
provides an ideal positive control for opioid receptor immunoreactivity.
3.2.2.2 Opioid Receptor Localisation in Prinrary Culture
Many studies have used ligand binding, autoradiography and biochemical responses to
confirm the ptesence of OpRs in primary cultures of dissociated cells fiom rat brain
(Vaysse et al., 1990). brainstem (Miller and Azmitia, 1999), and dorsal root ganglion (Fan
and Crain, 1995; Chen et al., 1997). Few studies, however, have used ICC to look at
opioid peptides or opioid receptors in primary cultures. with the exception of He (1992)
who detected dynorphin and enkephalin presence in dendate gyrus cell cultures, Kulkarni-
Narla (2001) who studied DOR and KOR expression in ileal myenteric neurons (He et al.,
1992; Kulkarni-Narla and Brown,200l) and Lee et al. (200?) who studied fluorescent
ligand binding in cortex cultures (Lee 2002). No ICC localisation of opioid receptors has
been reported in primary cultures of the brainstem. Most studies on OpR functions in
primary culture use rat dorsal root ganglion cells (MacDonald and Werz, 1986; Werz et al..
1987), striatal cells (Maus et al., 1990), hippocampal cells (Vaysse et al., 1990),
hypothalamic cells (Di Scala-Guenot et al., 1990; Vaysse et al., 1990), and cells cultured
from the cerebral cortex (Erikson et al., 1990: Erikson et al., 199?). Cells cultured from
different brain regions may regulate OpRs ditferently due to expressions of different forms
of adenylyl cyclase, and g-protein coupled receptors in these regions. The present studl
provides a good immunocytochemistry based model for further studies on opioid recepto-'
expression in cultured cells of both primary and established cell lines.
3.2.2.3 Developmental expression of MOR and DOR
Previous studies have shown that OpR expression changes during development. Thes;
changes have been described in detail in Chapter I (Section: 3.2.1) and Chapter 6. Brieflr,,
OpR binding studies show that MOR and DOR expression levels increase during late
foetal and early postnatal development (Tsang et al., 1982; Villiger et al., 1982; Kornblurn
et al., 1987: Attali et al., 1990; Xia and Haddad, l99l:Zhu er al., 1998). The level of
expression is dependent on the brain region studied. Opioid receptor development occurs
earliest in the brainstem and later in the striatum, midbrain and coftex (Coyle and Pe t,
33
1976). The functional implications of chanses in expression during development have
bcen discussed in Chapter I (Section: t.3.7 and 1.4).
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3.3 METHODS
3.3.1 CELL CULTURE
3.3.1.1 Dissociated Brainstem Cell Culture
Primary cultures from brainstems of foetal and early postnatal rats were grown on poly-D-
lysine-coated coverslips in serum-free Neurobasal culture medium supplemented with B-
2J, as described in Chapter 2 (Secrion: 2.3.1).
3.3.1.2 SH-SYSY Cell Culture
The human neuroblastoma cell line SH-SY-SY was obtained f'rom Dr Mark Grimes
(Massey University, Palmerston Norrh, New Zealand). The cell line was grown in Roswell
Park Memoriai Institute 1640 medium (RPMI-1640, GIBCO, Invitrogen) containing 5
mgll- phenol red,? gll Na2COr, 30 nM selenium, l07o FCS (v/v), 50 U/ml penicillin G,
and 50 tt'ilml streptomycin sulphate. The cell line was grown either directly on the
polystyrene surface of the culturc dish or on circular coverslips (13 mm diameter).
Coverslips had previously been cleaned and then coated with 
-50 1tL of l0 pglml- poly-D-
lysine (Si-ema) in the same way as described for primary brainstem cultures (Chapter 2,
Section: 2.3.l).
Cell differentiation was induced by addition to the culture medium of I pUmL all-trans
retinoic acid (RA) (Sigma) (10 pM stock in lO\Vo ethanol). The 1000x stock solution ol
l0 pM RA was kept at 
-20"C in the dark. Cells were dift'erentiated for between 7-14 days
and fed twice weekly by removing the entire medium by aspiration and replacing it with
fresh medium containing RA.
Stock culturcs of SH-SYSY cells were passaged every 5-7 days by washing the attacherl
cells with sterile PBS, then adding trypsin solution to dissociate the cells (0.057o trypsin;
5.3 mM EDTA; Invitrogen). Culture medium containin-e FCS was added to the culture
dish, the cell suspension was transferred to a 15 mL sterile centrifuge tube (Becton
Dickinson, Christchurch, NZ) and centrifuged in a bench-top centrifuge for 3 min at 1200
rpm. The supematant was discarded. the cell pellet resuspended in fresh medium, and the
cell suspension transferred into new culture dishes.
ti5
3.3.1.3 LLC-PKI Cell Culture
A pig kidney cell line, LLC-PKI, obtained l'rom Flow Laboratories (Elvine, Ayrshire,
Scotland) was cultured in RPMI-1640 medium (Invitrogen). Cells were glown on
coverslips and maintained and passaged in the same way as described above for SH-SY5Y
cells. LLC-PKt cells differentiate spontaneously upon reaching confluence, as evidenced
by the formation of domes in cultures. Domes are raised areas of epithelium that fbrm in
culture on non-porous surfaces as a result of vectorial (apical to basal) fluid transport under
the cell monolayer (Mullin er al., 1980).
3.3.2 IMMUNOCYTOCHEMISTRY
3.3.2.1 General Immunocytochemistry Methods
All cell culture samples were fixed, washed, and had endogenous peroxidase activity
removed as described in Chapter 2 (Section: ?.3.2.2) and Appendix 2 (Section 3). The
samples were washed between all steps for3x 5 min each in PBS containing}.?Vo Triton,
except alter blocking. Non-specific primary antibody binding sites were blocked at room
temperature lbr 30-60 min in the appropriate blocking solution. For non-TSA-amplified
samples, the blocking solution consisted of PBS containing 27o normal goat serum (NGS),
4Vo bovtne serum albumin (BSA), and 0.2%, Triton. For TSA amplification, the blocking
solution was supplied in the TSA kit. Blocking solutions were stored in 25 mL aliquots at
-20'C. All antibodies were also diluted in blocking solution to the appropriate
concentration. Primary antibodies were incubated with cells at 4'C overnight. Secondarl
antibodies were incubated lbr 2 hrs at room temperature, unless otherwise stated. Al
samples labelled with fluorescence probes rvere mounted onto slides cell-side up using
anti-fade mounting medium (Appendix ?: Section 7) and covered with number 0 coverslips
(BDH). The edge of the coverslips was sealed with clear nail varnish or Repai:
Vulcanising Rubber Solution (bicycle tyre repair glue) (Weldtite Products, Bar-ton orr
Humber, England) and protected from li-eht. Samples were viewecl, scanned and
photographed immediately after fluorescent staining, although fluorescently labelled cells
could be stored for 1-2 days at 4'C in the dark with only minor loss of fluorescence
intensity. Some DAB-stained coverslips were counterstained using 37a toluidine blue by
immersion in the solution for several minutes, washing and mounting. Toluidine bh,e
stains cell nuclei and improves visualisation of non-labelled cells, thus allowing altcells ro
be counted.
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To study OpR expression during development. all paired samples from each developmental
age and each time in culture were collected and stained at the same time as a matched set.
DAB colour development was stopped after the same duration of staining in these age-
matched samples. This procedure was used to prevent any differences arising fiom
variations in DAB colour development when the same samples were tested on different
days.
3.3.3 AMPLIFICATION AND DBTECTION METHODS
3.3.3.1 Digoxigenin Secondary Antibody Amplification Method
Digoxigenin (DIG) (l:10, anti-rabbit DIG), l:10, anti-mouse DIG), Chemicon), followed
by anti-Dlc FIRP (l:500, Roche), was used as an alternative to the biotin/avidin
amplification method. DIG-conjugated antibodies have the advantage of forming few non-
specific interactions with animal tissues, unlike avidin/biotin, which may bind non-
specifically to animal tissues.
3.3.3.2 Tyramide Signal Amplification
FITC- or Rhodamine- conjugated: FITC or Rhodamine labelled TSA was used to amplify
and visualise HRP-conjugated secondary antibodies. Atier incubation in secondary
antibody, samples were washed (3x 5 min) as previously described, then incubated with
TSA solution containing l:50 dilution of amplification reagent in the supplied butfer.
according to the manufacturer's instructions. Coverslips were incubated for 4 min at room
temperature, washed as described previously, and mounted onto slides using anti-fade
mounting medium.
Biotin-coniugated: TSArM-Biotin was used as an alternative to biotin labelled secondarv
antibodies because it increases the amplification of the signal. Primary antibodies wer:
incubated with cells as described previously, washed, incubated in HRP-conjugated
secondary antibodies (anti-guinea pig IgG HRP; l:2000 for MOR, and anti-rabbit Igti
HRP; l:5000 for DOR), washed, then incubated in TSA-Biotin (l:50), as per
manuf-acturer's instructions. After incubation in TSA'rM- Biotin (3-10 min) the tissue was
washed, then incubated in ExtrAvidin-HRP (l:1000) and washed again befbre DAB colorrr
development, as described previously in Chapter 3 (Section: ?.3.2.3) and Appendix 2
(Section: 4).
r) -,t, I
3.3.4 PRIMARY ANTIBODIES
33.4.f Rabbit anti-MOR (Chemicon)
Several different antibody staining protocols and combinations of antibodies were used for
MOR ICC (Table 3.1). Initially rabbit polyclonal MOR antibody against the C-terminal of
the rat MOR receptor was used (Chemicon International, l:2000-l:5000; Temecula, CA,
USA). The secondary antibody was FlTC-coupled, sheep anti-rabbit IgG (l:50-l:t50:
Sigma).
3.3.4.2 Rabbit anti-MOR (gift of Dr Stephan Schulz)
This anti-MOR antibody, raised against the amino terminal of the rat MOR. was kindly
supplied by Dr Stephan Schulz from the laboratory of Professor Vdlker Hdllt (Orto-von
Guerich University, Germany) (Schulz et al., I99S). Briefly, rabbit anti-MOR primary
antibody was used at a dilution of l:3000 for TSA-FITC, TsA-Rhodamine or TSA-Biotin
amplification. A dilution of l:1000 was used fbr non-TSA amplification for either DIG or
Biotin/ExtrAvidin amplification, as described in amplification and detection methods
(Section: 3.3.3).
3.3.4.3 Rabbit anti-MOR (Research and Diagnostics Antibodies)
Rabbit anti-MOR serum, specific tbr the carboxyl terminal of the rat MOR (Research and
Diagnostic Antibodies (R&D), Berkeley, CA, USA) (l:500) was incubated with either
cultured brainstem cells, LLC-PK1 cells, undifferentiated or RA-differentiated SH-SY5Y
cells. Signal amplification was carried out using anti-rabbit IgG biotin for 2 h at roolr:
temperature, followed by ExtrAvidin-HRP (Sigma). Antibody binding was visualisecl
using both colourmetric (DAB) and fluorescence methods. Immunofluorescence war;
achieved by substituting ExtrAvidin-FITC ( I :10001 Sigma) for ExtrAvidin-HRP.
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Negative contnf,ls were set up by: i) incubation in the absence of primary antibody or ii)
incubation with primary antibody in a cell line (LLC-PK1) that does not express MOR and
DOR or iii) pre-incubation of the primary antibody with an excess of the MOR peptide
used to generate the antibody (250 pgiml; Research and Diagnostic Antibodies, Berkeley,
CA) in order to compete with the tissue epitope sites. The peptide rvas added ro the diluted
antibody solution 45 min prior to incubation with the tissue in order to allow binding of the
peptide to the primary antibody.
3.3.4.4 Guinea Pig anti-MOR (Chemicon)
The guinea pig (GP) anti-MOR antibody con'esponds to amino acid residues 384-398 of
the carboxyl-terminus of the cloned rat MOR-I. Briefly, samples were incubated with
primary antibody, GP anti-MOR (l:2000) tollowed by anti-GP IIRP (l:2000, Zymed
Laboratories Inc., San Francisco, CA, USA) and then amplified by the TSA (FITC,
Rhodamine or Biotin) amplification protocol.
3.3.4.5 Rabbit anti-DOR (Chemicon)
To detect DOR in cultured cells using colourmetric DAB reagent, rabbit anti-DOR
antibody (l:1000) against the rat receptor was incubated with cells. the cells were washed,
and then incubated with anti-rabbit DIG (l:10), washed again, then incubated with anti-
DIG HRP (l:-500). To detect DOR by fluorescence, primary antibody (rabbit anti-DOR'
was incubated at a lower concentration (l:3000) than tor colourmetric detection, the cell:
were washed, then incubated in anti-rabbit IgG DIG (l:10), washed again, then incubatecl
in anti-DIG HRP (l:500), washed once more, then treated with TSA (FITC or Rhodaminet
rcagent.
3.3.5 DOUBLE-LABELLING EXPERIMENTS
Double-labelling experiments werc carried out using a method modified from Rocheville
et al. (2000) and Pecci Saavedra et al. (1993) (Pecci Saavedra et al., 1993; Rocheville ct
al., 2000). Double-labelling experiments were carried out using a neuronal specifrc
marker. mouse anti-MAP2 (l:1000. Sigma). and guinea pig anti-MOR (l:2000, Chemicon)
or rabbit anti-DOR (l:2000. Chemicon). Alternatively. samples were double-labelled wi'h
MOR and DOR antibodies instead of OpR and MAP2 antibodies. Double-labelling wrs
possible because the primary antisera were raised in different animal species (Figure 3.1).
')0
Double-labelling was carried out in the sarme way as for single-labelling, except where
indicated. Primary antibodies were incubated together on the same samples in blocking
solution overnight, washed, incubated in one HRP-conjugated secondary antibody (for
example for MAP2 detection, anti-mouse IgG-HRP) for I hr at 37'C, washed (3x 5 min),
amplified using TSA-FITC, and washed again. Peroxidase activity was then removed by
incubating the cells for l5 min in hydrogen peroxide solution (Appendix 2: Section 3) but
replacing 507o methanol with ddH2O since methanol causes a reduction in the fluorescent
signal. The sample, labelled in this case for MAP2, was then washed and incubated with
the other secondary antibody specific l'or the second primary antibody (for example, for
MOR detection, anti-GP-I{RP) as described ahove, washed (3x 5 min), then incubated with
TSA-Rhodamine, washed, then mounted onto slides in anti-fade mounting medium. Carc
was taken after fluorescence labelling to protect the samples from light during washes and
subsequent incubations. When using this double-labelling method, it was necessary to
carry out multiple controls to ensure speciticity of the staining. These controls are
described in Table 3.2.
3.3.6 COUNTERSTAINING OF THE NUCLEUS
Propidium iodide (PI) was used to label the nucleus in some fluorescently labelled samples
to help pinpoint antibody localisation within the cell body and identify the proportion of
positively labelled MOR and DOR cells. Without PI labelling of the nucleus, it is difficuh
to identify individual cell bodies in cell clumps. PI stock (100 pglml- in anti-fade solution
and stored in the dark ut 4"C) was diluted immediately before use in PBS washing buffer tc
a final concentration of I pglmL. Samples were then counterstained with PI afte.'
fluorescent labelling was complete, then washed and mounted as previously described.
1fl
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Figure 3.1
Method for Double-Labelling using TSA
Double-labelling of MOR and DOR using Tyramide signal amplification (TSA). Cells were
incubated with primary antibodies ( | a. t b). tbllowed by an HRP-labelled secondary antibody (Step
2). TSA amplitication was then carried out. depositing a fluorophore (FITC) (MOR labelling) (Step
3), and the FIRP activity of the t'irst secondary antibody tbr the MOR signal was removed (Step 4).
to allow independent detection of the second primary-secondary antibody combination (DOR
labelling) (Step 5). followed by'fSA amplification of the DOR signal using TSA-Rhodamine (Step
6). llence. MOR is labelled with FITC (green; and DOR with Rhodamine (red) in the same sample.
Table 3.2
Double-Labelling Method Validation
'l'he controls used to ensure that: a) peroxidase removal was complete after staining with the first
antibody and b) there was no loss of the fluorescent signal from the first antibody during staining l;lr
the second antibody binding sites.
Primary antibody First
Secondary Antibody
First
TSA detection
Second
Secondary Antibody
Second
TSA detection
Final Signal
Observerl
guinea pig anti-fvlf,R
rabbit anti-DOR
IrrOR+ DOR
anti-GP([G) l-FF
antFGP(bG) l-FP
anti-GP(bG) l-fiF
FIIC
Fnc
FIIC
anti-Rabbit (bG) FnP
anti-Rabbit (bG) l-FF
anti-Rabbit (bG) FRP
Rhodamne
Rhodanine
Rhodanine
FTTC
Rhodanin,-.
FITC and Fhod.anine
rabbit anti-DOR
guinea prg anti-lvlCR
f\PR+mR
anti-Rabbit (bG) FRP
antr-Rabbit (bG) HRP
anti-Rabbil (bG) FfrP
FITC
Ffrc
Frc
anti-GP(BG) FFF Fhodanine
Rhodanine
Rhodanine
Fnc
Rhodanine
FIIC and Rrodanine
anri-GP(bG)FFP
anti-GP(bG) FFF
.)2
3.3.7 CONFOCALMICROSCOPY
Fluorescence was visualised using a Leica TCS 4D confocal microscope with a
krypton/argon laser fitted with a 63x/1.4 NA or 40x/1.4 NA objective. Phase contrast
images were generated under transmitted light using a 40x/1.4 NA phase 3 lens. The
computer software programmes NIH Image (Wayne Rasband; http://zippy.nimh.nih.gov)
and Adobe Photoshop'" (Adob. Systems Inc.. 1996) rvere used to analyse and display the
images. As an alternative to confocal microscopy, an Olympus AX70 photomicroscope
(Olympus Optical Co., Tokyo, Japan) equipped with fluorescence and brightfield optics
was used to obtain images. The confocal microscope settings are shown in Table 3.-3. The
excitation and emission wavelengths for thc f'luorescent probes used in this study are
presented in Table 3.4.
Table 3.3 Confocal microscope settings
Fluorophore
Excitation
Filter
Excitation Beam
Solitter
Detection Beam
Splitter Barrier Filters
FITC BP 488 DD Mirror BP FITC
Rhodamine BP 568 DD RSP 580 LP 590
PI BP 568 DD RSP 580 LP 590
DAB BP 488 DD DD LP 590
Confocal filter settings allows the excitation, emission, and splitting of the wavelengths of light to bt
carefully controlled tbr each fluorophore. Abbreviations: Double dichroic mirror (DD); long pass
fitter (LP) (transmits wavelengths above the given value); band pass filter (BP) (allows transmission ol'
light around the given wavelength); second beam splitter (RSP).
Table 3.4 Excitation and emission wavelengths of fluorophores
Fluorophore
Excitation
Wavelength (nm)
Emission
Wavelength (nm)
FMC 490 520
Rhodamine 580 605
PI 535 670
Excitation and emission wavelengths of fluorophores.
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3.4 RESULTS
3.4.T SELECTION OF ANTIBODIES
Primary cultures from brainstems of all developmental ages tested (El6 to P6) and after
varying times in culture all showed positive staining for both MOR and DOR. Positive
labellin,e was seen with both colourmetdc (DAB) and fluorescent Iabelling methods.
Diff'erences were observed in the intensity of the staining with the antibodies tested from
different sources and with the use of ditferent amplification techniques (Table 3.1). Very
weak staining was observed in cells in which the primary antibody was directly bound to
FITC-labelled secondary antibody. This staining pattern was usually very ditfuse and
rcquired high voltage settings on the confocal microscope. Greater amplification was
achieved using DAB colourmetric detection, although this signal was also very weak
without the use of TSA-Biotin in the amplification protocol. No differences in the staining
patterns of membranes versus cytoplasm were observed with the ditl'erent primary
antibodies used. In all cultures regardless of the primary antibody used, a mixture of
membrane and cytoplasmic staining was seen rn ditferent populations of neurons on the
same coverslip. Specific subcellular localisations were not easily detected in DAB-stained
neurons due to the nature of the deposition of the coloured product. Ofien, staining of the
cell membrane obstructed the view of cytoplasmic vesicle staining because the tighr
microscope could not focus through the deposited coloured product on the plasmz
membrane. For this reason most cellular OpR distribution patterns were determined b1'
fluorescent detection on the confbcal microscope. General staining intensity fbr eaclr
antibody and each amplification technique was ranked on an arbitrary scale from no
staining (0) to weak staining (t), moderate staining (2), and very strong staining (3) (Tabl,:
3.1). The most specific staining, and the most intense, of both MOR and DOR occufferl
with TSA amplitication, presumably because lower primary antibody concentrations were
possible, thus, preventing the non-specilic bindin-e seen at higher concentrations with
conventional amplification methods (Table 3. 1 ).
3.4.2 DETERMINING ANTIBODY SPECIFICITY
SH-SYSY cells were used as a positive control for both DAB and fluorcscent labellirg
methods. These cells showed both MOR and DOR immunoreactivity and the stainir g
intensity was similar to that seen in primary cultures of brainstem cells. Some prima"y
rt4
antibodies were supplied with a blocking peptide that was used to test the specif icity of the
antibody. The peptides for the rabbit anti-MOR antibody from R&D Antibodies and from
Chemicon blocked most of MOR antibody binding at antibody dilutions greater than
1:1000 (Figure 3.2).
3.4.2.1 Negative Controls
LLC-PKr pig kidney cells showed no immunoreactivity when incubated with MOR (Figure
3.3A) or DOR (not shown) antibodies, and. thus, this cell line was used ils a negative
control to test antibody specificity in each experiment. Cultured brainstem cells were
incubated with blocking solution containing no primary antibody and were developed the
same as MOR and DOR antibody-labelled cells. This second type of negative control also
showed no immunoreactivity (Figure 3.38 & C). At MoR primary antibody
concentrations higher than l:1000, the MOR blocking peptide was unable to completely
block MOR antibody binding when used at a concentration of 250 pg/ml. Numerous
amplification techniques were attempted (Table 3.1). Some of these, such as FITC-
labelled secondary antibodies failed to adequately label the cells. The strongest signal
development was always achieved with TSA.
3.4.2.2 Positive Controls
The neuroblastoma cell line. SH-SY-5Y, has been reported in the Iiterature to express botl-
MOR and DOR (Yu et al., 1986) and was used in this study as a positive control to help.
establish the immunofluorescent procedures. Diff'erentiated SH-SYSY cells showed ar'
increase in both MOR and DOR immunoreactivity (Figure 3.48 & D) relative to non.
differentiated SH-SYSY cells (Figure 3.3A & C). Staining intensity was greater in cell;
displaying a more neuronal morphology, in particular, cells with neurite outgrowths.
Staining of neuronal processes cor.rld be seen using both fluorescent and colourmetri:
labelling methods. Fluorescent labelling observed with the confocal microscope was best
for determining the cellular localisation of OpRs within single cells when the cells were
scanned in three-dimensions. DAB colour development was easier for determining the
intensity of staining within cell populations. and for comparing cultures from different
developmental ages. MOR and DOR staining was observed on the plasma membrane ,rf
the cell body and on neuronal processes, as well as in the cytoplasm. Both membron€ orrd
cytoplasmic staining was observed in both bipolar and multipolar neurons, and rro
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morphologieally distinct cellular e-haracteristic coutd be deteimihed from the staining
pattern observsd in any olre n€uron. No nuclear stainine of fuIORaod DOR was f.aund in
ady nouron$ or astrocytes. In some culturos, lymp-hocytes could be s-een that werE stained
pooitive for bsltt MOR and DOR, and these lyrnphocy,tes sften ghowed nuclear staining.
Both MOR and DOR are.knowtr to be expressed in lymphocytoo (for review see) (Eidlach
2000); therefore, the lmrnurrolabelling of both the €ytoplasm and the nueleus of
ly,mphocytes seen in the p-r€sent a-tudy are likely to be specific. This result adds suppoft to
.the validation of the opR irnmgnost&ining prorocol used in this srudy'.
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Figure 3.2
Peptide Blocking of Antibody Binding
MOR labelling of SH-SY5Y cells using DAB colour de-velopment without (A) and with (B) pre-
incubation with the MOR peptidc used to make the artibody (anti-MOR rabbit antibody and pepride
fiom R&D Antibodies). Note that the MOR immunostaining has bec-n partially blocked by the
peptide. 'fhese figures were scanned at thc same l'oltage and laser seilings on the confocal
microscope. Scale bars = 20 pm.
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Figure 3.3 Negative Controls
MOR (guinca pig anti-MOR. Chemicon) staining
of LI-C-PK, cells (A). Primary brainstem cells in
culture with no primary antibody for MOR (l)) or
DOR (C) but the usual secondary antibody and
amplilication steps using'fSA-biotin followed by
DAB colour development. Note the absence of
DAB staining in all three negative controls.
Itrightfield optics using an Olympus
photonricroscope. Scale bars = 20 pm.
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Figure 3.'l
DOR and MOR Labelling of SH-S\'5Y Cells
DOtt (A ) (rabbit anti-l)OR. Chcnricorr ) lnd \l( )lL {(') {guinea pig anti-N,{OR. ('hcnricon }
labclling ot'uron'ing unditl'ercntiatcd Sll-S\ rY cclls. antl I)Olt (t])and l\1OR (l)) labclline of
retittoic acid-ditl'crentiated SII-S\'-5\'cclls. ('clls rvclc trcatccl in culturc u,ith l() nM rctinoic
acid liu l0 dars. Nolc tlrc tiurkcr opi,rid rc(cl)lor staininr on ce'lls clisplaring a turlrc ncurtlnal
ntorphologr'(n) tlrart the llat. lcss tlil'le'rcrrtiirtetl cells Drcscnt in thc sarnc culturc tiish (l'). Scalc
hars = l0 rrnr.
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3.4.3 OPIOID LABELLING OF DIF}-ERENT CELL TYPES IN PRIMARY
CI"JLTURES OF THE RAT BRAINSTEM
MOR and DOR staining of brainstem cells in primary culture were examined using DAB
staining (Figure 3.-5, Figure 3.7 and Figure 3.8). MOR and DOR positive cells in culture
were classified according to their morphology as either bipolar or multipolar neurons, type
I or type 2 astrocytes, or other cells, using a photomicroscope equipped with brightfield
and phase-contrast optics. Neurons could be seen as phase-bright cells, ol'ten growing on a
layer of astrocytes (Figure 3.58). Astrocytes wele commonly closely associated with
MOR- and DOR-positive neurons and, with the light microscope, looked as if they were
connected to each other (Figure 3.5A). The most intense MOR and DOR staining was
seen on neurons whose identity was conflrmed by double-labelling with the neuron
specific marker MAP2. Fluorescent double-labelling of MOR and MAP2, or DOR and
MAP2, with FITC and Rhodamine showed colocalisation (Figure 3.6). Fluorescence was
observed by confocal microscopy. Combined images showed that most (>95a/o) of the
opioid receptor labelling was on MAP2 positiv'e neurons.
OpR staining intensity was also partially quantified by brightfield microscopy using DAB
(Figure 3.7 and 3.8). Staining intensity of cells was classifled on a scale ran_eing trom 0 to
3 (0 = unstained, and 3 = intensely stained) for each cell type described above. Primary
brainstem cultures were labelled with the rabbit anti-MOR antibody (Chemicon) or the
rabbit anti-DOR antibody (Chemicon) and arnplified using anti-rabbit IgG DIG and anti-
DIG HRP before colour development using DAB. Differences in opioid receptol
exprcssion between the different cell types present in culture werc assessed. Both MOF'
(Figure 3.7) and DOR (Figure 3.8) labe lled cells were seen at all developmental ages testerl
(Figure 3.9). Data pooled from all developmental ages fbr MOR (P < 0.002, n = .i
coverslips f}om each developmental age, Kruskal-Wallis test) and DOR (P < 0.0001, n = .l
coverslips from each developmental age, Kruskal-Wallis test) showed significantly greater
staining intensity of neurons compared rvith glial cells. The actual intensities are difficult
to compare directly because glial cells are llattened cells, whereas the soma of neurons is
rounded, and thus, may appear darker because of its thickness. There were no significant
dil'ferences in the staining intensities between bipolar and multipolar neurons or between
type I and type 2 astrocytes (data not presented). Not all neurons showed OpR
immunoreactivity. No difference in the percent of OpR positive neurons was seen'n
cultures from the diff'erent developmental ages. ln all cultures, 40-707o of the neurolls
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were OpR positive (with the same percent of MOR and DOR positive cells present in all
cultures). Large variations in the percent neurons, however, were seen between cultures
prepared on different days.
In Summary, it was concluded that: a) OpR expression was greater in neurons than in glial
cells, but that there was no difference between bipolar and multipolar neurons: b) there was
no obvious difference between the number of MOR and the number of DOR expressing
neurons in the cultures; c) astrocytes expressed both MOR and DOR, but at very low
Ievels; e) There were no obvious dit'ferences in the number of cells stained or the
proportion of MOR- versus DOR-positive cells between cultures prepared from different
developmental ages.
3.4.4 OPIOID RBCEPTOR EXPRESSION TN PRIMARY CULTURES DURING
DEVELOPMENT
3.4.4.1 Neuronal MOR and DOR Expression During Development
MOR expression changed during late foetal and early postnatal development in primary
cultures of the rat brainstem. Data pooled from MOR-labelled neurons of foetal (E l6-El8)
and postnatal (P1-P6) cultures showed that developmentally more advanced postnatal
stages were mol.e intensely stained (P < 0.006, n = 423 cells, Mann-Whitney test) than
foetal cultures (Figure 3.9A). There were no significant clifferences in DOR expression
levels during development (Figure 3.98).
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Figure 3.5
Morphology of Opioid Receptor Positive Cells
DOlt-labelled (rabbit anti-l)OR. ('henricon) l: lti primarl brainstem cc'lls (A) r'isualised b1'
DAB. Note the darkly stained D()R-positile ncurons (n) and thc less intenscly staincd ty'pc
I astroc)'tc (g). Astrocvte/neuronal and ncuronal/ncuronal conneclions can be seen. (B)
Phase-cttntrast rnicroscopy ol'a lbetal Hl6 prinrary brainstenr culture shous phase-bright
neurons (n) lying ttn top ol'a layer ol'astroc1,tes. I\4OR staining of this same photo using
brightlicld optics can bc seen in l:igurc 4.7A. tlrightticld (n; and phase-contrast
nricroscopv (fl). Scale bars = 20 pnr.
Figure 3.6
MOR and MAP2 Colocalisation
Contbcal imagcs ol- MOR (guinea pig anti-fv{OR) and MAI)2 douhlc-labclled rat
hrainstem cells in culturc shorving MC)R-positive cclls (grccn) ancl MAP2 positir.c
neurons (red). Sorne cells shou'MOR labelling ol'the cytoplasnr of lhe sonra (s): lvhereas,
MAPI localisation is usually in thc cell pr()ccsscs (p). No nuclear (nu) staining is seen.
Some single neurons show doublc-labelling ol'both MOR and MAP2 (B) (i'ellow).
Similar results were ohtained lbr D()l{ and MAP2 staining in culture (results not shorvn).
Scale bars = 20 trm.
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Figure 3.7
MOR Expression During Development
Foetal El6 (A, B), E20 (C. D) and postnatal P3 (E, F) culrures showing the distribution of MOR (rabbit
anti-MOR, Chemicon) visualised by DAB. Some cultures (A. B. & C) have been counter-stained using
toluidine blue to visualise the nucleus and aid in the counting of cells. MOR expression is shown during
development after 4 (A, C. & E) and 9 (8. D. & F) days in culture. No significant differences were
observed in the staining pattern over timc in culture. Brightfield microscopy (A-E), Transmitted light
confocal microscopy (F). Scale bars: 20 pm.
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Figure 3.8
DOR Expression During Development
('onlbcal pictLrres (I]&W)shouirrg lX)R crpression lusing DAI]) in lbctal l:16 (n ). E2() (U). ancl
postnatal Pi (('& D). and P6 (E & l-')cclls during developmcnr. and alier 4 (A. t]. C. & E)and 9(l) & lr) days in culture. Ctlnlircal transnrirtccl light inragcs. Scale bars = 20 prnr.
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Figure 3.9
MOR and DOR Staining Intensity of Neurons and Astrocytes in
Primary Rat Brainstem Cultures from Different Developmental r\ges
Staining of neurons and astrocytes in primary brainstem cells cultured from late
tbetal and early postnalal rats (mean + SEM). I'here is an increase in staining
intensity of MOR during development (A), but no change in the staining intensity of
DOR (B). Neurons stain nrore intensely for both MOR and DOR than astrocytes.
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Figure 3.10
MOR Labelling of SH-S\'5Y Cells
Conlircal scrial scctions (.,\-lj)through N.l()R-lahellcd SII-Sll5Y cclls (guirrea pig anri-
NI()R. ('hcmic()n)(grcen) using lrranriclc'anrplilication (l:l'l C'). (lclls uerc countcr
staincd witlr prtrpidiurrr i,rdide {r,:tl ). Notc thc labelling ol'thc ccll nrenthrarrc (nr).
cltoplasnt (c). and pr()cc{scs (p}irs shorvn bv thc arrous. Scalc bar = lrJ Urn.
I {)5
Figure 3.1|
DOR Labelling of SH-SYSY Cells
Conltrcal sc'rial scclions (/\-l')through DOR-labclled Sll-Sll5Y cells (rabbit anti-DOR.
Chemicon) (green; using t1 riunidc trnrplilication (FII'C). Cells were counter stained witlr
propidiurrr iodide (red). Notc the sirnilar staining ol'both MOR (see Figure 3.9) and
DOR (this figure) in Sll-SY-sY cclls. Scale bar: 20 pm.
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3.4,4.2 Glial Cell Expression of MOR and DOR During Development
Staining intensities of glial cells in the cultures were similar at all developmental ages. In
all culturcs labelled with either MOR or DOR, glial cells showed only weak staining that
was difficult to distinguish from background. As mentioned above, the thinness of the
flattened glial cells made it difficult to comparc staining intensities directly with neuronal
staining. Type II astrccytes, however. were only lightly stained, despite having a rounded
soma similar to multipolar neurons. Astrocytes clearly stained more intensely than the
negative control cell line, LLC-PKt;thus, it can be concluded that the cells contain a low
density of OpRs of both rhe MOR and DOR subtype.
3.4.4.3 Stability of Opioid Receptor Expression in Culture
Opioid receptor expression wos measured in cultures established from fbetal (E16) and
postnatal (P6) brainstems afler 4, 7, and l2 days in culture. There were no significant
differences in either MOR or DOR immunoreactivities with time in culture (data not
presented).
3.4.5 INTRACELLULAR DISTRIBUTION OF OPIOID RECEF'TORS
The three-dimensional, intracellular distribution of opioid receptors was examined by
confbcal microscopy. In addition to plasmtr membrane receptor staining, a population o1
internalised receptots was present in neurons. Internalised OpRs wele seen as punctate or'
diffuse staining within the cytoplasnr of the soma and in the neurites. Membrane-bouncl
and internalised opioid receptors were present in both neuronal and glial cells culturerl
from the rat brainstern (Fig 3.12,3.13,3.14. and 3.15) and in SH-SY5Y cells (Figure 3.10,
3.11, and 3.14C). Nuclear staining was only seen in the occasional lymphocyte that wal
present as a contaminant in the cultures.
All SH-SY5Y cells stained positive for MOR (Figure 3.10) and DOR (Figure 3.llr.
Staining was strongest in the plasma membrane, neurites, and cytoplasm but was absent in
the nucleus. Sometimes the staining was diffuse; whereas, other times it was punctatc.
Double-labelling experiments showed colocalisation of MOR and DOR in SH-SY5Y cells.
This colocalisation of opioid receptors was found in the membrane, cytoplasmic vesicles,
and on processes. Not all MOR were colocalised with DOR receptors. and not all DOR
werc colocalised wirh MOR. Distinct MOR or DOR stained regions of the cell showed trp
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as red (MOR) or green (DOR) staining, rather than yellow (MOR and DOR) (Figure
3.14C). Often MOR and DOR staining was fbund in the axon hillock region of neurons.
Here the staining was usually intense and mostly intracellular. In other neurons intense
staining was seen in the axon and dendrites. There was no clear pattern or trend to the
staining pattern except the absence of nuclear staining in neurons and glia.
3.4.6 COLOCALISATION OF MOR AND DOR IN CELLS CULTURED FROM
THE RAT BRAINSTEM
Similar to SH-SY5Y cells, MOR and DOR were colocalised in some cells in primary
cultures of the rat btainstem from both foetal (Figure 3.14A) and postnatal cultures (Figure
3. 12, Figure 3.l48 and Figure 3.15). Colocalisation was not prcsent in all areas of a cell or
in all cells. As with SH-SY5Y cells (Figure 3.14C), there were regions within a cell that
had only MOR, or only DOR, immunoreactivity. Serial optical sections through a group of
MOR and DOR double-labelled cells in a Pl culture using confocal microscopy revealed
some predominantly MOR-positive cells adiacent to predominantly DOR-positive cells.
Other cells showed colocalisation of MOR and DOR in the same clusrer (Figure 3.15).
One region showing high MOR and DOR colocalisation is where the two cell membranes
and processes meet. In these regions it is possible that MOR and DOR are present in
boutons and synaptic junctions although the resolution in the present study is not sufficient.
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Figure 3.12
Double-Labelling of MOR and DOR in Culture
Contbcal se'rial sections througlr MOR lguinea pig anti-MOR. Chemicon) (rcd) and DOR (rabbrt
anti-DOR. Chemicon) (grecn)double-labelled cells fiom postnatal (P3) brainstenr cultures after 4
days in culture. Opioid receptor colocalisation is shown in yellow. Scale bar = 20 pm.
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Figure 3.13
Three-Dimensional, Confocal Analysis of MoR and DOR Staining in Primary
Culture
Confocal images showing similar staining pattems of MoR (A & C) (guinea pig anti-MoR.
Chemicon) and DOR (B & D) (rabbit anti-DOR. Chemicon) (green). Diffuse intense MOR (A) and
DOR (B) membrane staining of ncurons (n) and diltuse w'eaker staining of nearby type I astrocyr.es
fbr DoR (g). Some MoR (c) and DoR (D) labelling of neurons was also puncrate (p) and
cytoplasmic. Cells are counterstained with propidium iodide (red). Scale bars : 20 pm.
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Figure 3.14
MOR and DOR Double-Labelling
Cronfocal images of MOR (guinea pig anti-MOR, Chemicon) (red) and DOR (rabbit anti-DOR.
Chemicon) (green) double-taLrelled cells lrom foelal El6 (A) and postnatal Pl (B) primary
brainstem culture, and SI{-SYSY cells (C). Colocalisation (yellow) can be seen in some areas.
Negative control with no primary antibodies (D) shows no staining at the same confocal laser
setting used in A, B, & C. Scale bars = 20 pm.
Iu
Figure 3.15
Serial Confocal Sections Through a Group of Pl Cells Expressing MOR and IIOR
('onltrcal serial sections through a group o1'eells cultured fronr postnatal (Pl ) brainstem alier 8 days in
culture (A-l-). Clells arc double-labcllcd lbr lrlOR (guinca pig anti-MOR. C'hcmicon) (green) and Dr)R
(rcd). A phase contrast conlbcal transnritted light irnage (F) shows the same ficld ol'I'ic-w as A. B. ( . D.
& E. Note the punctatc DOR stainin{ (red) in several cclls surrounding A MOR-positive (green) ce | (2).
Also note that not alI cells shorv OpR inrnrunoreactivity. Arrows shou'areas o1'colocalisation where
neuronal processes ol'the neighboring cclls meet. Scale bar = 20 g rn.
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3.5 DISCUSSION
3.5.I ANTIBODY TESTING FOR IMMTINOCYTOCHEMISTRY
Antibody quality and speciticity was a problem early on in the study. Few opioid receptor
antibodies were commercially available a[ the start of the research, with the exception of
one rabbit anti-MOR antibody from Chemicon. This antibody proved to have undesirable
high background staining properties when used at the high pl'imary antibody concentrarion
initially required to give an adequate signal. TSA signal amplification however, helped
overcome the low signals initially observed using standard biotin/avidin amplification
techniques and a lower primary antibody concentration with lower background staining
levels could be used. Early studies by others involving opioid receptor localisation used
ligand-binding assays to determine OpR distributions in the brain (Mack et al., 1984; Xia
and Haddad, l99l). Some investigations used fluorescently-tagged opioid receptor
peptides, demonstrating specific binding by competition. but these studies were unable to
detect opioid receptors directly by microscopy because of the weakness of the signal (Kolb
et al., 1983; Kolb et al., 198-5; Koman et al., 1985; Mihara et al., 1985). The peptides ofien
bound to more than one type of opioid receptor, and the covalent attachment of the
fluorophore to the peptide in many cases altered binding activity, making it difficult tc
determine specific OpR distributions. In the mid to late 1980's, antibodie$ were made tr,
peptide ltagments of OpRs, and the antibocly binding was monitored (Glasel et al., 1983;
Carr et al., 1986; Myers and Glasel, 1986). These early immunostaining prorocols,
however, were only suitable for labelling transl-ected cell lines in which there was massiv,:
over-expression of receptors (Madsen et al., 2000). In 1988, Maneckjee et al. annealed on,:
of the first polyclonal antibodies to MOR tncl showed ICC fluorescenr labelling of MOI{
on a non-transfected neurotumour cell line. NCB-20 (Maneckjee et al., 1988). This was
the flrst study to use ICC for visual detection of MOR in a non-transfected cell line. MOlt
staining was seen on both the membrane and within the cytoplasm, and the staining pattern
was similar to that seen in the present study with SH-Sy5y cells.
Due to the initial unknown quality ol'the antibodies chosen in the present stucly, and the
weak staining patterns observed, numerous positive and negative controls were essential o
ensul€ receptor specificity, while amplifying the signal adequately to visualise staining.
Four different MOR antibodies were selected in our study, all targeting rhe cytoplasmic
carboxyl-terminal region of MOR. Several different splice variants of MOR have becn
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described in the literature (Gavdriaux-Ruff et al., 1997; Koch et al., 1998; Pan et al.. 1999:
Abbadie et al.,2000a; Koch et al.. 2001), and all of these MOR antibodies have been
demonstrated to be specific for the MOR-l receptor splice variant (Schulz et al., 1998). In
the present study all of the antibodies gave adequate staining, prnvided TSA amplification
was used. The DOR antibody from Chemicon was the only DOR antibody tested in the
present study, because it gave good, reliable staining, and was generally easier to work
with than the four MOR antibodies. To some extent, the ease of using the DOR antibody
was due to the experience gained with the earlier development of staining techniques lbr
MOR antibodies.
3.5.2 CONTROL FOR ANTIBODY SPECIFICITY
Throughout this study, LLC-PKr pig kidney cells showed no immunoreactivity for either
MOR or DOR using ICC and Western blotting techniques and were used as negative
controls. No pleviously studies, however, have mentioned the presence or absence ol
OpRs on LLC-PK1 cells. These cells were used as a negative control to ensure thal
immunoreactivity was only correlated with the presence of opioid receptors. Controls
using no primary antibody werc also used to ensure that there was no reaction witl'
endogenous HRP and that no non-specific DAB colour deposition occurred. DAB car
produce a brown colour on non-labelled cells if incubated for too long dunng the colou'
development step. These negative controls were incorporated into every staining
experiment and were incubated and developed for the same amount of time as thr:
experimental samples.
SH-SYSY cells were used as positive controls because they have both MOR ancl DOlt
opioid receptors present both before and after RA-induced dift-erentiation (Kazmi anJ
Mishra, 1986; Yu et al., 1986; Yu and Sadie, 1988; Cheng et al., 1995a). Dift-erentiation
could be confirmed by the morphological changes that occurred during neuronll
maturation, including the formation of long neuritic outgrowths with networks of
interconnecting processes (Pfrhlman et al., 1984; Pihlman et al., 1990). [t has been shoun
by others from radiolabelled binding experiments (Yu ancl Sad6e, 1988) thar differentiatic,n
of SH-SYSY cells causes an increase in expression of MOR. This increase in expression
could clearly be seen in the present study. which employed ICC detection protocols.
Differentiated SH-SY5Y cells with long neuronal processes showed increased staining f,rr
tI4
both MOR and DOR when compared to the more strongly attached, undift'erentiated SH-
SY5Y cells with shofter processes (Figure 3.4A & C). There have been no repofts in the
Iiterature tlom radioligand binding to suggest that DOR levels are increased in
differentiated SH-SY5Y, although an increase was clearly seen in our cultures using ICC.
The increase in MOR and DOR staining in RA differentiated SH-SYSY cells suggests rhat
OpR ICC using the amplification techniques described in the present stucly, is in fact
quantitative. However, the incrcase in staining must be large enough to be visualised. The
increase in MOR with RA differentiation in SH-SYSY cells has been reporred by others to
be approximately 32-40 o/o (Yu and Sad6e, 1988). Taking these findings into accounr, rhe
present study would expect to observe changes in OpR expression above this 307o range.
Changes in OpR expression below this level are unlikely to show statistically significant
changes in expression levels unless large sample numbers are used. The use of positive
(SH-SYSY cells) and negative (LLC-PKr cells) controls in conjunction with pepride
blocking confirmed that the antibodies used were specifically lahelling their purported
targets. The best single negative control u,ould be to use tissues from MOR ancl DOR
knockout mice to be absolutely cerlain that the primary antibodies were bindin-p
specifically. These knockout models werc not available in New Zealand at the time these
expedments were performed.
3.5.3 CELL TYPE.SPECIFIC OPIOID EXPRESSION IN CULTURE
MOR and DOR are known to be present on neurons and glial cells within the brain (Hause-
et al., 1990; Stiene-Martin and Hauser, l99l; Mansour et al., 1994; Chao et al., 1997).
Changes in astrocyte opioid receptor expression levels with the cell cycle have beerr
reported (Thorlin et al., 1999; Anders et a|.,2000), with increased expression occurring i'r
mitosis. The neurons and astrocytes in the present study, however, are unlikely to be
undergoing mitosis. Brainstem neurons undergo their last cell division between El0 and
El5 (Aftman and Bayer, 1980; Phelps et al.. 1990; Lakke,I99l), whereas, rhe astrocytes in
serum-free culture do not divide si-enificantly (Marriott et al., 1995). In the primary
cultures ol'the present study, MOR and DOR staining was significantly greater on neurons
than on glial cells. This was true l'or each developmental age tested, and in general,
staining of most astrocytes was no higher than backgrouncl levels. ln our culture moclel it
is possible that the occasional stronger staining of astrocytes seen in some cultures cou d
be attributed to their stage in the cell cycle, although this parameter was not monitore,C.
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The serum-free Neurobasal medium used in this study has been reported by others to
reduce cell proliferation (Brewer et al., 1993); thus, astrocyte cycling through the cell cycle
should be minimal. Wilkin et al. (lg9-5) has reviewed the functional significance of OpR
exprcssion in astrocytes (Wilkin et al,, 1995). In general, opioids play a role in inhibiting
cell division in astrocytes (Stiene-Manin and Hauser, 1990, l99l).
The present study is the first to describe OpR expression in cultures of brainstem neurons
during late foetal and early postnatal developrnent. A large number of neurons in culture
showed positive immunoreactivities in single labelling studies of both MOR and DOR
(between 4O-707o of total neurons in culture). It is difficult to ascenain whether the
number of OpR positive neurons present rn the present cell culture study using ICC
technique is within the expected irr liuo expression levels of MOR and DOR within the rat
brainstem.
Previous cell culture studies, by others, have measured the amount of opioid ligand binding
in cells cultured from regions other than the brainstem. Comparisons between OpR
expression levels in cell cultures isolated from diff'erent brain regions are difl'icult to due tc
OpR expression being different in different brain areas (Mansour et al., 1988; Delfs et al.,
1994; Mansour et al., 1994; Ding er al., 1996b; Cahill er al., 2001b). Irt vit,o MOF,.
immunoreactivity levels in the middle layers of the adult rat cortex have been described a;
moderate, whereas in the same study, brainstem staining was described as 'especiall.r
abundant' (Moriwaki et al., 1996). These results support the MOR immunoreactivity tbun,l
in the present study (Chapter6). One study ol pig myenteric neurons in culrure, althougr
not stating the percentage of OpR positive neurons, did state that a small percentage (10%)
of the cultured neurons were positive l'or both DOR and KOR (Kulkarni-Narla and Browrr,
2001), implying that single DOR labetled cells were much greater than 107o. Anorhr:r
study measuring dynorphin-immunoreactivity (endogenous KOR ligand) in cultured
dendate gyrus cells showed between 807a to 90Vo of neurons were OpR positive (He et al.,
1992). A recent study by Lee et al. (2002) using cultured rut cortical neurons showed
around 6.37o of neurons were positively labelled with fluoro-dermorphin, a fluorescently
tagged MOR-specific ligand. The staining pattern observed lvas also punctate and withrn
the soma and processes, similar to the staining patterns seen in the present study. In the
same study by Lee et al. (2002), DOR labelling with f'luoro-deltorphin, labell,:d
approximately I l.5Vo of cultured cortical neurons (ke 2002). Although some regions of
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the cortex have high expression levels of'MOR and DOR, the exprcssion levels within the
brainstem are greater' (Ding et al., 1996b; Moriwaki et al., 1996) especially when the
density of OpR positive neurons were measured (Delfs et al., 1994). Taking these findings
into account we would expect neurons cultured from the brainstem to show proportionally
more neurons stained positive for MOR and DOR than cultures from the cortex. The 407o
toTOVo of neurons expressing MOR or DOR in brainstem cultures seen in the present study
is therefore within realistic levels. The high proportion of MOR and DOR positive
neurons is not likely to be due to staining artefacts because of the rigorous controls used to
test for non-specific staining. It is likely tlrat the new TSA amplification techniques
allowed detection of very small receptor numbers compared with other more limited
traditional methods that use radioactive binding or avidin/biotin ICC amplification
methods.
Studies investigating opioid receptor expression in tissue slices have shown that the
brainstem has a high density of both MOR- and DOR-positive cells in particular regions of
the spinal trigeminal tract (STT), nucleus of the solitary tract (NTS) and nucleus ambiguus
(NA) (Atweh and Kuhar, I977; Mansour et al., 1988; Delfs et al., 1994; Din-e et al., 1996b:
Cahill et al., 2001b). Cells in primary culture may have altered receptor e.rpression thai
differs fiom irt uivo cell expression due to changes in the cellular environment and/or'
changes in receptor-receptor and receptor--elial interactions. However, the number of OpF:
expressing cells in the present study remains high, suggesting no significant loss of OpF:
expression.
3.5,4 OPIOID RECEPTOR EXPRESSION DURING DEVELOPMENT
Using ICC with DAB colour development, MOR immunoreactivity was shown to increas:
with developmental age of the brainstem tissue used for establishing the primary culturcr;.
These findings are supported by radioligand binding experiments that show an increase in
MOR expression between late foetal and early postnatal development in spinal cord (Attali
et al., 1990; Rahman et al., 1998), hindbrain (Spain et al,, 1985), and whole brain (Petrillo
et al., 1987). In the present study, the estirnation of MOR levels during development Ly
quantitation of Western-transferred MOR immunolabelled protein (described in Chapter 6
(Section: 6.4.4)) also supports the visual observations of staining intensity in cultu:'e
(Figure 3.9). From the present rcsults, it can be concluded that MOR expression increases
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between El6 and P6. Unlike the clear changes seen with MOR, DOR immunoreactivity
was similar in cultures established trom late tbetal and early postnatal animals. An
increase in expression of DOR durin-e early postnatal development has been reported,
based on radioligand binding in the spinal cord, (Attali et al., 1990; Rahman et al., 1998)
and whole brain. (Petrillo et al., 1987), although results from the present study do not
support this. Using ICC (Chapter 3). no changes in DOR expression were seen. In
brainstem homo-eenates from different developmental ages (Chapter 6), quantitation of
Western-transferred immunolabelled protein indicated a decrease in the expression of DOR
in the brainstern during development. Changes in expression levels that are too small to
detect using ICC methods may accouut fbr these discrepancies. In addition, the normal
variation commonly seen between cultures established from similar stages may mask small
changes that do occur. Some papers report an increase in DOR expression at a later
developmental age (Pl4) (Spain et al., 198-5) than was possible to test in our primary
culture model, since brainstem neurons older than P6 were difflcult to establish in culture.
Some older cultures were attempted, however. the rcsults were not encouraging.
The increased expression of MOR during development is well known and accepted (Spain
et al., 1985: Tavani et al., 19851 Petrillo et al., 1987), and may be related to the
development of opioid related functions during early development. For example, in thi
maturation of opioid responses to respiration, which have been described in detail ir.
Chapter I (Section: 1.3.7). Opioids are involved in the control of foetal, neonatal and adul:
breathing movements (Grunstein and Grunstein, 1982; Shook et al., 1990; Cheng et al.,
1993a; Gray et al., 1999: Liu et al., 2000; Moss and Laferridre, 2000), with changes in tht:
degree of response to opioid ligands occurring during development. These changes in
sensitivity may relate to changes in OpR expression. The significance of this is discusse,J
in more detail in Chapter 6.
The expression of DOR is generally accepted to increase during development (Spain et at.,
1985; Tavani et al.. 1985; Petrillo et al., 1987). However, the data presented in the present
chapter shows DOR expression in cells cultured from the rat brainstem does not change
significantly. Western blot results fiom brainstem lysates (Chapter 6) show a decrease jn
DOR expression with development. The significance ol'these findings is described n
detain in Chapter 6.
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Some DAB-stained cultures were scanned on the confbcal microscope and the density of
stedning measured using NIH Image software (data not presented). This gave a numerical
value for staining intensity that replaced the visual 4-point scale used for Figure 3.9. The
use of image analysis software, although making the data more 'quantitative', it did not
alter the overall findings. Because no quantitative density measurements were taken
during the early stages of the study and since the re-analysis of all the earlier data by this
method would be unlikely to yield any new infbrmation, no density analysis results have
been presented here. Staining intensity measurements were performed blind, whether they
were assessed visually or by NIH image analysis, thus, removing any possible bias.
MOR and DOR staining pattems did not change with time in culture, suggesting that the
cells in culture are stable, remaining at the same developmental stage as when they were
isolated, with no developmental up- or down-regulation of receptors. The absence of
developmental clranges in OpR expression with time in cultured cells is probably a
consequence of removal of signals controlling the developmental changes when the cells
are isolated. When brainstem tissue is isolated, neuronal connections are lost and cannol
be re-established in the culture dish. The suspension of the developmental state in culture
has some beneflts. Primary cultures are typically unstable with time as differentiatior
factors are diluted out and chromosomal aberrations occur. A stable culturc is an idea
system in which to study factors controllin,e leceptor expression levels. Since the contro.
of OpR expression during development is not understood, cell culture may provide a model
in which specific factors affecting expression can be assessed individually. For example,
neurotransmitters and growth factors can be added to cultures in a conholled manner an,l
changes in OpR expression monitored.
3.5.5 INTRACELLULAR DISTRIBUTION OF OPIOID RECEPTORS
MOR and DOR have been shown to be present on the plasma mernbrane, in axonal and
dendritic processes (Besse et al., 1990; Cheng et al., 1996; Svingos et al., 1998; Abbadie et
al., 2000b), and in cytoplasmic vesicles (Abbadie et al., 2000a; Cahill et al., 2001b). Th:s
distribution could clearly be seen in the present study in neurons from primzry brainstern
cultures and in SH-SYSY cells. Although differences in staining patterns were seen n
individual neurons in culture, there were no overall differences in staining patterns n
cultures established form different ages. Neurons from both late foetal and early postnatal
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cultures showed a variety of membrane and cytoplasmic staining patterns, and staining
could be diffuse, punctate, or a mixture of both, depending on the individual neuron. Both
MOR and DOR undergo rapid down-regulation following exposure to their respective
agonists (Chang et al., 1982: Law et al., 1983; Puttfarcken and Cox, 1989). Down-
regulated receptors presumably give a punctate, non-membranous staining pattern if the
rcceptors are sequestered into intracellular vesicles. The reason for the diffuse cytoplasmic
staining is unknown, but may relate to poor antibody resolution of smaller vesicles. Opioid
receptor localisation within the cell, specifically down-regulation of opioid receptors ftom
the membrane to cytoplasmic vesicles, is discussed in detail in Chapter 4. Punctate
staining of MOR and DOR within the cell body may be due to newly synthesised receptors
awaiting insertion in the membrane. MOR and DOR receptols may also be awaiting
transpofi to the neuronal processes, although recent studies suggest that OpR are recycled
locally, as no changes in immunoreactivity were observed between the soma and processes
with agonist exposure over time (Lee et al., 2002). However, the methods used in the
study may not have been sensitive enough to visualise receptor trafficking. Also, the
receptors could have been transported retrogradely, as well as anterogradely. Transpott ol
OpRs may be important in cultured neurons with rapidly growing neuritic processes. Fol
example, cytoplasmic OpRs may be transported to neuronal processes for OpRs insenior,
into these pefipheral processes. Future experiments specifically measuring the synthesis o-'
new OpR proteins may help determine if this is the case.
Having a large population of inactive receptors inside the cell has the advantage oi
providing a mechanism for a fast response or up-regulation. Excess OpR expressiorr
within the cell may allow for a sudden increase in opioid function if the cell becomes over-
stimulated, or they may act to down-regulate a neuron when too much excitatory input
comes to it. It remains to be determined if this in fact the case. MOR and DOR doubls
labelling in the present study was often greatest in closely associated neurons cr
connecting processes. The resolution in tlie present study, however, is not sufficient to
determine if this staining was localised to boutons and synaptic junctions. In future
electron microscope studies will be needed to conflrm this.
In the prcsent study, diflbrent staining patterns were observed, for example, punctate,
diffuse, membranous, and cytoplasrlic. However, no trend was seen in the staining pattern
with cell morphology or the developmental age of the culture. In future experiments, tlte
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cells could be labelled with antibodies to specific neurotransmitters, or neurotransmitter
receptors and the staining pattern of OpRs determined. This would help to correlate OpR
staining pattern with cellular functions. Although not examined in the present study,
particular cell populations such as GABAergic or cholinergic neurons may be regulated
differently by dift-erent OpR subtypes and OpR trafficking within these cell types may be
dillerent. Colocalisation expedments using ceil specific markers may help determine if
this is the case.
3.5.6 COLOCALISATION OF MOR AND DOR
Double-labelling experiments were possible using standard double-labelling techniques
(Pilowsky et al., l99l; Pecci Saavedrar et al., 1993), because the primary antibodies used
were raised in different animals (guinea pig anti-MOR, and rabbit anti-DOR). Fluorescent
detection of these antibodies used FITC and Rhodamine because these tluorophores emit
wavelengths of light that can easily be separated using standard confbcal microscope filters
that prevent bleed-through of signal (Titus et al., 1982; Parks et al., 1983; Entwistle and
Noble, 1992; Matsumoto et al., 1993). This procedure ensures that colocalisation is real
and not a bleed-through artefact. Regular laser alignment checks of the confoca
microscope were undertaken during thc study to ensure that false positive or false negative
colocalisation data were not collected as a result of poor laser alignment.
In primary cultures of the brainstem and in SH-SY5Y cells, colocalisation of MOR antl
DOR was evident in many cells. Primary cultures showed colocalisation at all ages, front
late foetal to early postnatal stages. MOR and DOR colocalisation has been reported irt
several brain regions, including the dorsal horn of the spinal cord (Cheng et al., l99i;
Abbadie et a1.,2002) and many brainstem regions, including the STT, NTS and NA (Ding
et al., 1996b; Cahill et al., 2001b). Colocalisation implies that both MOR and DOlt
ligands can dually modulate the response ol'a single neuron. Studies on MOR and DOlt
cotransfected cells have shown that these receptors form heterodimers that have novcl
signaling, binding, and functional properties (Jordan and Devi. 1999: George et al., 2000;
Bouvier, 2001). Although heterodinrers have not yet been described in vivo, there ate
atypical functional observations that may be explained by heterodimerisation. For
example, in MOR knockout mice there is reduced DOR-mediated analgesia and DOFI-
mediated respiratory depression (Matthes et al., 1998). Thus, MOR must interact wi'.h
l:!l
DOR in some manner, possibly by heterodimer formation between the two receptors. The
binding and functional properties of each opioid receptor subtype, although extensively
studied, cannot be fully explained, and this provides further evidence that heterodimers
may exist in cells wherc MOR and DOR arc colocalised. Only one MOR gene has been
described (Wang et al., 1994), although numetous splice variants exist (Koch et al., 1998:
Pan et al., 1999; Koch et al.,2001; Pan er a1.,2001). Thus, receptor subtypes may be
generated in part by heterodimerisation and in paft by variations in pre- or post-
translational modification of the mRNA.
3.5.7 SUMMARY AND CONCLUSIONS
Primary culture provides a good model to study opioid receptor expression during
development. There are several advantages of using primary cell cultures to study
developmental changes in opioid receptor expression. Cell culture enables three-
dimensional, intracellular localisation of receptors within the cell, and it is possible to
visualise individual neurons and their processes. This detail at the cellular level is not
possible using tissue slices, in part because thin sections are required for antibody
penetration, and these do not allow observation of long neurite processes that extenc
thtough a number of slices. The density of cells in slices also makes the individua
characteristics of each cell difficult to visualise due to masking of signals. In culture.
however, the cell density can be controlled, allowing individual neurons and thei''
processes to be easily observed. The disadvantages of using a tissue culture model are that
changes in gene expression may occur after cells are lemoved from their normal
environment, and developmental cues from other brain regions, including humoral
regulators (neulotransmitters, glial trophic factors) and synaptic connections are absent.
The present study is the first to measure MOR and DOR expression and distribution in
primary brainstem cultures during development. There are several advantages and
disadvantages associated with using ICC rather than radioligand binding to detect opioid
receptor proteins. Immunocytochemistry measures total protein, including membrant:-
bound receptors and internalised receptors; whereas, ligand binding usually measures only
functional protein and does not measure internalised receptors. When using membrar e
homogenates OpR presence on intracellular vesicles is not taken into account unless the,y
are specifically isolated by centrifugation, or cells are kept intact. When interpreting data
l'.r.2
from binding rtu.dis-s it is also important to consider incu ation conditions. Opioid E-gnnds
are sensitive to ineubatio.n conditions; for example, the presence of godiunrr in the buffer
decreases the binding affinity of OpR agonists to receptors Pen and Snyder, 1974).
The aell culture mode-l used in the present study did not show any ehanges in OpR
e-xpression with rime in culture; fherefore, the cells' differentiated pheno$rye w.as stable in
culture. Untque erpression levels, however, were seen with MOR when cells were,igolated
from differen't developrnental ages, and the patterns of exp ssion were similar to thoee
reponed by otbers for IvIOR expression during developrnent. Thus, cell culture provides a
usaful msdel to srudy foetal and early rrconatal developmental changes in OpR expression.
The culture systpm w.ould not,be su,itab,le for studies on rnaturatiqn in older pos-tnatal (>P9)
or adult animals. Because OpR expression is stable with time in culrurg this method has
the advantage that it ean be used to study factors that negulate OpR expession. It also
allows for a rnore flexible timing of experimental manipulations. All things considered,
the:primary cultue model described in 
-this study provides a novel $y$tem for investigating
opioid receptor express,ion and funation during developnrent of the brainstem.
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CHAPTBR 4
4 Opioid Receptor Regulation In Culture
4.I AIM
To demonstrate that primary cultures of rat brainstem neurons can be used to model opioid
receptor responses, MOR was cloned and transf'ected into a cell line to generate a positive
control that over-expresses MOR, thus providing u strong signal tor ICC monitoring.
MOR down-rcgulation in response to an opioid agonist was then assessed. Enhanced
expression of the cloned MOR was also used to test the specificity of the opioid receptor
antibodies.
4.2 INTRODUCTION
MOR was used in this study to evaluatc opioid receptor (OpR) regulation in cultured cells.
and to observe if cultured brainstem cells express functionat OpRs. MOR-transfected cells
and SH- SY5Y cells were used as positive controls to study opioid receptor regulation
SH-SY5Y cells endogenously express opioid receptors in culture (Kazmi and Mishra,
1986; Yu et al., 1986), and MOR localisation in both MOR+ransfected cells and non'
transfected SH-SY5Y cells are regulated in culture on exposure to MOR agonists anrl
antagonists (Prathert et al., 1994; Kramer and Simon, 1999; Remmers et al., 3000).
Opioid receptor function and regulation is extremely complicated and not very well
understood. The current understanding of OpR regulation has been described in detail i:r
the introduction (Chapter l: Section: 1.2.3). Most studies have been carried out on
transfected cells that over-express MOR or on established cell lines. such as the
neuroblastoma cell line SH-SY5Y that endogenously expresses MOR. Primary culture';,
however, may provide better models to study opioid receptor function in the brainstetn
because the cells more closely resemble the natural state. OpR-positive cells in dift'erent
regions of the brain have unique functions that relate to the location of the receptors
(Mansour et al., 1987; George et al.. 1994; Arvidsson et al., 1995a; Elde et al., l99i;
Monteillet-Agius et al., 1996; Svin-qos et al., 1996; Wittert et al., 1996). For example,
OpRs in the prc-Bdtzinger complex. nucleus of the solitary tract (NTS), and nucleus
ambiguus (NA) of the brainstem are involved in respiratory modulation (Sessle and Henry,
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I"985; Dashwood et al., 1988; Shook et al.i 1990; Xia and Haddad, 1991; Takita et al.,
1998; Gray et al., 1999; Lafenidre et al., 1999); whereas, OpRs in the periagueductal gray
(FAG) play a role in pain modulation (Vaughan and Christie, 1997). OpRs h:ave b,een
shown to coloealise with various other neurotransrnitters and neurotransmitter receptofs
@ing pt a1.." 1995; Wang et al., 1996-: Gong et al., 1997; Commons et al,, 1999). The
differenf funcdons of MOR. in different brain regions may be due to unique receptor sub-
t)p€s, unique splice-vadant distributior-rs (Koeh et al., 1998; Pern'et al., 1999; Abbadie et
al., 2000a; Koeh et al., 2001), localisation with different neurotransrnitters or
rteur.otransmitter receptors (Ding of al., 1995; Wang et al., 199.6; Gong et al., 199':l;
Cornrnons et aL, 1999; Aicher et al., 2000a; McDonald and Mascagni, 2001), or fomation
sf heterodimers with novel binding characteristics andlor signal transducfion pathways
(George et a1.,, 2000; Bouvier, 20Ol; l,evac et al., 20Ol; Ramsay et al. 2ffi2]. A single
neuronal'cell line model like SH-SYSY can be used to study OpRs, but may not adoquately
reflest the.properties sf all MOR-containing cells in the brain. To better understand MOR
function in the brains,[em, a brainstem primary coll model has been,analysed and compared
with the more classical cell cuhure models of OpR regulation involviqg transfe-cted solls
and established eell lines.
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4.3 METHODS
4.3.I CEI,L CULTURE
Several cell lines were used in the present study to find a cell line with a high efficiency of
MOR transf'ection.
4.3.1.1 COS-7
The COS-7 Afiican green monkey kidney cell line (SV-40 transformed) from Amedcan
Type Culture Collection (ATCC, VA, USA) was grown in DMEM (Invitrogen) with low
bicarbonate (1.5 g/L), l0 7a FCS (v/v;,50 pM selenium, penicillin G (50 U/mL), and
streptomycin sulphate (-50 pglm|-). The cell line was passaged using trypsin as described
for SH-SY5Y cells Chapter 3 (Section: 3.3.1.2).
4.3.1.2 H44l
H44l cells are a human lung bronchoalveolar adenocarcinoma cell line (ATTC). The cells
were maintained in RPMI-1640 medium (lnvitrogen) supplemented with l07o (v/v) FCS,
50 pM selenium, penicillin G (50 U/mL), and streptomycin sulphate (50 pglml). Cells
were passaged l:10 every week using trypsin-EDTA (Invitrogen) in the same way as
described for LLC-PKr cell lines (Chapter 3. Section: 3.3.1.3).
4.3.1.3 SH-SYsY
See Chapter 3 (Section: 3.3.1.2) for detailed characteristics and culture methods of theSH-
SY5Y neuroblastoma cell line.
4.3.2 MOR CLONING
All cloning experiments were carried out under the New Zealand Environment Risk
Management Authority (ERMA) approval code, CMDOI138, in a certifiedPC2laboratory.
4.3.3 EXPERTMENTALDESIGN
Primers were designed using Oligo 6 sofiware (Version 6.02, Molecular Biology Insights
Inc., Plymouth. MN, USA) spanning the start and stop sites of rat MOR mRNA (GenBank
accession number L22455) (Thompsorr et al., 1993). The MOR forward primer spanned
the start codon and the reverse primer spanned the stop codon at site 1366 (Figure 4.1)
Optimal calculated annealing temperature of the MOR primers was 57.8oC, yielding i
t2(,
predioted t196 bp PCR produet (Figure 4.1). The'lyophiliged primers were pureh,ased
frona lnvitrogen. The prrimere were centrifuged and reconstitr:rted at 100 pM in TE buffer
(10 mM Tris; I mM EDTA, pH 8.0) and stored at 
-209C. At least 17 nuoleotides in the
region of interest cornplementary to MOR were included in e-ach primer. Some primers
included a terrninal aftB (+4Gs) Gateway-specific sequence rteed.ed for insertion of the
PCR produst into the, GatewaJru (GW) vectors. The GW eloning system Lras the
advantage that it maintains gene orientation and reading frame, cssential features for
successful transfeetion experiments. This system also allows the gene to be easily moved
into differEnt vectors. Some revelseprimers were also tagged with the FLAGsecluence
(C-TACTTGTCGTCATCGTCCTTGTAGTC (reverse complernent)), whic,h was used to
provide antibody-labelling of IvIOR transfecbd cells with FlAG-specific antibodies, The
pattern of staining of transfected eells labelled with the anti-FLAG antibody was compmed
with staining bJ MOR antihody (guinea pig anti-MOR, Chernicon) to ensure its MOR
opecificity. Anti-,FLAG antibody was aleo used !o,measure transfestion efficiency.
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Figure 4.1 MOR Sequence
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cacgagcttc tgcctgccgc
gacggagcct agggcagctg
gagtgctctc agttacaqcc
-
caccggccca lJggaacacca
agcaccr-ggc tcctggctca
tctgaaccgc accgggcttg
catggtcaca qccattacca
cggaaacttc clggtcaLgt
catctacatt ttcaacctt-g
€gagtgtcaac taccLgatgg
^$^--L-^-t +.-^t-^--^-uLUddLdgdL LduLduqdua
ccgctacatt gctgtctgcc
caaaatcqtc aacgtctgca
catggcaacc aeaaaataca
aacctggtac tgggagaacc
ggtcctcatc atcactgrfgt
gctatcgggc tccaaagaaa
ggtcgtggct gtattLaLcg
gctgatcacg atlccagaaa
gggttacacg aacagctgcc
gcgatgcttc agagagttct
t.cgagtccgt cagaacact-a
ttccactagg gctggtccat gtaagaatct
aggctggggc gcgtggaacc cgaaaagtct
gcagcaggcc ttcagcacca tggacag€g
agacccctta gctcaggcaa gttgcLcccc
cgttgatggc aaccagtccg atccatgcgg
cagcctgfgc cctcagaccg gcagcccttc
clact ctatc gtgtgtgtag tgggcctct t
aagatacacc aaaatgaaga ctgccaccaa
cgccttagcg accagta"u. t@
cttcggaacc atcctctgca agatcgtgat
catattcacc c{-ctgcacca tgaqcgtgga
agccctggat ttccgtaccc cccgaaatgc
ctcttctgcc atcggtctgc ctgtaatgtt
catagattgc accctcacgt tct.cccaccc
ctqtgtcttt aEcttcgctt tcatcatgccr
gatgatctta cEactcaaga gcgttcgcal
tctqcgcagg atcacccgga tggtgctggt
ccccatccac atctacgtca tcatcaaag(:
gacggtttcc tggcacttct gcattgcLtl.
tctttacgcc ttcctggatg aaaacttcatt
ctcgtccacg atcgaacagc aaaactccar:
ctccacggct aatacagtgg atcgaacta,t
fr!f{./ri/rfdn
tgagagqaag
+ 
- ^^+ ^-+ ^^LdLULd'j L9U
a,-d: 
^f n-f -YvYeu!YUsv
act t gt ccca
gcgggaacga
+,-1+,-^^^^+L Ud L9VLUU L
a1- gtga t tgt
ctctggcaqa
gaacat ggcc
tgt- tcaccag
acccagtcaa
act gga tcct
ggcalJqqgtc
tgctcaaaat
At F 
- ^^-^^+9LLqLr:jLJuuL
aggacaggaa
t ct-gct,ggac
^---^-++F^-UUdLdL LLUA
tgaatccagt
gcatcccaac
gggaacat cc
1321 ccaccagcta gaaaatctgg aggcagaaac tgrctccattg cecLaactgq gtctcacact:
1381 atccagaccc tcgctaagct t
-> Sequencing Primers
-+ Cloning Primerst Start and stop codons
Primer sequences are shown in bold, and indicated by arrows.
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4.3.3.1 RNA Isolation
For RNA isotation experiments. all glassware was baked for 4 hrs at 180"C. and ill
solutions wele autoclaved and/or made up with diethyl-pyro carbonate (DEPC) treate d
water (Appendix 2: Section 8). Micropipette filter tips and plasticware were purchase d
certified RNAse free, and a separate set of pipetters, dedicated only to RNA isolation, wits
used to prevent RNAse contamination.
A 50-100 mg piece of brainstem tissue trom an adult male rat was isolated ard
immediately transferred to a 1.5 mL microfuge tube containing I mL of TRIZOLo Reagettt
(Invitrogen). Tissue samples were immediately homogenised using a Polytron PT t200C
power homogeniser (Kinematica AG, Switzerland) for 30 sec at full power, taking care lo
keep the probe immersed. The sonicator probe was prepared earlier by immersion in
RNAse away@ solution (Molecular Bio Products Inc., San Diego, CA, USA), air-drierl,
then washed 3 times in DEPC-treated water before immersion in the sample. Tl'e
homogenised samples were incubated at room temperaturc for 5 min befbre the addition of
0.2mLofchloroform. Thetubeswereshakenvigorouslybyhandforl5secandincubated
at room temp for 2-3 min. Samples were centrifuged at 12,000 rpm for 15 min at 4"(1.
Following centrifugation. the upper, clear aqueous phase containing RNA was transfentd
into a new tube, and 0.-5 mL of l}Oo/r, isopropyl alcohol added. The solution was mixed
and incubated at room temperaturc for l0 min before centrifugation at 12,000 rpm for l0
min at 4oC. The supernatant was removed. and precipitated RNA could be seen as a gel-
like pellet at the bottom and on the sides of the tube. One mL of 7570 ethanol (prepared
with DEPC-treated water) was added and the pellet resuspended using a vortex mixer. The
sample was centdfuged at 7500 rpm for 5 min at 4uC. The supernatant was discarded and
the RNA pellet allowed to air dry fbr 5-10 nrin before redissolving in 21 pL of water. The
concentration of RNA was determined by diluting I prl- of RNA sample in 99 pL watt'r
and the absorbance measured in a spectrophotometer at 260 nm. The concentration c'f
RNA was determined from the nucleic acid extinction coefficient (50) using the following
calculation.
Concentration (pglpl,) = A:co x dilution x 50
t?)
4.3.3.2 Reverse Transcription- pCR (RT-PCR)
Diluted RNA (l pL of 2 ngllL) was used immediately after RNA isolarion in the RT-pCR
reaction. The remaining RNA was stored at -80"C. The integrity of RNA was determined
by running a sample of RNA (2 pL of RNA. ancl 2 pL of DNA Loading Dye) on a 0.8(%
agarose gel. Care was taken to reduce RNAse contamination by using DEPC-treated
solutions. RNAse away@ solution was usecl to wash the gel tank. Two-step RT-pCR rvt,s
performed using C. thenn. Polymerase@ (Roche Diagnostics GmbH, Mannheinr,
Germany)' Two-step RT-PCR was chosen so that each step could be performed undr:r
optimum conditions. The following reagents were pipettecl into a thin-walled
RNAse/DNAse-free PCR tube (Invitrogen). Reagents were thawed, vortexed, and placerl
on ice before setting up the reactions (Table 4.1). Oligo dT primers (Invrtrogen) were
diluted to I pM, and 0.4 pL was added to the reaction. The oligo (dT) reaction was carried
out at 60oC for 45 min in a PCR machine (Progene Techne, John Morris Scientific, NZ:)
and placed at 
-20oC overnight or until the next rcaction step.
Table 4.1 Reagents used for RT-pCR
Component Volume per
Reaction (pL)
Final Concentration
-5x RT Buffer 4.0 l0 mM Tris-HCL, pH 8.5, l0 rnM KCl, 60 mM
(NH.r): SO+.2 mM MeClr
DTT 1.0
-5 rnM
dNTP mix,
2-5 mM
0.64 0.8 mM each
DMSO 0.6 5 cla
C. tltenn.
polymerase
1.5 6 units
Primer, 20 pM
oligo dT
or mu reverse
primer
0.4
1.0
0.4 pM
1.0 pM
RNA (2 ndpl-) lpL I
Sterile distilled
water
Up to 201tL Lip to 20 pL
TOTAL 20 wL
As an alternative protocol, the reverse MOR primer (-5'-TAG GGC AAT GGA GCA GTf
TC-3') was used in this reaction to specilically amplify MOR cDNA from the roral mRNy''.
in contrast to amplification of total cDNA fl'om toral mRNA. The quantity and quality cf
l3l
the product was determined by agarose gel electrophoresis, and the product was purified
using a DNA gel purification prorocol (Secrion: 4.3.3.5).
4.3.3.3 Polymerase Chain Reaction (pCR)
PCR was performed using the Expand High Fidelity PCR System@ (Roche Diagnostics).
This system uses a thermostab.le Taq DNA polymerase. A proofreading polymerase is
included to increase the yield and reduce the number of PCR-induced errors. All reactio's
were performed on ice, taking care not to contaminate samples with foreign DNA. Mast:r
mix solutions were made from individual stocks ancl were added to sterile 0.2 mL pCR
tubes (Invitrogen) as shown in (Table 4.2). After the appropriate amounts of Master mrx
were added to each individual reaction tube, fbrward and reverse pdmers (Figure 4.2) we:e
added, along with the DNA template.
MOR primers were used both with and without the GW and FLAG tags, and pCR
conditions were optimised for annealing temperature and cycle number, A hot start pCR
cycle was used consisting of 94'C fbr 60 sec followed by 40 cycles of 95"C for 15 sec,
57.5'C for 90 sec, and 72"C for 15 sec. This 4O-cycle sequence was then follow ed,by 72'C
for 5 min, and the reaction was then held at 4"C.
l3l
Figure.l.2 MOR Cloning and Sequencing Primers
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Table 4.2 Solutions used in PCR reactions
Master mix I
Master mix 2
Reagent Volume
Sterile dd H2O 19.25 pL
10x Expand Hi Fi Buffer
(with 15 mM MgCl2)
5pt
Expand Hi Fi Enzyme Mir 0.75 pl-
rOTAL VOLUME 25 uL
4.3.3.4 Agarose Gel Electrophoresis
DNA samples containing 5 pL of DNA loading dye (107a Ficoll; 0.O25Vo bromophelol
blue) were run on 0.8olo agarose (lnvitrogen) gels containing I pg/ml of ethiclium blomide
(lnvitrogen) in TAE buffer (0.04 M Tris-acerare, I mM EDTA, pH g.0). A 100 bp DIJA
ladder (BioRad, CA, USA) was used as a standard. Electrophoresis was performed at 100
V for I hr, or until the dye front was 2/3 ol- the way down the gel. Bands were obserr ecl
under UV light and polaroid photographs taken. Some samples needed fbr later
experiments were excised from the 
-qel with a clean scalpel ancl ptaced in clean microfi ge
tubes for gel purification of the DNA,
4.3.3.5 DNA Gel Purification
DNA bands of the appropriate size for MOR were cut out of the agarose gel and purif.ed
using a QlAquick@ gel extraction kit (Qiagen, GmbH, Germany). The gel slice r.zas
weighed, and 300 pL of QG buffer (pH 7.-50) was added for every 100 mg of gel. t'he
Reagent Volume
ldArP (10 mM)
dCTP (10 mM)
dGTP (10 mM)
dTTP (10 mM)
DNA Template (10 ng)
5'Primer (100 pM)
3'Primer (100 pM)
Sterile dd HpO
1pL
1pL
1 trl
1pL
5 trl
1.5 pL
1.5 pL
13 uL
rOTAL 25 ttL
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sample was incubated at 50"C until the gel slice had dissolved. Isopropanol (100 pL cf
1007o) was added per 100 mg of gel slice. and the sample was mixed. A QlAquick@ spin
column provided in the kit was placed in a 2 mL collection tube, and the sample was
loaded and centrifuged in a tabletop microl'uge for I min at 13,000 rpm. Flow-tlrrough was
discarded and 0.75 mL of PE buff-er added. The solution was incubated fbr up to 5 min at
room temperature before centrifugation tbr I min at 13,000 rpm. The flow-through was
again discarded. the column centrifuged again, and the residual flow-through discarde'd.
Thecolumnwasplacedinaclean l.5mLmicrofugetube,and30pLof elutionbuff'er(10
mM Tris/HCl, pH 8.5) was added to the centre of the QlAquick@ membrane. The sample
was left to stand for l min to increase the DNA yield, and then centrifuged at lull speed 1br
I min. Approximately 28 pL was recovered from the column. Purified DNA was stored at
-20'C until needed for later analysis.
4.3.3.6 pGEM@-T PCR Cloning Method
The purified MOR DNA PCR procluct u,as ligated into the pGEM@-T plasmicl (Prome ga
Corporation. Madison, WI, USA), fbllowing manufacturer's instructions. Cloning reage'lts
(Table 4.3) were placed in sterile 0.2 mL PCR tubes, mixed by pipette, and incuba:ed
overnight at 4uC. The attributes of the pGEM-T plasmid are described in Appendix 4.
Table 4.3 Reagents used to ligate I\{OR into pGEM.T vector
Reagent
Standard
Reaction
Positive
Gontrol
Background
Control
2X Rapid Ligation Buffer
ff4 DNA Liqase) 5uL 5uL 5
oGEM@T Vector (50 no) 1uL 1uL 1
PCR Product 3uL
lontrol Insert DNA (4 nq/ul 2uL
T4 DNA Liqase (100u/mL) 1uL 1uL 1uL
Deionised Water 0pL 1u'L 3uL
Final Volume 10 uL 10 uL 10
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A 5 pL aliquot of this mixture was adcled to transform 50 prl- of DH5cr competent bacterra
(lnvitrogen), as described below. This pGEM@-T uecto. has a B-galactosidase (pGAl-)
colour selection feature that causes fbrmation of blue colonies if the FGAL gene is nrt
disrupted by an insert of DNA. Transformed bacteria are plated onto LB-amp agar plat,:s
(Appendix 2: Section I0) pre-coatecl with 60 pL of X-galactosidase (XGAL) solution (liO
pL of 40 mg/ml XGAL; l0 prt- of I M IPTG). White colonies were picked and culrurr:d
for DNA miniprep using the alkaline lysis merhod (see below).
4.3.4 TRANSFORMINGBACTERJA
Plasmid DNA from the cloning reactions was used to transform library efficien,:y
competent DH5o cells (Invitrogen). A l0 cm diameter petri dish containing LB amp agar
(LB medium with l.5Vo agar (DIFCO. Becton Dickinson, MD, USA) and 50 prg/nrl
ampiciflin, Appendix 2: Section l0) or LB-kanamycin agar (LB-medium with l.5Vo agar
and 50 ttg/mL kanamycin) was used to grow the bacteda, depentling on rhe anribior.ic
resistance characteristics of the plasmid. Fitiy pL of competent cells were thawed on ir:e,
placed in a 1.5 mL microtuge tube, ancl I pL of plasmicl DNA added. This mixture \ras
gently mixed and placed on ice for 30 min, tlren heat-shocked at 40'C in a waterbath for.2
min, then placed on ice for a further 2 min. SOC medium (450 ytL)(ZVo rryptone, 0.52o
yeast extract. 0.o5vo Nacl, 2.-5 mM KCl, 20 mM glucose, l0 mM MgCl2, pH 7.0,
Appendix 2: Section ll) was added and the mixture incubated at 37oC for I hr. This
mixture was then plated onto LB plates. left at room temperature for I hr, then turned
upside down and placed in a 37"C incubator overnight.
4.3.5 MINIPREP ISOLATION OF PLASMID DNA
4.3.5.1 Miniprep Standard Alkaline Lysis Method
Using a stetile toothpick, sin-ele colonies were used to inoculate 2 mL LB medirrm
(Appendix 2: Section 9) containing appropriate selective antibiotic (50 pg/ml ampicillin
or kanamycin) in a sterile 20 mL tesr tube with a Ioose-fitting cap. The tube was placed in
a shaking incubator at 37"C ovemight. The next day, 1.4 mL of this culture vuas
transfemed to a I.5 mL microfuge tube, and centrifuged for I min at 13,000 rpm. I'he
supernatant was removed and the pellet resuspend in 100 pL of ice cold GTE Bufter ,50
mM glucose, 25 mM Tris HCI pH 8.0, ancl l0 mM EDTA, pH 8.0) and incubated at ro,rm
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temperature for 5 min. The bacteria were then lysed by adding 200 pL of P2 buffer (0.2 M
NaOH, l7o SDS). The tube contents were mixed by inverting the tube several times,
followed by incubation on ice for 5 min. Protein in the lysate was precipitated by acldirrg
150 pL of ice-cold P3 Buffer (3 M potassium acetate, pH 5.5). The samples were vortext:cl
gently for: l0 sec to resuspend the pellet and then incubated on ice for l0 min. Tubes we:e
centrifuged for l0 min to pellet the plotcin. The supematant was rcmove<l and placed in a
fresh tube, and 400 pL of phenol:chroroform:isoamyl alcohol (24:24:l) was added. The
sample was vortexed briefly, then centrituged fbr 5 min at 4uC to separate the phases. The
top aqueous phase was transferred to a fiesh tube and 900 pL of ethanol added. Tlre
sample was then mixed using a vortex mixer and centrifuged for a further l0 min to pellet
the DNA. The supernatant was removed, the pellet washed once with I mL of 70Vo
ethanol. The sample was recentrif'uged and the ethanol removed. The DNA pellet was
allowed to dry at room temperature for 10-20 min. When the pellet was dry, 30 pL of l'E
buf,f'er containing 50 pg/ml RNAse was aclded, and the sample was mixed and incubat,:d
for l0 min at rcom temperaturc to dissolve the DNA. A 5 pr[- aliquot was removed to
determine DNA concentration. The aliquot was added to 495 pL of dd HzO and tne
absorbance of the solution measured at 260 nm in a spectrophotometer. The DNA
concentration was calculated using the following calculation.
Concentration (pg/p,L) 
= 
Azro x dilution x 50
The purified DNA was PCR-amplified using MoR-specific primers and the prodrrct
electrophoresed on a 0.8Vo agarose gel to confirm the presence of MOR inserts. If the
appropriate 1200 bp MOR band was present, the purified plasmid DNA was used in
subsequent PCR reactions with MOR primers containing the GW and FLAG sequen(es
inserts that are necessary for cloning into GW vectors. After successful PCR with the CW
primers, the DNA was electrophoresed on an agarose gel, the appropriate sized bands wcre
cut out of the gel and the DNA purified using the DNA gel purification protocot describecl
earlier. DNA from this step was then used in the cw Bp reaction.
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4.3.6 MIDIPREP ISOLATION OF PLASMID DNA
4.3.6.1 Midiprep Using Qiagen plasmid puritication System
The Qiagen plasmid puritication system (Qiagen) was used to puril'y DNA required ftr
mammalian transfection experiments. This system was used because it removjs
endotoxins, which are detrimental to transf'ection experiments. A flask containin-q 50 n L
of LB-amp was inoculated with a 200 pL aliquot of a miniprep culture containing the
pDEST 12.2 plasmid with the MOR-FLAG tagged DNA. The culture was placed in a
shaking incubator and agitated overnight ar 220 rpm at 37"C. The next day. cells were
harvested by centrifugation (6000 rpm tbr l5 min at 4"C in a SS-34 rotor in a Sorval RC:B
centrifuge)' The supernatant was cliscarded and the pellet rcsuspended in 4 mL of l)l
Bulfer (50 mM Tris-HCl, pH 8.0, l0 rnM EDTA) ancl incubated at room temperature lbr 5
min' Four mL of P2 buffer (200 mM NaOH, l7c SDS) was adcled to lyse the cells. Tre
tubes were invefted 6 times and then incubatecl at room temperature fbr 5 min. proteins
werc precipitated by adding 4 mL of chilled P3 butfer (3 M potassium acerare pH 5.5) tne
samples invened 6 times to mix, and then incubated on ice for l5 min, Samples we,re
centrifuged at 20,000 rpm for 30 min at 4nC. The supernatant was placed in a fresh plas:ic
centrifuge tube and recentrifuged at 20,000 rpm for 15 min at 4"C. Meanwhile, the
Qiagen-tip 100 was equilibrated with bufl'er by applying 4 mL of QBT Buffer (750 mM
NaCl, 50 mM MOPS pH 7.0, t5% isopropanol, O.ISVo Triton X-100), and allowing rhe .ip
to empty by gravity flow. The supematant containing the DNA was then applied to rhe
column and left to empty by gravity flow. The Qiagen-rip was washed with l0 mL of eC
butf'er (l M NaCl, 50 mM MOPS, pH 7.0. l57c isopropanol) ancl allowed to empry. This
step was repeated, and the Qiagen-tip placed above a clean 50 mL Corex centrifuge tul)e.
The DNA was eluted with 5 mL of eF Buffer (1.25 M NaCl.50 mM Tris-HCl, pH g._5,
l57o isopropanol). The DNA was precipitated by adding 3.-5 mL of room remperarrrre
isopropanol, mixing and centrifuging for 30 min at 15.000 rpm at 4"C. The supernat.rnt
was removed, and the DNA pellet was washed with 2 ntl- of 70?o ethanol. and ti en
recentrifuged for l0 min at 15,000 rpm at 4oC. The ethanol was removed ancl the Dl.lA
pellet allowed to air dry for l0-20 min betbre resuspending in 200 pL of TE buffer (l rnL
of I M Tds; 200 pL of 0.5 M EDTA, pH 8.0). The yield of DNA was determined from its
absorbance at 260 nm, as described oreviouslv.
38
4,3'6.2 lvridiprep concertrM Hi|gh pure prasmid purjfrcation systcm
For DNA sequencing, a Concert High Pure Plasmid Purificati.on Kir Clnvitrogln), si'milar to,
the Qiagen ki't, was used to prepare plasmid DNA acoording to the manufac,turer's
instructions.
43.5,3 Gateway BPReaction
The BP reaction allows rapid cloniug of PCR products synthesised with the appropriate
attts tags (Figure'4.3) into a range of GW enffy vectors. Onse the gene is in the entry
c'lone, it is earily transfrErred ts other GW vectors, each with specific properties. Fsr
example, vectors designed for trarisfection into rnammaliart expression systems (pDEST
l2-2). MOR DNA was cloned into the GW pDONR 201 Veenor (Appendix 4). Reagents
ftom the kit (Iable 4.4) were added ro a 1.5 mL microfuge tube at foom temperanpe,
mixed, and incubated at 25t f:or 60 rnin. One Ft of protejnase K solution was added and
the solution incubated for l0 min at 37oC according to thp m,anufactur€r's insffuctions.
One pL of th,is reacfion was usod to transform 50 FL of library effieie-ncy DH5a competenr
oells as previorlsly d-escribed (Section 4.3A: Transfornling, bac,teria), The h,ansformed
bac'teria wer€ sprsad ontotB plates containing s0 pg/mlkirnamy-cin (sigma).
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Table 4.4 Reagents required for the GW Bp reaction.
Component Negative control Positive Control le
PCR product
(with attB tags)
40-100 fmol
l-5 pL
PEXPT- tet
Positive control
(-s0 ng/trl-)
lpL
pDONR 201 Vecror
(150 ng/pl) lpL I trl- lpL
BP Reaction Buff'er
(5x) 2t[ ? ttL 2vL
TE Buffer 5 trl- 4vL To8pL
The next day, colonies, selected with a toothpick, wel€ grown in 2 mL of LB medium
containing 50 pg/ml kanamycin. The bacteria harbouring the pDONR 201 vector
containing MOR were puritied using the miniprep alkaline lysis method as previously
described. DNA tiom this reaction was PCR amplified using the MOR primers ro see il it
contained MOR DNA. Only DNA that could successtully PCR amplify MOR wils usrtd
for turther reactions. The remaining culture was used to make glycerol stocks by addi,rg
l07o (vlv) glycerol. The stocks were stored ar 
-80oC.
4.3.6.4 Gateway LR Reaction
The LR reaction is the second reaction in the GW cloning system. The LR reaction ir, a
recombination reaction between an entry clone and a destination vector and is equivalent to
highly specific cutting and ligation reactions. In this reacrion proteins cut to the lefi and
right of the gene within the attl- site of the entry clone (Figure 4.3). This is then ligated to
the appropriate site in the destination vector. The destination vector used in this studv
(pDESTl2.2) is designed for mammalian expression expedmenrs.
The LR reaction requires linearised DNA for optimal results. The entry pDONR 201
vector, with the MOR DNA insert was linearised by cleavage at the Apa I restriction site
within the GW cassette. Ten pL of DNA l}om rhe BP reaction was added to I pL of Apa I
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enzyme (Roche), 2 pL of Apa I restriction enzyme butfer A (Roche), and 7 pL of sterile cld
HzO in a 1.5 mL microfuge tube. The solution was mixed, and then incubated fbr 60 m n
at 30'C. This linearised entry clone was used in the following LR teaction.
Following the manufacturer's instructions, reagents were added to 1.5 mL microfuge tubes
(Table 4.5), mixed using a vorlex, and incubated for 60 min at 25"C. One pL of proteina;e
K solution was adcled to the template reaction and incubated for l0 min at 37"C. After the
LR reaction was complete, I pL of this reaction was used to transform 50 pL of libra:y
efficiency DH5s competent cells (Section 4.3.4). The transformed cells were then platcd
onto LB plates containing 50 pg/ml ampicillin and grown in an incubator overnight at
37"C.
Table 4.5 Reagents required for the GW LR reaction
Component Negative control Positive Control Sa
LR Reaction Buffer
(5x) 2uL 2vL 2uL
PENTR-gus
(50 ng/ttl-) IFL
Entry Clone
(100-300 ng/reaction)
0.4 pL
Destination Vector
pDEST 12.2
(150 ne/pl-)
lpL lpL luL
TE Buff-er To8pL To8pL ToSpL
4.3.6.5 DNA Sequencing
DNA sequencing of the plasmid DNA. purifiecl using the Concert High Pure Plasnrid
Midiprep Purification System, was performed in the Victoria University of Wellingr.on
DNA Sequencing Facility using an ABI Prism 377 DNA sequencer (Perkin Elmer Applied
BioSystems, Foster City, CA, USA) and appropriate sequencing primers (Figure 4 2).
Sequencing was carried out to ensure that the MOR DNA was in the correct reading fiame
and contained no errors. Both strands werc sequenced at least once in both directions.
t4l
PCR tubes were p,laced'on iceand 4 pL BigDyeru terlninarion rnix @erkin Elmer), 250 ng
of DNA te,mplate, and 0.8 pL of tpM Brjmer mix added. 'The cyelb seguencing reaetion
was carried out in a Gene Amp 9600 PCR rnachine (Perkin Elmer) and consisied of ?s
clcles of 96"C for l0 sec, SfC for 5 sec a1d 60"C for 4 min, with a fitral hold at 4eC. Tfie
reaction was then: transferred to a Sepadex G50' ,sequen'cing pudfieatiion ,spin, soluxnn
(Appendix 2: Section 12) for dgsalting. The,eluted sample$ were lyophil,ised and stored at
-zOeC until electrcphoresis was carried out. Lyophitise, sampXes wer€ supplied to the
sequencing techrlician and analysed on an ABI prism 377 DNA qeqrr€ncer, fsllowing the
marurfiaonrrer' g instruetion s,
1+:2
125 bp 125 bp
By-product
Transform E c'ri 'lil
BP Clonase
Enzvme mix
200 bp 200 bp
DONOR VECTOR
pDONR 201
too bp loo bp
ENTRY CLONE
Kan resistance
Figure 4.3
Cloning a PCR Product using the Gateway Bp Reacfion
A gene flanked by the Gateway atB I and attB2 sites can be cloned between the attl- | and
attl2 sites of an entry vector, and transformed into E. coli. Kanamycin (Kan) resistant
colonies can then be selected.
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4.3.7 TRANSFECTION OF MAIVTMALIAN CELL LINES
Two different methods were used to transtect a numberof different mammalian cell lints,
and several different volumes of transfection reagent werc tested to optimise transfectirtn
efficiency. Transfected cells that were used for immunocytochemistry were grown r)n
PDL-coated slides as previously described (Chapter t, Section: 2.3.1.2).
4.3.7.1 FUGENETM6 Transfection
Cells were dissociated using trypsin-EDTA in the same way as for passaging (Chapter 3,
Section: 3.3.1.2), resuspended in 10 mL culture medium without antibiotics, centrifuged at
1000 rpm for 5 min and resuspended in I mL of culture medium. Ten pL of the c':ll
suspension was removed and added to 80 pL of medium and l0 pL trypan blue (0.2% in
PBS). The proportion of viable cells was determined by dye exclusion using a
haemocytometer. Cells were platecl at 3 x lOs cells/3-5 mm plate, grown overnight, and
checked the following day to ensure the cells were 50-8070 confluent, Serum-free medium
(94 VL or 97 pL) was placed in a sterile microfuge tube and either 3 pL or 6 pL,
respectively, of Fugenet"6 teagent (Roche) addecl to give a final volume of 100 pL. Cirre
was taken to prevent the Fugene tM6 reagent from touching the sides of the plastic
microtuge tube. Gentle tapping mixed the tube's contents, I pg of DNA was added. and
the solution mixed again. The tube's contents werc incubated at room temperature for 15
min before addition to the culture dish. The medium in the culture dish was gently swirled
to mix. Cultures were incubated between 12 hr to72 hr in a 57o COz atmosphere itr a
humidified. 37oC incubator.
4.3.7.2 Lipofectanrine Transfection
Cells were platecl the day befbre transfection as described for Fugene t*t6 transfection.
Six pL of Liofectamine reagent (lnvitrogen) was added to a l.-5 mL microfuge tube
containing 941tL of serum-free, antibiotic-free, culture medium and the reagent combined
with I pg of DNA within 5 min, accordin-{ to the manuf-acturer's instructions. Samples
were mixed gently and incubated at room temperature for 20 min befbre adding to the
culture dish as described above.
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4.3.8 IMMI.JNOCYTOCHEMISI'RY
Cells cultured on coverslips were flxed and prepared for ICC by removing endogeno.rs
peroxidase activity (Chapter 2; Section; 2.3.2.2) and blocking in TSAIM blocking soluti,rn
as prcviously described in Chapter 3 (Section: 3.3.2.1t.
4.3.9 ANTI-FLAG ANTIBODY LABELLING OF TRANSFECTED CELLS
A FLAG-tag sequence was added to the cloned rat MOR DNA sequence so that expressecl
protein could be detected using an anti-FLAG IgG mouse antibody (l:1000) (Sigma). Tlris
primary antibody was incubated overni-eht, washed. incubated in goat anti-mouse H}tp
(l:500) (Sigma) for I hr, washed, ancl incubated in TSA'rI'-FITC (or rhodamine) for 3 nin
as previously described (Chapter 3: Section: 3.3.2.2). Cells were also labelled using the
anti-MOR antibody or double-labelled using anti-FLAG and anri-MOR antibodies, rhe
latter using the double-labelling protocol previously clescribed in Chapter 3 (Sectir,n:
3.3.5).
4.3.10 MOR RECEPTOR IN VITRO REGULATION
MOR regulation was monitored in cell culture using the ICC method of Koch et al. (191,8)
(Koch et al., 1998). In order ro down-regulate MoR, the MoR agonist [D-Ala2, N-Nle-
Phe1, Gly-olslenkephalin (DAMGO) (l pM) was added to culr.ur€s fbr up to 4 hr, and cells
wete fixed for ICC after 1,2, or 4lrrs. Some cultures were prc-incubated with a sterile
solution of 50 pM monensin (Sigma) (5 rnM (100x) stock in ethanol) for 60 min prior to
DAMGO administration. Monensin traps MOR in cytoplasmic vesicles by preventing
endosome acidification (Koch et al., 1998). Control cells were cultured at the same ti ne
but were not treated with DAMGO. Cytoplasmic and membrane staining of incliviclral
cellswasscoredonascaleof0=nostaining, 1=lightstaining,2=mediumstaining,ind
3 = intense staining. Volta-qe matched confocal images of serial sections through the cclls
were scored by blinded observations. Staining intensity measurements of at least 100 ce lls
from 4 coverslips taken from 2 separate experiments were performecl blind by 4 differ:nt
people and the data collated (n = 4 coverslips). A multiple comparisons test (based on
Kruskal-Wallis rank sums, P< 0.001) was carried out according to the criteria outlined in
Hollander and wolf-e (1973) (Hollander ancl worfe, r973b) (Appendix 3).
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4.4 RESULTS
4.4.1 MOR CLONING
RNA was successfully isolated from the adult rat brainstem at a concentration of l.1i-5
P9/PL. The integdty of the RNA was confirmed by elech'ophoresing a portion of t1e
sample on an agarose get. If the RNA was not degracled, the sample was used immecliately
for RT-PCR reactions. Initial PCR experiments (fiom the cDNA obtained in the RT
reaction) only worked with the short MOR cloning primers, not the longer primers with tle
GW or FLAG sequences. It was therefbre necessary to clone MOR into the pGEM-T
plasmid (Figure 4.4A) before PCR u'ith MOR-GW-FLAG primers were successful (Figu"e
4.4). Following this, MOR was cloned into the pDONR 201 Gw vecror, then into the
pDEST 12.2 vector. Successful MOR clones in the pDEST 12.2 vector were used f,tr
transf'ection experiments. The clones were confirmed by DNA sequencing. Multiple
sequencing runs were combined using SeqmanTM II software (DNASTAR Inc.) and a
consensus sequence formed from these multiple sequencing runs (Appendix 5). Resulls,
displayed using the Jellyfish program (LabVelocity Inc., San Francisco, CA, USA ).
showed that the MOR consensus sequencc calculated fiom the multiple sequencing rurrs
did not contain PCR-induced errors (Figure 4.5).
4.4.2 MOR TRANSFECTION OF MAMMALIAN CELL LINES
MOR-transt'ected cell lines were used as controls to check that the guinea pig anti-MOR
antibody (Chemicon) was specifically labelling MOR. Double-labelling MOR-transfectr,d
cells with anti-FLAG antibodies and dircctly comparing staining patterns confirmed this.
Transfection experiments were also usecl as a positive control to test whether cultured cells
from the rat brainstem express OpRs that were capable of being regulated by opio d
agonist exposure. MOR function was assessecl by treatment of cells with a MOR agonilt,
DAMGO, and measuring receptor internalisation (down-reguration).
MOR was successfully transf-ectecl into SH-SY5Y cells and H44l cells using borh
Lipof'ectamine and FuGENETM6 reagents. There were no differences in transf'ectic.n
efficiency between lipof'ectamine and FuGENE rM6. Although SH-Sy-5y and H44l cells
were successfully transfected, transfection into COS-7 and LLC-PK' cells was n,rt
successful- H44l cells had low transfection efflciencies (about 37a) under all conditiorrs
tested, with varying DNA concentrations ancl transfection reagent concentrations, ard
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were, therefore, not used in further experiments. SH-SYSY cells were chosen for fur-ther
MOR transfection experiments because they gave the best transfection efficiency of t5e
cells tested, on the order of 17Vc. Transfection efficiency was measurecl using anti-FLAG
antibodies (TSA-FITC) on Pl-counterstained cells after 5,24,48, ancl TZhr of transf'ection.
Transfected cells were counted as a percentage of the total number of cells in 3 fields cf
view, using a 40 X lens on the contbcal microscope. The average transfection efficiencies
for 5, 24, 48, and 72 hr, were 3Vo. l5Tr,, lTVo and, 97o, respectively. For all further
experiments the 24 hr transfection periocl was chosen because it gave the best transfecti,rn
efficiency, with an average of 17%, and a range of 5-25Vo. Higher transfection efficiencies
are desirable, as they allow a greater number of cells to be studied in each expedment.
SH-SY5Y cells endogenously express MORI therefore, labelling experiments w€-re
performed using the anti-FLAG antibocly. This antibody binds to rhe FLAG sequence rt at
was added to the end of the MOR sequence during cloning. Some experiments using tre
guinea pig anti-MOR antibody (Chemicon) werc also carried out. Transfected cells
expressed much higher levels of MOR than non-ttansf'ected SH-SYSY cells and corrld
easily be detected by ICC at lower voltage settings on the confocal microscolrc.
Tmnsfected cells were also double-labelled with both anti-FLAG and anti-MOR antibodres
(Figure 4.6). and both antibodies gave iclentical staining, confirming that the guinea p,ig
anti-MOR antibody trom Chemicon was specific for MOR.
No cross-reactivity was seen between DOR and MOR with the DOR specific antibody
used in the present. study. In some experiments (data not shown) MOR-transf'ected H44l
cells were immunolabelled for DOR, although no H44l cells showed labelling for DOR.
MOR-transfected SH-SY5Y cells clouble labelled with DOR and FLAG specific
antibodies, showed no DOR immunoreactivity using the same confbcal microscope laser
voltage settings (in SH-SY5Y cells, endogenous DOR expression levels could of course ire
seen at high voltages in the same way as endogenous MOR expression). These results
confirm the specificity of the DoR antibocly for rhe DoR receptor.
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AMOR PCR from pGEM-T vector
1 2000 bp
a 1000 bp
1 500bp
MoR PCR from pDEST 12.2 Gateway mammalian croning vector
DNA
Ladder
2000 bp
1500 bp
| 000 bp
{ 500 bp
Figure 4.4 MOR PCR
(A) PCR of MoR from the pcEM-T vector using the MoR FWD Gateway (GW) ancl
REV FLAG GW primers. showing a 1200 bp band in several PCR reacrions in lanes I
2.4,5.7 & 8. Another band can be seen at approx 2400 bp and is likely to be a double
copy of MoR. The 1200 bp product was purilied liom the gel and cloned into GW
vectors pDoNR 201 and pDES'l- 12.2. Note the negar.ive controlin lane 3 and the
molecular weight markers in lane 6. (B) MoR pcR primers. only colonies in which
MoR PCR amplification was successl-ul as shown by a 1200 bp product were
sequenced and used for transtbction experiments.
B
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Figure 4.5 Scquence Alignment of the Cloned Rat MoR-r Receptor
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Figure -1.5 Sequcnce Alignment of the Cloned Rat MOR-l Receptor
-fhe 
consensus DNA scquence fiorn the cloned rat MOR arrd the rat MOR sequence
code l-22455 ti'orn GenBalrk shou'ing the correct sequence lbr the MOR- | receptor
II 3l 6l .'I
Cloncd lfolt
Rat l{OR Scgu
ConFensus
I'GCACCITGGACAGcAtqAl&ctfacftrit:4CfctiaffAGGgI.fcAsfAGff.tCTtrcTctGACCCCTTAIICTCAC GClrG
---------TTtiECACCATtr6ArA6fiFCdECrrrifCCAGC'CTAf,ACCAGCGACTGCTTA&f,CCCCTrl6rr-clC trAAE
16l l?l ra]. 19t zOL zJ.I zzL 231
egcaccgrgcccegggaacaccagc gacEgfc EcagaccccEtsegc tca! geoag
a-t 9I IOT Itl LZL r3t I1t l r51
eJ-otred r{tn TTGgTCf CCAC.,:AC(TGL:LlTr-fTGf'CTf AA(TrGTL-CCAI-CTTGITtrOCA.&!-C&T'TCcGATCCITGCCeTCTEaAI CCGCI
Rat lft|n, Sequ TTTICTCCCIAGCACCTGBT:Tr':TFL1ff'-'A.afTTCT|:I rACOTTtiATtrtrAAEcAFrq|] GATL'C.ATGC,:trTCTGAJ,CEECI
consensus EtgccccccaqcacccggccEcEggcEcaacccgttcccacgEtgatqgfcaaccagrcccEatccatgcggtcigaaccgca
C.Aonad ll0*
Rat non S|'qu
Consen3us ccggqctcgtgcggrgaacgaDag|cctgrqlccctcag{rrcgq|cagccctcccaEggftcBsagfccatcaccotcaggqcccEc
z4I e5r 26l 27L zaL ?9L 30r 3ll
c-LONGd liOR TAITETATL:6T TGTTjTAS'I.R-:G1:fTI.TTf GEAA4CTTL.CTC6TCAT6T'TETEATTI'TIT6ATACTCC.TTA^TII},I\6AC
Rat ilOR S|'q|x TtClrrATctrTQTcTtiTADTctcc-cTt.1-rr&GITAfTTCTTcCTcATGTATCTGTtITGTIaGAT&CleClltllT.irA&Af
conaensus cacEctaccgEgtg€grcagEqrgEccrcrtcggaaactEcctqtgtcaEgtacgtgaccg|caagacacaccaaaatJaagac
r:C66FCTTrc{:66GAlf cAfAal:r:TST6f CgTrAGlct-FGCAL':cf CTTCcATCCTCACAGc('ATTAUC|\TCITl;|;CCCTc
tcFSGCTTEOCOCG*3(FA!AGf {TlfTCf r:CTf4OtcCG6CAGr:Ct:TTf,TATFGTC&CAoCC*TTADCATCXICT iC€trTE
32'1 33r 34I 35I 35I 31t
cl-oncrl t[oR. T6ccacr-aatATcTs.r4fi-rrflrcr:TTtrTETGtr€AGtrf GccTrtGL-Gll:f*tTAr:lcTGcrfTTTE!.6^C-TG rcMcT
Rat lioR sequ TfffAccttEtTfTAtATrrTrttcL--rrGL"TcTc6cacifoct'Tr GccAcca6TAatcToqcgrTTrJo 6TtrrltlcT
consen9us cgccaccaacaEcLecatLrtcaaccct'gtcbccgfqeagacgcctEagcgaccagtacactgfcccEtstcagagtgtrcaact
40.1 rlt I 42r 431
381 391
46r 47L
CILo'red ilON. AIiCTTATEGEAACITGGCC!]TT|$GAAI:| AT':I?ITECA.A.GATCGT6ATCTfAATASATT$TT.CAAL.AT6TTC ACEAcT
N,At I'OE SgE|r ACCTGATGOEIAI]ATEGCCI"TTCtrGAA':FATC'IFCTECAAGJTIGT€}ATET'AIf&GITTACTACATAITGtrT'ACCiGC
csnsensus acctgatggg|aac€'tggccctstcggaaccaEseEctg€aagatcgtgatcEcaacagatEacgaceacatgttcaecggc
4AI 491 501 511
44r 451
9ZL 53r 54,t 55r
gLO'rCd ITON. ATATTCACCL-TTT6CACL'AT(;AGTIiTI;IiAf I]6ETII:ATTI?fTGTCTffC$TCI:AETI'AAAGCC'TGGITTTCCCTICI:CC
Rat lloR scqu TTATT€rrtccTL-TGCAECIfl (,ACC$'I 
'-;6Af fGCTACiTT|;CTFTCTGI|]ACCCAtrTCTAiOfEqTGcATTTCCf TACTICConsensua atatsccaccctccgcacc6tgagcgrtgrgaccgceacacfqrcgqlEctqccacccagtca.aagccccg{taettccgeacccc
561 .s?I 5Al 591 601 6ll 62r 63r
CJ.on6d !iON, CCEAAAT&IiCAATAIT:GTEAAgETI.]'trI]AAI:TGtrATCL-Tt:TCTfCT$CIA,TEEb-TTTEECTUTAATGTTCAIE.( {3.{J:CA
Rat llOR SFqu I:I:RAAATGC']AJ\AI\TESTCAICGTTTGCAArIEGATICTCTCTTCTGCCITIGTTCTgTCTGTTATG:TCATC'.CIACCA
ConSentus ccgiaaacgccaaaaecgEcsacqEct'qrc€'accgqatccEcccEE6cgccaEcgqEccgcetgcaacgit.t'cacgqeaacce
641 65I 661 67L 6ar 691 ?OI ?TI
cloncd uon cala.aTAc4GL;EA6c,GrfTt-r-ATAGATTrtcaErcTcacETTmcf Elr.f &AA|]rTfcrAcTctcracllAcfTEcTrlLalATr
R,at TTOR SEqu CAAAATASATE{AEGGI'TIIATAGATTIf,CAECCTTA':C-FCTSCI:TTCCAAI:CTC6TACTGOGI&AATCTtr?:AA^IITC
corlgenrus caaaatacaqgcagggfgLccatagatEgra6ectcaeq.ttctcccacccaacceqg,tsaecgg'{tagaacc Egccrjaaaats
7?l ?31 ?4r ?51 ?61 all ?81 'tgr
Cloned EOR TETETCTTTATCTTCTC1-rrI-4TrjTtrC|:GFTECTC4TfATCAfTiiTGTGTTACGGTcTr'lJrG&Tr:TrrCGArff,AltrA6
Rat lfOR segu Trit[TcTfrATcTfCcrTTTcATrATtrctrGTCL-TCITTcITCAfneIETGTTACDEcCTfrTftTCTTACtr&f'fClt*trAG
consetlsus EgEgrct.ct6ccEtcgccEtcaccacgccEgtcct'caEcateaccgtgtgTcEacggtccEgaiqaEcttacgac ecaagrag
95r 861 8?l801 8lt 431 A4La2r
Cl-oned lion
Rat tll'n' Scgu
Con3enaug
E6TTt:STATIiT'ITTf FCDITCCAASEAAAAGGTC{'EGT'TTCTGL:GCAEATf,ACCCGCATG4TGCT-trGTEGTC ;:rG&CTG
CGTTI;ECATGCTATE66GT:l'tCI.IAril^AAADGAETGGAATCTECGCTOGATCICCCGG*TtrgIBCTtrGTGFrtC !.IECCTG
cgrtccgcaEgetatcqggcEccaaagsalaggacaggraatcEgrcgcag€fatcac€cqrg.atg{ttgct{tgt{|grtc J:tqigctg
95L 9?l
301 91r
Cl-on€d IIIOR TT.TTtATCtrTfTE-fT66&r f f I:rATr:I:ACATETICGT.--IrTjE*TIAAAEC64TtrAT,:IISATTCCAtrIIAfCAf ATTTCAE
Rat liOR' Sequ T&TTTITECTflIETTCTiACTCCEIT,:fACATTIACGtCATCATCA AGCGTfG,ATCACOATTICACAAACCACATTTCA.F
8A-I 89I 921 931 94L 951
ro2r lo3t
Consensus taEecatcgtctgctgqacccccatccacaecc'acgrtcalcatcaaagicqlctgrac.cacgactcc{lgaaaccacatttcagt
100r rolt
CJ-otred EOn' ACFDTTTfT-Tc'iEt'c'rffTLia.lTTtffTT-fEGbiiTAc&CriA^CArir.-TGf CTGA*T||-AGTTfTTTACtrT:CTTf CT!6ATGA
Rat liOR Sequ ATGGTTT|CrGGCACTTCTGCATTG|TTTGGGTTACAL-GIACAGETGCCTGIATECI'TTCTTTACTCTTCCTtGiATGA
Consensus acggEttccEggcacicct,gcaLcgcEtBqgggtac6.cgiaacagcEgcccgaatccag.tecLt'eacgccttcc cggabga
10<u IU5r. l06r 107r IOSt lo9l IIOI III I
Clorreit r{On r.&IcTTf A/\Gtl6ATC-fT'Ir:AGA6rtsTTrTOC.[TcCCIAC(-TL-GTCCACGATCGiACAGCT,\AACTCilffCGI-ETCFGTC
Rat l(oR sequ AltcTfiAAccGJ\TccrTr:-l'cAoArrTTfTccaTcEl*AccTccTcrlafFlTccAAt:-lficAAr^cTccrcTf trl 'eTcrGTc
Corrsengus aaacctcaagcgiatqcLCcagagaqCt,ctgcaEcccaaccicgtccacqatcqaacagicaaaacCccactcgtl{ttccgCe
tIzl 1r3.1 II4I llSr rt61
9Ar. 991
Ll:rI
C]-oned llOR ACAACACTAGGEI'ACATT:C|TrCAr 
'(.CTATTA'TTITGGITCG 
A|TAACCACCAGCTAGAAAATCTGGiL€A| IAGIAArT
Rat ltOR scgu j,GA.ICIC.TASGGAACITfII-TCCAIfiligTA 'fACtc EtrATf,EAAtrTAACcAcSACCTAtjA}lATC'TcGAtr':AGIAAFT
gorr!ensut agaacqctagg:gaacaEccctccacgqccaatacagrtgg'accgaadtaaccaccagcEa{iaaaatctggaggrjagaaacs
lZOr 121r I?2L t23r LZ4L 1261 L2 IT
llTt llSl
c.l-sneil llOR
nat llon Sequ
CongettsuS
GfTrcATllIc-
E ET|; C ATTA-CCT}ACTOGGTCTCACAC CTTC CIGAC C CTC GCTIAGCTT
qrcEccattgcc
IZsI
r50
Start and stop codons
Figure 4.6
Labelling of Transfected SH-SYSy Cells
Double-labelling using (A) anti-FLAC (red) and (B) guinea pig anti-MoR (Chemicon) (greerr)
antibodies in MOR transf'ected. monensin and DAMGO-treated SH-SY5Y cells. FLAG-labellerl
MOR-transl'ecled SFI-SY5Y cells (C) (green) with no lreatment with either DAMGO or mon:nsin.
showing mainly membrane staining. Negative control for (C) with no primary anti-FLAC antibody(D). Figures C and D were counrerstained with PI (red). Scale bar:2d u m.
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4.4,3 MOR,REGT]LATION
4,4.3.! Non-Tlansfectud eelb
In no:r'transfeeted, monensin-pre-treated SH-SYSY cells, thefe were significant increases
in cytoplasmic staining of IvIOR in colltrol cells (rnonensin but no DA,trvICO) and in cells
treated with the MOR agonist DAN4CO for 2hr (Figure 4."?8, D & F) arrd 4 hrs (Figure
4.88 & F). lVlembr.ane stalning, however, showed no siguificant diff-erences in intensity
between control cells (rrurnensin but no DAMGO) and cells treated witl,r
monensinDAMGO. The increase in cytoplasmic, staining occurred within the first hour,
with no significant further increases after 4 hrs (Table 4.6). Prirnary cultures also showed
an inerease in,cytoplasmic MOR staining afler t-reatmen[ with moRensin and DAMGO
(Figure 4'9), although this difference was not significant due to the inherently large
variqtion jn MOR, staining patterns in these cuLfires. In untrested, control cultued
brainstem cetls. (Figure 4.9A, C & E), the plasma q|e.mbrane staining appcars xnore inrense
tllan the cytoplasmic staining; whereas, in the cells treated with rnonensin, followed. by
D.A'MGO for 2 hr (Figure 4,98, D & F), the ,staining appe'arc, rnore intense in the
cytopla$m.
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Figure 4.7
MOR Regulation in Non-Transfected SH-SYSY Cells (A)
Non-transfected Stl-SY5Y cclls labellcrd with antibodies to MOR (guinea pig anti-MOR.
Chcnricon) (green) and counte.rstaincd with I'l (rcd). Contnrl cclls (A. C & E) (ntonensin (50 pr
M) without DAMGO treatrncnt). and (l]. I) & l") aftcr prctrcatnrent w'ith ntonensin (50 U vl)
lbllowed by 2 hr DAMGO (I pM) . Scalc'bar = 20 p m.
t_s3
Figure 4.8
MOR Regulation in Non-Transfected SH-SHSY Cells (B)
Monensin (50 pM) treated non-translbcted SH-SYSY cells after (A) 0 hr and (B) 4 hr DAMGO 
, 
I
pM). Note the increase in punctate cytoplasmic staining with the guinea pig anti-MOR antibody(Chemicon). Non-transfbcted Sll-SYSY cells shown in phase contrast (C. |l) and with MOR
labelling afier monensin treatmenr atier (l)) 0 hr and 1F) 4 hr trearment w.ith I pM DAMGO. Nr re
the intense (w'hite colour) cytoplasmic staining in the DAMcO-treatetl cells (A & F). Scale bar: 20
pm.
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Table 4-6 MOR regulation in non-transfected, monensin pretreated SH-SYSY cells
MOR cytoplasmic and membrane staining of SH-SYSY cells were ranked on a scale from
0 (no staining) to 3 (intense staining) before and atter the addition of the MOR agonist
DAMGO ( I ttM) for I hr and 4 hr. There was a significant increase in cytoplasmic staining
between the control (monensin but no DAMGO) ancl after I hr and 4hr DAMGo(monensin and DAMGO). Multiple comparisons based on Kruskal-Wallis rank sums (p<
0.00t ).
4.4.3.2 Transfected SH-SYSY Celts
MOR-transfected SH-SY5Y cells express much higher levels of MOR than when norr*
transf-ected. The localisation of the receptors, however, is the same. MOR-transfected SI{-
SY5Y show an increase in cytoplasmic staining in response to DAMGO and monensin
trcatment in a similar way to non-transt'ected SH-SY5Y cells, but the increase is mu,:h
more apparent in transfected cells (Figure 4.8D & F). This ditference is probably due to tne
more intense staining being easier to visuaily rocarise in the cell.
Treatment
No. of Gells
Counted Average Membrane
Staininq Intensitv t SEM
Average Cytoplasmic
Stainino lntensitv * SEI
Control 243 1.4 + Q.g7 1.7 + Q.g6
DAMGO
thr 173 1.2 + 0.07 2.3 + Q.Q6
DAMGO
4hr 194 1.3 -r 0,07 2.3 t 0.06
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Figure 4.9
OpR Regulation in Dissociated Brainstem Cell Cultures
Priman'culturcs ol'rat brainstcm l)l cells alicr4 davs in culturc'labclled u.ith antibodies t:
MOR lgLrinea pig anti-lvloll. ('herrricon; (grcenl and counterstained 
''ith 
pl (red). c,onrrol
cells (A, C'& tr) (moncrrsin (-S0,,Nl) withor-rt DAM(i() treatmcnt). and (8. D & l) cells afiqr
prctrqatnlent rvith nronc'nsin (-5() i,M) lbllowsd b1 2 hr DAM(i[) ( I lfvt) . Scale bars : 20 
,m1.
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4.5 DISCUSSION
4.5.I MOR CLONING AND TRANSFECTION OF MAMMALIAN CELLS
The rat mu opioid receptor was cloned in 1993 by Chen et al. (Chen et al., 1993b) aptl
Thompson et al. (Thompson et al., 1993), r,,,ith a deduced potypepride of 398 amino acirl
residues. Once cloned. MOR coulcl be transf'ected into cells that do not express MOFI
(such as kidney cells). or have low levels of MOR expression (such as neuroblastom:r
cells)' MOR transfection studies have increased our knowledge of how MOR is regulate,l
(Koch et al., 1997; Koch et al.. 1998: Law ancl Loh, Iggg). Transf'ection of mutared cr
truncated rcceptors has increased our knowledge of which rcceptor amino acict residues are
responsible fbr ligand binding selectivity and which are responsible for receptor regulation
(Pak et al-. 1997; Pak et al., 1999). Opioid receptor regulation in MOR-transfected cel s
was not studied in detail in this work because such experiments have been rvell
documented in the literature (Koch el al., 1998; Law et a|.,2000c). In the present study,
transf'ected cells were used as controls for interpreting MOR responses in non-transf'ectt,d
primary cultures and SH-SY5Y cells. Changes in receptor localisation patterns in the;e
cells were more difficult to measure due to their lower endogenous expression.
In the present study, transfection experiments helped confirm the specificity of the guinea
pig anti-MOR antibody. Identical staining pirtterns were seen with anti-MOR and anti-
FLAG antibodies, confirming the specificity of the MOR anribody. Anribocly specificity is
an essential requirement for meaningful immunocytochemistry and immunohistochemistry.
Other studies have used ICC (Keith et al., 1996; Koch er al., 1998; Ingnarova et al., I9{r9;
Koch et a1.,2001) or fluorescent ligand binding (Gaudriault et al., 1997) to study OIR
regulation on exposure to opioid agonists in transfected kiclney cells to monitor the rate of
receptor internalisation. In the prcsent study, these techniques were used in an
endogenously expressing cell line (SH-SY5Y) and in cultured brainstem cells. Althotrgh
MOR+ransfected cells provide a good model, the results must be interpreted with cautron
because transfected cells over-express receptors above endogenous levels, and this orer-
expression may alter the properties of receptor regulation. In the present study, MOR
agonist-induced down-regulation in both transfected and non-transfected SH-SY-5Y c:lls
was observed, as a result of receptor internalisation. To a lesser extent, this was also seen
in rat brainstem cultures, although the ICC data were difficult to interpret due to the high
amplitication of signal required for the low endogenous MOR expression levels.
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4.5.2 OPIOID RECEPTOR REGULATION
Opioid receptor regulation has been described in detail in the Introduction to this thesis
(Chapter l: Section L2.3). Monensin is an inhibitor of endosomal acidilication and.
therefbre, blocks receptor recycling to the plasma membrane by trapping internalised
receptor proteins in the endosome (Koch et al., 1998). Agonist induced desensitisation
involves phosphorylation of intracellular OpR domains and is regulated by protein kinases
as has been described in the main Introduction (Chapter l: Section 1.2.3). In the presenl
study, MOR was rapidly internalised in all the cell lines examined, including primarr
cultures of brainstem cells. Internalised receptor was generally characterised by punctat(:
cytoplasmic staining. The punctate nature of the staining presumably reflects thr:
packa-eing of the receptors in endosomes. The significance of diffuse staining is unknown,
but is unlikely to be due to fluorescent signal above and below the plane of focus, a;
confocal microscopy reduces this problem. The staining pattern could however be a r
trftefact of the amplification steps used. in which the enzymatic amplification (TSA)
deposits large amounts of fluorophore. porentially limiting the resolution of small Op){
containing vesicles.
The increase in cytoplasmic stainin-e occurred within the first hour after I pM DAMGif
ffeatment, with no further increase seen by 4 hr. These results are supported by the wor-k
of others who have shown that reccptor internalisation occurs rapidly and is complete
within I hr (Koch et al., 1998: Pak et al., 1999). In studies using forskolin-srimulatcd
intracellular cAMP production to assess receptor activity (Law et al., 2000cS), SH-Sy5y
MORs have been shown to be down-regulated in the prcsence of I pM DAMGO. Down-
regulation of OpRs occurs rapidly with internalisation of receptors into endosomes whe,re
they are either degraded or recyclecl to the membrane. Long-term changes in gene
expression also occur, but not within the time period used in the present study (Ko et irl.,
1999). Receptor phosphorylation has also been clescribed (Xiang et al., : Chen er al., 1993a
Minami, 1995 #382; Pak et al., 1997; Kramer ancl Simon, 1999) and is an important step in
OpR down-regulation.
MOR and DOR are also regulated difl'erently. A recent study of Xenopu.s oocyre
expression system showed MOR down-regulation occurs at a slower rate than DOR dorvn-
regulation due to the activation of arrestin (Lowe et al., 2002). Differences in the
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responslveness to alrestin-mediated desensitisation were due to differcnces in OpR
phosphorylation. Phosphorylation of the C-terminal and 2nd intracellular loop of DOR was
required for arrestin-mediated rapid down-regulation, r.vhereas MOR phosphorylation of
the 2nd intracellular loop was requirecl. The phosphorylation of DOR at the two regions
described leads to more efficient activation of arrestin, and was hypothesised to be the
reason for faster down-regulation oi DOR. Differences in the regulation properties ol
different OpR subtypes have not been studied in primary culture. The culture mode
described in the present study (Chapter 2) expressing both MOR and DOR (Chaprer 3) wil
provide a useful model in which to studv these diflbrences.
lt is possible that different cell types within the brain are regulated differently. For
example, neurons in the cortex may have different OpR regulation properties than th:
brainstem. A recent study, the first to clemonstrate OpR-mediated internalisation ir
cultured neurons (cortex), showed dermorplrin ancl deltorphin induced MOR and DOlt
clathrin-dependent internalisation, which could be blocked by naloxone (Lee er al., 20021.
The study by Lee et al (2002) is the first study to determine OpR down-regulation in
culture and it remains to be deterrnined it'these regulation properties are also found rn
cultures of other brainstem rcgions inclucling brainstem neurons cultured in the prese.lt
study. Down-regulation of MOR was seen in the present study, using DAMGO, althoul;h
it was not determined if this was via a clathrin-dependent pathway.
Different MOR splice variants demonstrate diff-erent mechanisms of regulation (Koch et
al., 1998; Koch et a1.,2000: Abbadie and Pasternak,200l: Koch er a1.,2001). For
example, in a study by Koch et al. (1998) MOR-I and MOR-IB splice variants, which
differ in their C-terminal amino acid composition showed different regulatory parrenls.
MOR-lB-transfected cells had a slower desensitisation rate and an accelerated recepror
reactivation of the internalised receptor in endosomes back to the plasma membrane on
exposure to DAMGO (Koch et al., 1998). In the mouse lateral septum in vivo MOR-l l;nd
MOR-IC showed differences in MOR internalisation. MOR-l was internalised by
DAMGO, but not morphine, whereas; MOR-IC was internalised by both DAMGO rrncl
morphine (Abbadie and Pasternak, 2001). Diff-erences between rhe two splice-variants lie
in the alternative splicing of the carboxyl terminus. Different OpR agonisrs. and splice-
variants showing different down-regulation properties is an imponant ne\e, area of research
whereby the mechanisms of addiction, tolerance and desensitisation are being elucidaterl.
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The present study is the first to use ICC to demonstrate MOR regulation in non-transf-ected
cells that endogenously express ancl regulate MOR. The heterogeneous cell populations
found in primary cultures makes clevelopmental chan-ees in regulation difficult tc
determine by ICC techniques, especially when studying the different cells in culture whicl-
all show different extents of membrane versus cytoplasmic staining, both with and withou,
agonist exposure (see MOR localisation Figures in Chapter 3). If there are any overal
changes in the regulation of OpRs during developmenr it may be able to be quantifierl
using cAMP measurements.
Receptor up-rcgulation in response to opioi<l antagonist exposure was not examinecl in th:
present study. An attempt was made to replicate a study by Keith et al. (1996) using 0.4 lr{
sucrose to prevent receptor internalisation. but the neuronal cells were too sensitive to
osmotic shock to survive in these experiments (Keith et al., 1996). The original work wls
carried out on kidney epithelial cells (HEK 293), which are less sensitive to osmol;r
changes than neuroblastoma (SH-SY5Y cells) and primary neuronal cell cultures.
In summary, developing a primary culture model to study endogenously expressed MOR
will contribute to our understancling of MOR regulation in vivo. Using ICC, OpR
regulation was assessed in transfected SH-SY5Y cells and, with poorer resolution, in non-
transt'ected SH-SY5Y cells and in primary brainstem cultures from foetal and neona,at
animals. This technique was less effective in measuring OpR regulation in primi.ry
cultures because of the variations in staining intensity between neurons within a sinlgle
culture, and between similarcells from diff'erent cultures. ICC also has distinct limitaticns
because of its inability to provide quantitative results. A more quantitative methocl, such as
measurement of intracellular cAMP production, could be used to measure OpR regulati,rn,
since opioid peptides inhibit cAMP accumulation (Arden et al., 199-5; Chan et al., lgg5).
This method measures cAMP accumulation in culturecl cells by measunng basetl cAlvIP
levels using 132P1cAMP and synthesised cAMP by measuring [3H1cAMp levels. The r:rrio
between the two radioactive cAMP levels can then be calculated. This method was used
by El Kouhen et al. (1999) to measure MOR down-regulation by DAMGO in M()R-
transfected HEK293 cells (El Kouhen et al., 1999). This same merhod used in primary
cultures may provide a more quantitative measure of OpR down-regulation in
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endo€enously expressing primary sutrtures, as it would cornbine the regulation
measurenrents of all cells in culture.
4.5.3 SU.I.\,flVIARY AND EONCLUSIONS
Mu opioid receptors are down-regulated in pri:mary rat brainstem cultures established ftom
fostal and early postnatal rat& MOR is rapidly inbrnalised on exposure to the MOR
agoniot DAMGO in the $ame way ds non-troo$fecled, and MOR-transfected, SH-SYSY
cells, suggesting MOR exptessed in cultured brainstem cells is functionaly regulated. ICC
,techniques however, arc not sensitive enough to determine if differences oc,cur during
dEveiopment in the rate and level of OpR down-regulation.
The guinea pig anti-MOR antibody (Chemieon) used in the present study specifically
Iabels MOR and this was confirmed by double labelling ex.periments with antibodies for'
FLAG and IvIOR.- The rab,bit anti-DOR anfibody'(Chelrricon) showed no crossreactivity
for MOR (Data not shown).
Frsm this study it can be concluded that the antib.odies used are binding specifically for
MOR and DOR. In primary brainstem culturss IUOR is functionally down-regulated b'y
DAMGO" a MOR,selective agonist.
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CHAPTER 5
5 MoR and DoR Expression In Purkinje celts of rhe
Rat Cerebellum
5.1 AIM
During the course of the present study on rut brainstenr opioid receptors. MOR and DOR
distributions were determined in brain sections by immunohistochemistry (IHC). During this
study' immunoreactivity for both OpR subtypes was also observed in the rat cerebellum in
panicularinthePurkinjeneuronsofthenrolecularlayer. Theaimofthisstudywastoconfinn
that both MOR and DOR are present in cerebellar tissue. as it is currently accepted that Mr)R
is not expressed in the rat cerebellunr. although MOR expression has been described in
cerebellar tissues fronr most other mammalian species.
5,2 INTRODUCTION
5.2.1 MOR AND DOR EXPRESSION IN THE BRAIN
MOR and DOR protein and mRNA localisation within the CNS and peripheral rissues h.ive
been extensively studied using immunohistochemistry, in sittt hybridisation. radiolabelled
ligand binding, and RT-PCR (Atweh and Kuhar, 1977; Mansour er al.. lggg; Xia and Hadcrad,
l99l: George et al.. 1994; Mansour et al.. t9941 Arvidsson et al., 1995b; Mansour et al.. 1995:
Wang and Wessendorf, 2OOZ). Each class of opioid recepror shows distinct expression
patterns within the brain (Delfs et al.. 1994; Mansour er al.. 1994: Bausch et al.. l9g'5a;
Mansour et al., 1995; Ding et al., 1996b: peckys and Landwehrmeyer. 1999; cahill et al.,
2001b). Most brain areas show good correlation between protein and mRNA expression
patterns, although sorne differences lrre noted. These differences may be due to either the
mRNA signal being absent in neuronal processes, or to variations in sensitivity of the different
methods used. The latter problern arises because of different binding affinities of the probes
for their targets and the use of diff'ercnt signal amplification rnethods.
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5,2.2 STRUCTURE OF THE CEREBELLIIM
The cerebellum is a brain region involvecl in fine control and planning of complex mc,tor
activities. It is made up of several lobes. including the anterior lobe. posterior lobe, rrnd
flocculonodular lobe. and has three main functional zones, the vermis. lateral. rrnd
interrnediate zones (Kandel et al.. 2000). Regions of the cerebellum are separated by
numerous fissures. which divide the tissue into lobules. Cerebellur neurons rue segregated
into three distinct layers. the outernrost molecular layer, the Purkinje cell layer, and the
innermost granular layer. The rnolecular layer contains stellate and basket cell inhibitory
interneurons, the dendrites of inhibitclry Purkinje cells, and the axons of excitatory grarule
cells' Purkinje cell axons project to the deep cerebellar nuclei and provide the output of the
cerebellar cortex. The inner granular layer contains densely packed, small granule cells, Golgi
interneurons. and mossy fibre terminals that provide aff'erent input to the cerebellum (Kardel
et al., 2000).
5.2.3 CEREBELLARFUNCTION
The cerebellum has functions that include learning and planning of complex motor parte:ns,
evaluation of sensory infbrmation, modulation of descending motor systems in both the
brainstem and cerebral cortex, regulation of postural balance and eye movements, ancl
regulation of body and limb movenrents (Kandel et al., 2000). Purkinje cells, which are
inhibitory in function, project to the inf'erior olive, vestibular nuclei, and reticular formatio;r in
the brainstem, rcgions that all express both MOR ancl DOR (Mansour et al.. lgg4). Purkinje
axons project through the white matter to the vestibular nuclei and provide inhibitory our-put
that is mediated by the neurotransmitter y-aminobutyric acid (GABA). In other regions. for
example, the dorsal horn of the cat spinal cord, GABA-containing neurons synapse rvith
MOR-expressing neurons (Gong et al.. 1997). In the rat cerebral cortex, many Mr)R-
expressing neurons also stain positive fbr GABA (Taki et a|.,2000). Neurons expres;ing
DOR have also been shown to synapse with CABAergic neurons (Commons et a|..2001).
These colocalisation studies suggest a possible role for opioids in the cerebellum of
modulating Purkinje cell activity. Both opioids and the cerebellum play roles in modulating
vestibular function (Kandel et al., 2000). Nystagmus caused by vestibular deafferentatic,n is
reduced by administration of naloxone. an OpR antagonist (Dutla et al., 1996). OpRs ma) act
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by hyperpolarizing Purki'nje cells, thus, preventing Furkinje cell inhibition of the vestibtrlar
nuclei and other braia regions.
5;.i2.4 SPECIES DIF'FERENCES IN MOR AND DOR DISTRIBUTIONS IN THE
CEREBELLI.JIVT
Species differenees exist in opioid receptor expression in the oerebellum, and the OpR.
subtypes that are present vary. In the rabbit and human, MOR is expressed in the oerebeilu,m
at high levels and DOR at low leyels (Lu et al., 1993; Peckys and Landwehrmeyer, 1999),
with both NIOR and DOR expression highest in the Purkinje cell layer. In the rat ir is
generally acceptod that within the cerebellum only DOR is expressed (ab,leitner, l99z$; Abeyta
et al., 2ffi2), In the present study we report s,trorag exp ession of MOR protein in purhnje
cells of the rat oerete'lltrm, with some MOR protein exptession also seen within stellate cells
in the external molecular layer.
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5.3 METHODS
5.3.I IMMUNOHISTOCHEMISTRY
5.3.1.1 Tissue Fixation
Foetal brain tissue was fixed by removing the whole brain and placing it in paraformaldehyde
fixative solution (4Vo paraformaldehyde in PBS. pH7.4) overnight at 4oC. Adult brain tissue
was fixed by cardiac perfusion of a rat that had been deeply anaesthetised with pentobarbital
(65 mg/kg ip) (Nembutal). A miclline incision was made rhrough the skin ar the base of the rib
cage. exposing the xiphisternum. A central cut was made along the rib cage and the I ibs
folded back to expose the heart. The left femoral vein was exposed and cut immediately
before inserting a blunted needle into the lefi ventricle. The needte was taped into place rrnd
connected to tubing, which passed through a peristaltic pump (Watson Marlo Ltd, Cornwdl"
England) and into a reservoir bottle containing ice-cold PBS. The PBS was perfused into the
circulation at a flow rate of I I ml/nrin until the perfusate was free of blood (10-15 min). 'l'he
perf'usate was then replaced with ice-cold 4cl parafbrmaldehyde in PBS (pH 7.4) and perfur;ed
tor 30 min to fix the brain tissue. The brain and rostral spinal cor<l were carefully remor ed
and placed in fixative for 2 hr at room temperature. The tissue was then transferred to pBS
containing 307o sucrose at 4oC and left overnight, or until the brain had sunk to the bottom of
tlre container. This final step prevented tissue darnage during freezing. Befbre sectioning, he
brain was stored frozen for up to 60 days at -70.C.
5.3.1.2 TissueSectioning
Fixed tissue was mounted in Cryo-M-bed fieezing compound (Bright Instrument Company
Ltd. Huntingdon, UK) and cut using an HM 500 OM series cryostat microtome (Micronr
International GmbH. Walldorf. Germany). Free-floating 20 pm or 30 pm serial cororral
sections were placed in labelled 1.5 mL microf'uge tubes (or l0 rnl- vials for sagittal sectiorrs)
containing PBS. After sectioning, the tis.sue was pemneabilised in PBS c<lntaining 0.lZo Trit,rn
X-100 for 30 rnin. then endogenous peroxiclase activity was removed by incubating sections in
a solution of 5OVo methanol containing I% wlv hydrogen peroxide. The sections were washed
3x 5 min and stored in PBS containing 0.1% sodium azide for up 7 days at 4"C. The sodium
azide was washed off befbre immunolabelling because it inhibits the peroxidase enzyme us.:rl
in the detection methods.
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5.3.1.3 Antibody Labelling
Several sections were incubated in the same microfuge tube in 200-300 1tL of prinrary
antibody' For washing, antibody solutions were carefully removed with a micropip,:tte,
leaving the sections at the bottom of the tube. The sections were washed in pBS containing
0.l7o Triton X-100 (4x 5 min washes), then blocked tbr I h in blocking solution suppliecl rvith
the Tyramide anrplification kit (perkin-Elmer). Sections were then incubated overnisht at X.C
in primary antibody diluted in blocking solution.
5.3.1.4 Detection of MOR
The anti-MOR antibody (guinea pig anti-MOR, l:1000. Chemicon) was dilured in blocking
solution prior to use and incubated ovemight at 4uC on a rocker platform. The free-floating
sections were washed with PBS containing 0.017o Triton X-100 (4x 5 min each), and the s tes
of primary antibody binding detectecl using a rabbit anti-GP IgG-HRP-conjugated secondary
antibody, (Zymed Laboratories, San Francisco. CA), diluted l:3000 in TSA blocking solution,
and incubated for I h at room temperature. Unbound anti-GP IgG-HRP was relnoved by
rvashing 4x for 5 min each in PBS containing 0.017n Triton X-100. An amplification step
using TSA-biotin (Perkin-Elmer) was perlbrrned following manufacturer's instructions as
outlined in Chapter 3 (Section: 3.3.3.2). The secrions were then washed in pBS and incuba:ed
for 30 min at room temperature with ExtrAvidin-HRP (Sigma), diluted l: 2000 in pltS.
Immunoreactivity of cells was detected hy DAB (Sigma) staining (l pg/ml in 0.1 M
phosphate buffer (pH 7.a), containing 0, l%, hydlogen peroxicle), with or without nic,iel
sulphate (0.039o) until suitable colour clevelopment had occurred.
5.3.1.5 Detection of DOR
For immunostaining of DOR, sections were preincubated in TSA blocking solution fbr I h at
room ten'lperature, then incubated ovemight ut 4"C on a rocker platform with DOR antibocly.
(rabbit anti-DOR. l:1000, Chemicon) diluted in TSA blocking solution. The nexr day the
samples were washed 4x 5 min each as above. Bound primary antibody was detected by
incubating with an anti-rabbit IgG HRP-conjugated antibody (l:2000) for 2 h at rocm
temperature. Sections were washed, and the signal amplified with TSA- biotin a:rd
l(i6
ExtrAvidin-HRP, as described above for MOR. DOR sites were visualised using DAI] as
described above.
5.3.1.6 Mounting of Sections and Visualisation of DOR Immunoreactivity
The immunolabelled. free-floating tissue sections were rnounted on slides and air-dried l,rior
to dehydration through increasing ethanol and Hjsto-clear@ histological clearing solution
washes (National Diagnostics. Alanta, LISA) for 3 mrn edch (7OVo ethanol, 70%, ethanol;lt17o
ethanol:957o ethanol; 1007o ethanol; 100%,ethanol:2501, histo-ctear/75Vo ethanolSAVI h:sto_
clear/S0o/c, ethanol; 75Vo histo-clear/?5%a ethanol: l00Zo histo_clear). The sections \vere
mounted onto slides using DePeX mounting solution (BDH Laboratory Supplies. Pc,ole,
England). For high magnification digital irnages, stained sections were photographed using an
Olympus AX70 compound photonricroscope (Olympus. Tokyo. Japan) with digital car:rera
(Nikon COOLPH 995 3.34 mega zoom, Tokyo. Japan). For low magnification inraging of
coronal and sagittal sections, an inverted series SV I I stereomicroscope (Carl Zeiss
Mikroskopie, Jena. Germany) equipped with digital camera (AxioCam HRc, Carl Zeiss
Mikroskopie) was used. and images were capturecl using AxioCam 5.05 and AxioVision 3.1
software (Carl Zeiss Mikroskopie).
5.4 R-ESULTS
5.4.I DISTRIBUTION OF MOR AND DOR IN THE RAT BRAIN
5.4.1.f MOR and DOR Localisation in the Adult Rat Brain
In the adult rat. MOR and DOR distributions have been well documented in the literature
(Delay-Goyet et al., 1987; Mansour et al.. 1987. 1988: Delfs et al.. 1994; Mansour et al., l1)94;
Zastawny et al., 1994; Arvidsson et al., 1995a; Mansour et al.. 1995; Ding et al.. 1996b; I)fru
et a1.,2000; Cahill et al..200lb). In the present study. typical staining parrerns for these
receptors were seen in most brain regions. including the dorsal horn of the spinal cord (trH),
olfactory bulb. and in specific brainsrem nuclei (Figure 5.1).
5.4.1.2 Distribution of MOR and DOR in the Rat Cerebellum
Previous studies have shown that DOR is expressed in the adult rat cerebellum (Delay-Goyet,
1990; Ableitner. 1994; Bausch et al.. 1995a; Abeyta et al., z00z). Using a DoR-specific
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antibody' abundant DOR protein expression was detected in the present study within the l:rrge
cells of the Purkinje layer, in the dendritic processes of Purkinje cells within the molecular
layer. and in some stellate and./ol basket cells of the molecular layer in both adult (Fi.;ure
5.2A. C. & E and Figure 5.3A) and P6 rats (Figure 5.4A). Cerebellar secions were also
stained for MOR. Figure 5.2 (8, D. & F) and Figure 5.3B shows the sraining obtained in the
adult rat cerebellum. The patterns seen fbr MOR closely resemble the staining pattern seerr for
DOR, with positive staining in the Purkinje cell layer. the dendritic processes of the molecular
layer. and occasionally stellate and/or basket cells within the molecular layer. This stairring
pattern can also be seen in the cerebellunr of P6 rats labelted with rhe same MOR-spetific
antibody (Figure 5.48), although the granular layer in P6 rats shows more intense stairring
than the granular layer in adult cerebellum.
The distribution of both DOR and MOR in the rat cerebellum obtained by
immunohistochemistry is supported by fluorescent in slra hybridisation (FISH) detection using
fluorescently-labelled cRNA probes (Eli Mrkusich and Dr Darren Day, persc,nal
communication). As with ICC, FISH detection of both MOR and DOR mRNA shows
labelling of cells in the Purkinje layer and in some stellate and/or basket cells in the molecrrlar
layer. There is little tabelling, however. of the Purkinje cell dendrites within the molecrrlar
layer. This is consistent with the fact that mRNA is often found only in the cell body where
the protein receptors are synthesised.
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Figure 5.1
DOR And MOR Labelling in Brain Regions
Adult DOR (A & c') (rabbir anti-D()R. ('hcrnicon) and MoR (Il & D & F) (guinea pig anti-
MOR. Che-rrlicon) inrn:unoreactivitv in thc adult ra1 showing similar staining patterns fbr
t)olt and MOR: (A & B) dorsal h.rn ol'rhc spinal cord (coronal section): (c & D) the
ollactorv bulb (sagiual section): and (l:) brainstern (sagittal section). -l'he ncgative control ([--)
with no prinlary antihody shows no staining in a rcgion of the brainstem. Inrmunoreactivity
was detected with DAB and visuirliscd using brightlield nricroscop,v. Scale bars - I mm
a
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Figure 5.2
Distributions of DOR and MOR immunoreactivity in the Adult Rat Cerebe[um
Distribution ot DOR (A, C. & E) (rabbit anti-I)OR. Chemicon) and MOR (8. D, & F) (guinea pig anti-
MOR. Chemicon) immunoreactivity' in thc cerebellunr of the a<Jult rar. Intense sraining of Purkinje cells(Pk)and thcir dendritic processes (shown b-v arrous) is seen within the molecular layer (M). The granular
layer shor.rs sonle labelling (GrL). MOR is stained with DAB in the presence ol'nickel: whereas DOR is
labcled without nickel. Some edgc staining artifact can be seen. Scale bars = 200 pnr (A & B). 100 pm ((
& D), and 50 pm (E & F).
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Figure 5.3
DOR and MOR Labelled Purkinje Cells
High power images of adult rat cerebellum showing (A) DOR (rabbit anti-DOR, Chemicon) and (B)
MOR (guinea pig anti-MOR, Chemicon) immunoreactivity in Purkinje cells (arrow heads). Scale
bars :40 pm.
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Figure 5.4
Distribution of DOR and MOR immunoreactivity in the Postnatal P6 Rat Cerebellum
High power pictures of the postnatal P6 rat cerebellum showing (A) DOR (rabbit anti-DOR, Chemicon) and(B) MOR (guinea pig anti-MOR. Chemicon) labelling of the Purkinje cell layer (Pk) wirh weak labelling t,f
dendrites (shown by arrows) extending f'rom Purkinje cells in the molecular layer (M), Some staining of the
granular layer (GrL) below the Purkinje laver is evident. Cell bodies in the molecular layer can be seen ar,d
are probably stellate or basket cells (shown by arrow heads). scale bars:50 pm
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5.5 DISCUSSION
5.5.I MOR AND DOR DISTRIBUTTON IN THE ADULT RAT BRAIN
Coronal sections of the rat spinal cotd. hrainstem. and sagittal whole brain sections \ver€
labelled with MOR and DOR antibodies. The MOR and DOR staining parterns observed rvere
characteristic of MOR and DOR staining patterns described in tlre literature (Mansour ei al.,
1987' 1988; Delay-Goyet, 1990; Delfs et al., 1994; Mansour et al.. 1994: Zastawny er al..
1994; Arvidsson et al.. 1995a; Mansour et ll.. 199-5; Ding et al., 1996b; Moriwaki et al., I )96;
Diaz et al.. 2000; Cahill et al., 200 lb). The regions stainecl fbr both MOR and DOR incltrded
the dorsal horn of the spinal cord. olfactory bulb. and the striarum. Similarities with tlOR
labelling in the mouse brain were seen in thc olf'actory bulb (Bausch et al., 1995a).
In the present study. the distribution of MOR in the adult rat brain closely resembled the
distribution pattem reported in the literature using MOR-l antibodies (Ding et al.. 1996b) and
includes MOR detection in the olfactory bulb. striatum, and dorsal horn of the spinal r:orcl
(Mansour et al.. 1987, 1988; Arvidsson et al., 1995b; Dfaz et ar.. 2000).
The rabbit anti-DOR antibody (Chenricon) used in the presenr study has been recently rell
characterised. including one paper giving a detailecl comparison with another DOR antib,ody
which gave an almost identical staining pilrrern in rat brain (Cahill et al.,200lb). This DOR
antibody is therefbre Iikely to be specific fbr DOR. The strongest DOR staining in the srudy
by Cahill et al. (2001) was observed in the caudate putamen, venffal striatum. layers II. II[, V
and VI of the cerebral fi'ontal cortex. the diagonal band of Broca, and the dorsal horn ol the
spinal cord (Cahill et al., 2001b). Similar staining patterns were observed in the present study.
5.5.1.1 MOR and DOR Expression in the Adult Rat Cerebellum
It is generally accepted in the literature rhat MOR is not expressed in the rat cerebellunr
(Mansour et al., 1987. 1988; Delfs et al.. 1994; Mansour et al., 1994: Mansour et al.. l!r95:
Ding et al., 1996b). although a few studies have provided some evidence that MOR is pre,;ent
within the rat cerebellum. For exanrple. Barg. et al. (1989) showed both MOR- and D()R-
specific ligand binding in the rat cerebellurn during clevelopment (Barg and Simantov. l9i9).
In a more recent study. Wittert et al. (1996) demonstrated the presence of MOR mRNA in the
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rat cerebellum using RT-PCR (Wittert et al.. 1996). In addition to the above two stu,Jies.
Bausch et al. (1995) presented iln inrage or photornicrograph of positive NIOR
imnrunoreactivity in the cerebellunr of tlre rat within Purkinje cells, although the staining was
not mentioned in the text of their paper (Bausch et al., 1995b). There is no controversy that
MOR exists in the cerebellum of species other than the rat, including nlouse, rabbit and human
(Lu et al., 1993; Peckys and Landwehrmeyer, 1999: Hauser et al., 2000). Most OpRs iri the
cerebellum are found in the granule layer (Hauser et al., 2000) and in Purkinje celts (Bausr:h et
al.. 1995b; Peckys and Landwehnneyer. lggg). MOR and DOR receptors are ofren fourd in
the same brain rcgions, especially in brainstern nuclei (Chapter 6). The functional
implications of this in the cerebellum. renrains to be determined.
In the prcsent study, IHC staining of both MOR and DOR in the cerebellum of postnatal p6
and adult rats showed intense labelling of the Purkinje cell layer. with lighter sraining of
Purkinje cell dendrites present in the outer molecular layer. IHC techniques are nor
quantitative; and. therefore. the abundance of MOR relative to DOR could not be assessed.
Quantitative immunoblots and confocal irnmunof'luorescent staining of DOR protein in the
adult rat cerebellum has recently been reported. Purkinje cells were shown to express DOR at
comparable levels to other brain regions. such as the striatum and dendate gyrus, althcugh
expressiott in the gtanule cells was low (Mansour et al., 1994; Abeyta et al., ZO02). frOR
expression has also been reported in the rat cerebellar cortex. vermis. dendate nucleus, and
interpositus nucleus (Ableitner, 1994). The DOR expression patterns found in the prejent
study were consistent with the above findings. P6 r'ats showed greater expression of lroth
MOR and DOR in the granular layer than that fbund in the adult. This is consistent ,vith
developnrental studies on the cerebellunr in guinea pig and rat in which MOR and DOR
expression decreased between postnatal ancl adult animals (Barg and Simantov, 1989).
Purkinje cells. cerebellular astrocytes, and mossy fibres express the endogenous opioid agonist
enkephalin within the developing cerebellum (Wiliams and Dockray, 1983; Walker and King.
1989; Spruce et al., 1990; Osborne et al.. 1993). Enkephalin is rhe endogenous ligand for t,oth
DOR and MOR. Purkinje cells have also recently been shown to contain mRNA for er,do-
oligopeptidase (Hayashi et a1..2001), on enzyme that converts enkephalin precurson to
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enkephalin. Preproenkephalin mRNA and its peptide are also found in the cerebellum (Z;.rgon
et al.. 1985). The presence of endogenous opioid ligands and their receptors in the cerebellurn
is suggestive of a role for opioids irr the clevelopmenr or function of this brain region. The
functional significance of opioicl receptors ancl their peptides being localised to specific cell
types within the cerebellum has yer to be derermined.
5.5.1-2 Effects of opioids on cerebeilar Function and Development
Purkinje cells play a role in controlling gait. balance. facial movemenrs. and posturc. Opioids
are known to affect locomotion (ior review see)(Olson et al.. 1997; Yaccar-ino et al.. l,)99;
Vaccarino and Kastin, 20Ol). although no studies have proposed a functional link betv,,een
opioids and cerebellar motor control. It is possible that Purkinje cells expressing both lv{OR
and DOR may play a role in modulation of some of these complex motor functions.
Opioids play a role in the regulation of cellular proliferation in the developing CNS (Zagon
andMclaughlin, l99l;Bargetal.. 1993a: Gurwell etal.. 1996). Inthemouseandrat,opi:ids
inhibit neuroblast replication and clifferentiation in the developing cerebellum (Zagon and
Mclaughlin. 1983; Hauser and Mangoura, 1998). Opioids also affect granule cell
proliferation and differentiation in a highly selective rnanner. Since the data from the pre.;ent
study and the work of others has shown thtt these cells express MOR and DOR as well as the
opioid peptide preproenkephalin, it can be concluded that these receptors and their tigands
control at least part of granule cell growtli and clifferentiation. Treatment of granule cells
cultured from P-5 and P6 mice with rnorphine (a MOR prel'erential agonist) caused a decre:ase
in cell numbers and inhibition of neuroblast prolif'eration (Hauser er al., 2000). Ihe
localisation of OpRs and peptides withrn the cerebellum has important developmental
implications. particularly in the area of opioid abuse. and this is especially relevant in term; of
newborns of drug-addicted mothers. The use of opioids in pain relief during labour may rrlso
alter cerebellar function and./or development in the newborn. These speculations need tc, be
investigated, and the cellular distribution of MOR and DOR ro specific cells within the
cerebellum needs to be refined through the use of high-resolution techniques, such as
immunogold electron microscopy or confocal microscopy. Double-labelling with specific :ell
type markers such as calbindin to specifically label Purkinje cells woulcl also aid in the
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interpretation of the data (Wanner et al., lggT). Calbindin D28k is a calcium-binding protein,
wltich protects neurons against apoptotic cell death. The protein has a distinct distribution in
the brain and sensory system and is abunclant in specific neuronal cells. It is often used as a
positive marker for Purkinje cells within the cerebellum (puyal et al,. 2002).
5.6 SUMMARY AND CONCLUSIONS
Imnrunohistochemical staining of MOR and DOR in the present study demonstrated panerns
of expression in regions previously slrown to express OpRs. as well as MOR expression irr the
cerebellum a result not consistent with the consensus in the literature. This study is one or, the
t'ew to use IHC techniques to describe MOR expression in the rat cerebellum. especially irr the
Purkinje cell layer. One earlier IHC study has suggested that MOR is expressed in purt-inje
cells in the cerebellum (Bausch et al., 1995b). although the authors did not discuss the
significance of their finding and may not have realised that others report that MOR is nor
expressed in this region. The staining patterns observed for MOR in the present study rvere
similar to DOR in the rat cerebellum and to MOR in the human, rabbit, and mouse cerebellum.
The nrost likely reason that MOR wits not seen in earlier studies on rat cerebellar tissue was
the poor resolution of the methods used. In the present study, high-arnplification IHC methods
u'ere used, including TSA-biotin anrplification. Previous studies using IHC techniques 'vith
standard avidin/biotin amplification failed to detecr MOR. Given rhar mRNA FISH labeiling
has shown a strong MOR mRNA signal in the same areas of the cerebellum (EIi Mrkusich and
Dr Darren Day. personal communication), the present results are unlikely to be artefactual.
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CHAPTER 6
6 Developmental Expression and Distribution of opioid
Receptors In The Rat Brainstem
6.I AIM
The aim of this chapter is to investigate the distriburion of MOR and DOR in the rar brainsrem
during development. To achieve this, total brainstem homogenates tiom diff'erent stages c f rat
development were used to measure total MOR and DOR protein levels. using SDS-pAGI: gel
electrophoresis and western blotting. Imnrunohistochemistry (lHC) was performed on tissue
sectiotts from different developmental ages to determine pattems of expression dlring
development.
6.2 INTRODUCTION
6.2.1 MOR AND DOR EXPRESSION TN TTIE RAT BRAINSTEM DURING
DEVELOPMENT
Several investigators have studied OpR expression in the rodent brain during developrnent
(Coyle and Perr, 1976: pasternak et al.. l9g0; Leslie er al.. l9g2: Tsang et al.. l,)g2;
Wohltmann et al.. 1982; Spain et al., 1985: Tavani et al.. 1985; Kornblum et al., 1987; perrillo
et al.. 1987; Attali et al., 1990; Benr et al.. l99l: Xia and Haddad. l99l; Barg et al., l,)92;
Murphey and Olsen, 199-5; Zhu et al., t998: Tong er aI..2000; Beland and Fitzgerald.200l).
but f'ew studies have investigated the distribution and exprcssion patterns of MOR and DOR in
the brainstem (Xia and Haddad, lggl; Murphey and Olsen, 1995: Laferridre et al.. 1999).
Most studies have used ligand-bindin-g methods. and in most cases results reported fbr the
brainstem have been superficial. Ofien the whole brain is used, or the brain is separatecl into
forebrain and hindbrain regions. The present study concentrates on the lower brainstenr
regions that were used for primary culture (Clhapter 2.3, & 4), areas shown to be involved in
respiratory rhythm generation and modularion.
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6.2.2 MOR AND DOR DISTRIBUTION IN TIIE ADULT BRAIN
The distribution of MOR and DOR proteins and mRNA expression levels in sections of rat
brain have been extensively investigated by autoradiographic techniques (Atweh and Krrhar,
1977; Mansour et al., 1987; Temple and Zukin. 1987; Delay-Goyer. 1990: Diaz et at.. 2000;
Goody et al., 2002). immunohisrochemistry (lHC) (Arvidsson er al.. 1995a; Arvidsson e: al..
1995b: Ding et al.. 1996b; Cahill et al.. 200tb), and rn sirr hybridisarion (lSH) (Delfs e; al.,
1994:Georgeetal.. 1994; Mansouret a|.. 1994;Zastawnyetal., 1994). Someof thesestrdies
present contlicting distribution pattenrs. depending on the experimental techniques r.sed.
These diff'erences between studies are prohably due largely to ditTerences in sensitivity and
resolution between the techniques of receptor-ligand binding. antibocly binding, and rnRNA
hybridisation. Results from sonre ol' these studies are summarised in Chapter I (Tabte 1.2).
Difl'erent opioid receptor ligands have unique binding properries, but some ligands and
antibodies used in early studies were relatively non-specific. binding more than one rec€,ptor
subtype' ISH studies often give dif ferent labelling patrerns to IHC detection: possibly becluse
IHC labels receptors in neural processes as well as in the cell body; whereas, ISH k,bels
mRNA mostly in the cell body. Another factor to consider when interpreting OpR distribr.tion
patterns is the presence of multiple molecular fbrms of MOR and DOR that mar be
diff'erentially recognised by different antibodies and ligands. Most of these early studies tvere
carried out before these diff'erent isofonns of MOR had been described. To further comp;cate
matters. each MOR isoform has a unique distribution within rhe brain (Schulz et al.. 1998:
Abbadie et al., 2000b; Abbadie et al.. 2000a).
The general consensus from the literature on brainstem and spinal cord is that both MOR and
DOR are present in the dorsal honr of the spinal cord (DH) (Arvidsson et al., 1995a:
Arvidsson et al.. 1995b: Moriwaki et al., tggeDiaz et a1.,2000; Cahill et al..200lb) ar:d in
brainstenr areas of the locus coeruleus (Delti et al.. 1994; Zastawny et al.. 1994: Arvidss<,n et
al.. 1995a; Arvidsson et al.. 1995b; Moriwaki et al., 1996), spinal trigenrinal tract and nucleus
(STT) (Delfs et al.. 1994; Mansour et al.. 1994; Arvidsson et al.. 1995a; Arvidsson er al.,
1995b: Bausch et al.. 1995a: Mansour et al.. 1995: Moriwaki et al.. 1996; Cahill et al.. 2001b).
the dorsal motor nucleus of the vagus (12) (Delfs et al., 1994; Arvidsson et al., 1995a:
Arvidsson et al.. 1995b: Bausch et al.. 199-5a). nucleus of the solitary tract (NTS) (Delfs er al.,
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1994: Mansour et al.. 1994, Zastawny et ul.. 1994; Arvidsson et al., 1995a; Arvidsson er al.,
1995b; Mansour et al., 1995; Moriwaki et al.. 1996; Di;u et al.. 2000). and the nu(:leus
ambiguus (NA) (Delfs et al., 1994: Zastawny et al.. 1994; Arvidsson et al., 1995a; Arvidsson
et al', 1995b: Moriwaki et al.. 1996; peckys and Landwehnneyer, l99g).
6.2,3 THE EXPRESSION AND DISTRIBUTION OF MOR AND DOR DURING
DEVELOPMENT.
6.2.3.1 Early studies in the Developing Brain
There arc many published reports on opioid receptor expression during development thar are
based on ligand binding of brain homogenate samples in the rat (Coyle and pert. l.)76;
Pasternak et al., 1980; Leslie et al., 1982; Tsang et al.. 1982; Wohltmann er al., 1982; Spa n et
al" 1985; Kornblum et al., 1987; Petrillo et al., 1987; Attali et al., 1990; Kitchen et al.. l,)90;
Bem et al.. l99l), mouse (Tavani et al.. 1985; Barg et al.. Igg2\, pig (Laferridre et al., l!)99)
and guinea pig (Murphey and Olsen, 1994). Often the samples analysed are flrom whole brain.
without separation of brain regions, rnaking regional changes irnpossible to determine,
A f'ew studies have used ligand-binding autoradiography to show OpR bincting ro spet:ific
brain regions during development. One stucly showed MOR, DOR. and KOR binding in the
postnatal rat brain; however, the brainstenr was not included in this study (Kornblum et al.,
1987). Another investigation sholved binding by naloxone, a non-selective OpR antagc.nist
that binds MOR with a higher affinity than DOR, but again no mention was made of the
brainstem (Kent et al., l9S2). A thircl study described the postnatal distribution of MOR and
DOR in the brainstem of the pig by autoradiographic binding of the MOR agonist DAMGO
and the DOR agonist DPDPE (Lat'erridre et al.. 1999). MOR- and DOR-specific binding was
seen in the NTS, NA. and inferior olive (IO). Leslie et al. (1998) have demonsrrared KOR
ntRNA binding in foetal El7 rat brainstem in the region of the dorsal motor nucleus of the
vagus. hypoglossal nucleus, and NTS; however. the distribution of KOR was not compirred
with any other age group (Leslie et al.. 1982).
The nature of the ligand used in each study al'fects the specific distribution patterns obserred.
For example. naloxone and enkephalin can both bind to MOR and DOR receptors (Kent et al.,
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1982). These non-specific ligands show dit'terent expression levels compared to DAMGO and
DPDPE (Xia and Haddad, l99l). Direct comparisons between stuclies. however, are diffrcult
because of the different developmental ages used and the fact that the brain sections ar€ not
nratched.
6.2.3.2 Species Differences
Studies in diff'erent species have shown sirnilar opioid receptor distribution patterns to tirose
seen in the rat during development. ln the mouse. specific OpR expression levels during train
development were first described by Zhu et al. (1998) using ISH techniques (Zhu et al.. l99g).
Previous studies used ligand binding in forebrain and hindbrain preparations. but did not use
specific DOR ligands (Spain et al.. t9S5). In the mouse, MOR mRNA was first detected at
Ell.5 and DOR at 813.5. with an increase in expression with increasecl developmental age
(Zhu et al., 1998). In studies of newborn piglets. MOR binding by DAMCO increased ,vith
age; whereas. DOR levels, based on DPDPE binding did not change berween P2 and p2l
(Laf'erridre et al.. 1999). Opioid developnrent in the piglet tends to be ahead of developrnent
in the rat. with the highest densities found in the NTS and STT.
6.2.4 DISTRIBUTION OF MOR AND DOR DURING RAT DEVELOPMENT
Most studies sug-qest that MOR and DOR increase during development. DOR appears at a
later developmental age than MOR ancl KOR. which are first detected ar El2 and incr:ase
during the Iater foetal and early postnatal developmentar srages (Spain et al., l9g5: Tavani et
al'. 1985: Petrillo et al., 1987). DOR is not expressed until early postnatal development (S;rain
et al.' 1985; Tavani et a[., 1985; Petrillo et al., 1987). although some studies have dete:ted
DOR expression as early as E13.5 in the nlouse, using more sensitive ISH techniques (Zhu et
al.' 1998)' Comparisons in expression Ievels between species are difficult to make in t;rese
studies due to the variations in the sensitivities of these techniques. In preparations of w'role
brain fi-orn the rat (minus the cerebellum), changes were observed in opioid receptors during
postnatal development. DOR was flrst present at very low levels at P3, then increased to adult
levels at 3.5 months (binding was e.{pressed per g brain). MOR remained high during the
postnatal time period between P3 and P2l and in the adult (Petrillo et al.. 1987). In rht, rar
179
spinal cord, DOR increased in the 3rcl postnatal week (Arrali et al.. 1990), although the peptide
diprenorphine. which binds to both MoR and KoR, was used in this studv.
6.2.5 FUNCTIONAL IMPLICATIONS OF MOR AND DOR EXPRESSION IN THE
BRAINSTEM
The functional irnplications of OpR expression in the brainstem were discussed in detail jn
Chapter I (Section 1.3). For a review. see (Olson et al.. 1997; Vaccarino et al.. 1999:
Vaccarino and Kastin,200l). Brainstem nuclei are involved primarily in cardiorespiratory and
antinociceptive function. The vagus nerve contains afferent projections to the NTS fronr the
heart' lungs. and abdorninal viscera (Lawrcnce and Jarrott, 1996). and vagal stinrulrrtion
affects cardiopulmonary reflexes. swallowing. gastrointestinal motility. feetling.
antinociception, sleep and respiration. The brainstem areas involved in the contrcl of
breathirrg include the dorsal resprratory group (DRG) in the caudal NTS and the ventral
respiratory group (VRG), which includes the pre-Bcitzinger Complex (preB6tC), Btltzinger
Complex (BdtC). NA, and ventrolateral medulla (VLM). The NTS is a major affi:rent
integration or relay centre that plays a role in respiratory timing. The VRG, located in and
around the NA. includes the preBotC'. a region postulated to be responsible for generating the
respiratory rhythm (Smith et al.. l99l; Rekling and Feldman, 1998). Mosr brainjtem
functions become critical at birth. in particular. respiratory function. Studies in the guineir pig
have shown that morphine metabolites are more potent at inhibiting respiratory function in the
first weeks after birth (Murphey and Olsen, lgg4). This may be due to an increase in I\{OR
exptession in the brainstem during early postnatal development (Spain et al.. 1985; Tavani et
al', 1985; Petrillo et al., 1987). Abnormalities in opioid functions during early postratal
development have been implicated in SIDS (Chavez et al., 1979: McMillen" 1986: Storm et
al.. 1994).
There is a need for a more comprehensive look at OpR localisation and expression drrring
brainstem development because ligand-binding studies do not provide the specificity and
resolution required. Early studies lacked the sensitivity that more recent approaches provide.
and they should be interpreted with this in mincl. Using highly specific antibodies to I\{OR
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and DOR' the aim of the present study was to provide a more detailed and reliable picture of
OpR distributions in the brainstenr during development.
6.3 MBTHODS
6.3.1 QUANTIFICATION OF OPIOID RECEPTOR EXPRESSION
6.3.1.1 Sample Preparation for Western Blots
Three sets of samples front each developrnental age (age-matched samples) were useC to
measure OpR expression during developrnent. Brainstem tissue from sever-al diffi.rent
developmental ages was dissected fiom animals sacrificed by a lethal dose of pentobarbital
(Pentobarb 300; 100 mg/kg ip) (Chemstock Animal Health Ltd. Christchurch. NZ). Tissue
was placed on ice, washed in PBS. chopped into small pieces, and transferred into Western
Sample Buffer (8 M Urea. 3 M thiourea, 4o/a CHAPS and 40 mM DTT). The tissue was
incubated at room temperature on a vortex mixer for 10-30 min, and samples were stored
frozen at -20oC until applied to electrophoretic gels,
In addition to brain tissue pieces. cultured cells from dissociated brainstem tissue ,,vere
prepared for Westenr blots. The cultured cells were rinsed in PBS and mechanically deta:hed
fronl the culture dish by trituration with a I mL pipette in 0.4 mL of pBS. The suspended ;ells
in were placed in a L5 mL microfuge tube and washed in PBS (2x). The samples were pcoled
and centrifuged for 5 min at 3000 rpm. The PBS was removed and the cells resuspendcd in
sample buffer, incubated at room temperature with continuous vortexing fbr 10-30 minutes,
and stored at -20"C until required.
6.3.1.2 Concentration of Protein by Acetone precipitation
Selected samples were concentrated in the Westem sample buffer before electrophoresis in
order to prevent interference of salts in the buffer when large volumes are loaded. Sanrples
were precipitated for 5 min in 4 volumes ol'ice-cold acetone and centrifugecl at 14,000 rprn for
l0 min at 4nC. Acetone was removed by micropipette, and the pellet was re-solubilized n 
-5x
SDS loading buffer (62.-5 mM Tris-HCl pH 6.8, 27a SDS. ZOVo glycerol, lVo bromoplrenol
bf ue. 5%' $-mercaptoethanol) and electrophoresed on gVt, SDS polyacrylamide gels (Appc ndix
2: Section l3).
l8l
6.3.1.3 Protein Determination
Protein concentrations in brainstem tissue rnd cell culture samples were carried out accor-Jing
to a modified Bradford method. The protein assay used was first described by Bradfbrd
(1976) and modified by Sedmak and Grossberg (1977) to recluce inrerference by lipids and
detergents (Bradford, 1976; Sednrak and Grossberg, lg77). The method, using mod.fied
Bradfbld reagent (O.04Vo (w/v) Brilliant Blue G 250. in 3.57o perchloric acid). was further
modified for 96-well plates. A standard curve was prepared in 50 pL, ad.yusting the sarnple
volume with dH2O. Modified Bracltbrd reagent (250 1tL) was added, the solution mixed. and
the plate incubated at room temperature for l0 min. A microplate reader (VERSArlax,
Molecular Devices Corporation. Sunnyvale. CA, USA) was blankecl with sample b,rffer
lacking protein, and the absorbance of the samples was measured. at 620 nM. Sample prrrtein
concentrations were estimated fiorn a BSA standard curve (0 - 50 pg protein) t.sing
Softmax@Pro softwarc (Molecular Devices Corporation).
6.3.1.4 SDS-PAGE Gel Electrophoresis
All samples were analysed by electrophoresis on 1.5 mm thick, 87o SDS polyacrylamide gels
using a 47o stacking gel (Appendix 2: Section l3). The gels were casr and electrophores.:d in
a Miniprotean II or III cell (BioRad. Hercules. CA, USA). Appropriate amounts of pr,:tein
(10-70 pg) were added to each lane alongsideT pL of Benchmark presrained molecular w:ight
markers (Invitrogen) and electrophoresed in SDS running buffer (0.37o Tris, I.4Vo glycine.
0.17o SDS, pH 8.3) (Appendix: Section 14) at 150 V for I hr. Concenrrated proteirr gel
Ioading buffer (5x stock) (Appendix: secrion 15) was added to the samples in 1.5 mL
microfuge tubes to give a final concentration of at least lx loading buffer. The samples were
then boiled fbr l0 min on a heatecl dry block (Barnstead. Dubuque, lowa, usA).
6.3.1.5 Western Transfer
Proteins were transferred from polyacrylarnide gels to polyvinylidene difluoride (p\/DF)
membrane (BioRad) using a Trans Blot@ cell (BioRad). The PVDF membrane was s(,aked
for 5 min in IOOVo methanol. then 5 min in ddH2O, tl'ren placed in Western Transfer Buffer
(25 mM Tris. 192 mM glycine,pH 8.3 containing20Vo methanol) (Appendix 2: Sectior, 16).
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The materials used for transfer were stacked in transfer buffer in a Western Tralrsfer
Apparatus (Appendix 2: Section l9; Table l). avoiding air bubbles between layers. A small
magnetic stirrer was placed at the bottom of the transfer tank, whrch was fltled with ice cold
transfer buffer, and the dark grey side of the assembled cassette was placed on the side ne,rrest
the black electrode. The assembled tank wrth its cooling coil was placed on a magnetic srirrer
in a cold room at 4"C. and proteins in the gel were transferred for 4 hrs at t00 V intl the
PVDF membrane.
6.3.1.6 Inrmunostaining of Western Transferred proteins
After protein transf'er, the membrane was rinsed in ddH2O and blockecl. protein side up,
overnight at 4"C in l}Vo non-fat milk powder (Anchor) in Tris-buffered saline (TBS) (137 mM
NaCl.20 mM Tris, pH 7.6) containing 0.17o Tween 20 (BioRad, Hercules, CS, USA 11-
TBS). All membrane incubations were performed on a rocker platform. The next day, the
membrane was washed (3x 5 min) in T-TBS, and then incubated at room temperature for .l hrs
in primary antibody for MOR (l:5000. anti-MOR guinea pig, Chemicon) or DOR (l:-5000.
anti-DOR rabbit, Chemicon) diluted in T-TBS. The PVDF membranes were rinsed (2x 5 min
and ?x l5 min) in T-TBS, and incubated fbr I hr at room temperature with secondary antilrcdy
conjugated to HRP (for MOR, anti-GP HRP l:2000, and for DOR. anti-rabbit HRp t:5(f00).
washing as before.
6.3.1-7 Detection And Analysis of western Transferred proteins
HRP-labelled proteins were visualised using Lumi-light enhanced chemiluminescent substrate
(Roche) and developed using Kodak X-OMAT filnr (Radiographic Supplies Ltd. Christchrrrch,
NZ)' The chemiluminescent reaction was performed as per nranufacturer's instructions and
the film exposed between l-30 rnin prior to developing. The location of MW markers was
determined and the protein bands analysecl by scanning the filn using a Molecular Dynamics
Personal Densitometer SI (Molecular Dynamics, Sunnyvale. CA. USA). lmages were
analysed using lmageQuant software (Molecular Dynamics). The band density (rninus the
average background density of the filrn) was calculated for statistical analysis.
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6.3.2 IMMUNOHISTOCHEMIS'I'RY
Intnrunohistochernistry was perlblrlcd b1'the rnethocls described in Chapter-5 (Sectign 
-5.3 l).
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6.4 RESULTS
6.4.1 ANTIBODYQUANTITATTON
MOR and DOR antibodies stained in a quantitative manner. When increasing amounrs of
protein lysate were run on an SDS-PAGE gel. there was an increase in MOR and DOR lland
intensity in the Western blots (Figure 6. l).
6.4.2 MOR AND DOR EXPRESSION IN SH-SYsY CELLS
Antibody specificity was confirmed by using SH-SYSY and LLC-PKl cells as positive and
negative controls, respectively. tindift'erentiated SH-SY5Y cells showed MOR-positive
protein bands at 50 kD and 70 kD. and DOR-positive bands at 30 kD and 60 kD (Figure 5.2).
LLC-PKl cells showed no immunoreactivity for MOR or DOR proteins. A second neg,rtive
control experiment using no primary MOR or DOR antibody. only secondary antibolies,
shorved no immunoreactivityl therefore. all immunoreactivity observed was presumed to be
due to specific labelling by the primary antibodies. Some SH-SY5Y and brainstem sanrples
gave a band at approx 140 kD for MOR ancl 130 kD fbr DOR when the film was exposed for a
longer period. Other investigators have attributed this to opioid receptor dimer formrrtion
(George et al., 2000). Two MOR antibodies were tested in these experinrents to checl: the
specificity of the primary antibodies. Both the guinea pig anti-MOR antibody ancl the r,rbbit
anti-MOR antibody (Chemicon) gave immunoreactive bands at 50 kD and 70 kD. and both
produced similar changes in staining intensity during development when the same sanrples
were labelled on a separate Western blot (Figure 6.4).
All band intensity data obtained frorn the gels were norrnalised to rhe postnatal day 3 prrrein
band (P3) to allow comparisons to be macle between duplicate samples run on separate gers. or
protein bands visualised at diffelent chemilunrinescent exposure times.
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Figure 6.1
DOR and IVIOR Labelling of Adult Brainstem Tissue Lysates
Figure 6.2
DOR and MOR Labetling of SH-SYSY Cell Lysates
A
60 kD
30 kI)
B
70 kD
DOR
n
rI}
lo pg
Western blots of adult brainstem
lysates showing quantitative antibody
staining. (A) DOR (rabbir anti-DOR"
Chemicon) showing the two
immunoreactive bands at 30 kD and 60
kD. (B) MOR (guinea pig anti-MOR.
Chemicon) 70 kD band with 20 pg and
40 pg ofprotein. respecrively. A 50 kD
MOR band was also seen (data not
presented). Note the increased band
density with increasing protein
concentrations.
MOR
-
4o pg
''.<-Y.rf*
2o pg
DOR B
MOR
50
(A) DOR-labelled S[{-SYSY prorein lysare showing both
the 30 kD and the 60 kD bands (rabbit anti-DOR.
Chenricon) (40 prg/protein/lane). (B) MOR-labelled SH-
SY5Y protein samplc showing both the 70 kD and the 50
kD bands (guinea pig anti-MOR. Chemicon) (40 pg
protein/lane).
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6.4.3 MOR AND DOR PROTEIN EXPRESSTON DURING BRAINSTEM
DEVELOPMENT IN VIVO
All experiments using brainstem lysates were performed on at least three animals each .,rom
the adult and P6 age groups ancl three preparations of pooled foetal brainstem ti5sue.
Experiments using brain sections were perfbrmed at least 3 times. In the adult and p6 animals,
serial sections were taken and alternate sections were stained for MOR and DOR, respecti./ely.
In El6 animals, due to the small size of the brainstem, difTerent animals were used fbr I\lOR
and DOR staining. respectively.
Brainstem preparations from the same anirnal in each age group were run in duplicate gels
(same samples were run at different tinres) fbr MOR (Figure 6.4) and DOR (Figure 6.7). Jlorh
gels showed similar staining intensity clifferences between developmental age-nratched
samples (shown as error bars in Figure 6.4 and 6.7). The average values of these dupl cate
gels were combined with sirnilar results trom two other sets of age-matched developmt:ntal
samples (also run in duplicate) (Figure 6.48 & C and 6.78 & C). These resulrs were then
pooled giving an experimental sample of (n=3 preparations) for each developmental age.
As seen in SH-SY5Y cells (Figure 6.2) there are two main MOR immunoreactive banc.s in
samples of the rat brainstem. one at 50 kD and one at 70 kD (Figure 6.5). These findingr are
consistent with the findings of Abbadie er al. (2000) who report two MOR immunoreat:tive
bands at 46 and 66 kD (Abbadie et al., 2000a). The intensity of both bands changed during
development. The 50 kD band was present in both late foetal (El6) and early postnatal
developntent. but was present in the adult at very low levels (approx 3Vt,of total) (Figure
6'6A)' The 70 kD band was not usually present in the youngesr foetal age rested (El6) but
appeared during early postnatal development from P6 (depending on the level of
chenriluminescent exposure) and was greatest in the adult (approx 977o of total) (Figure 6.riB).
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MOR Expression
Sample I
E16 P1 P3 P6 P15 P36
Age
Sample 2
2.50
2.OO
1.50
1.00
0.50
0.00
E16 P1 P6 P15
Age
Sample 3
E16 P1 P3 P6 P15 P36
Age
Figure 6.4
MOR Protein Expression During Development in Aged-Matched
Samples
Total brainstem MOR protein levels (guinea pig anti-MOR, Chemicon) liom
Western blots from three separate sets of age-matched protein samples. each
performed in duplicate ( 
'- 
SEM). Band intensities have been normalised to the
P3 sample. Results show a small variation between the same lysate run on
different gels (en'or bars) with a larger variation between dilferent age-
matched protein samples (A. B, & C). All aged-marched samples show the
highest MOR staining in the adult.
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Western BIot Showing Developmontal Expression of MOR
we-gtern blot showing tsroR. expression during developrnent using a MoR specific
antibody (gu,rneapig anti-klo& chemicon). Therc are 2 inmunoreactive bands
Pt€sonti one at 50 kD ad the sther ai 70 kD, The 70 kD band insrca$es in intens-ity
with devetoprnental age; whereas the 50 kD band deereases in intensily with
developmental developmental age.Zfr 
_g of prstein was added to each lane.
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Figure 6.6
Combined Sample Data of MOR Expression During Development
There are 2 rnain MC)R immunoreactive bands one at 50 kD (A) and another at 70 kD (r3)
(guinea pig anti-MOR, Chemicon). Band density results showed that rhe 50 kD band was
present at higher levels in early developnrent. whereas the 70 kD band was present at
higher levels in late postnatal developmenr and in adult brainsrems. (c) Total band
intensity fbr MOR (-r0 kD + 70 kD) showed an increase in total MOR protein levels
during development of tht"'brainstem from late foetal through to adult.
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Combined 50 kD and 70 kD banct intensity measurements tiom 3 separate age-matched
sample preparations showed the total MOR protein levels increased with increirsing
developmental age (Figure 6.6C). MOR prorein expression was highest in rhe adult.
The same age-matched protein samples used fbr MOR protein expression studies were also
used lor DOR studies (Figure 6.7). Samples were run on duplicate gels and processr cl as
described for MoR above' There was some variation between duplicate gels (shown as 3rror
bars in Figure 6.7), with a larger difference seen between similar lysates from different
populations (Figure 6'74. B. & C). All samples showed an overall decrease in l)OR
expression during development.
Two DOR immunoreactive bands were seen in Western blots of brainstem homogenates one
at 30 kD and another at 60 kD (Figure 6.1 and Figure 6.8). The presence of rwo
immunoreactive bands in the present study is consistent with the studies of Carr et al. (19g7)
who found two DOR immunoreactive bands. one at 30 kD and another at 58 kD (Can et al.,
1987)' Both the 30 kD and 60 kD protein bands seen in the present study were more interrsely
stained at the younger developrnental ages (El6-P6) (Figure 6.8 and Figure 6.gA & B). 'fotal
DOR protein levels progressively decreasecl with increased developmental age through trr rhe
adult' This decrease in total DOR expression can be clearly seen when the 30 kD and 6rl kD
band intensities are combined (Figure 6.9C).
6.4.4 MOR AND DOR EXPRESSION IN CTJLTURED BRAINSTEM CELLS FROM
LATE FOETAL AND EARLY POSTNATAL ANIMALS
MOR and DOR immunolabelling was perfbrmed by Western blotting of lysates from cul:ured
rat brainstem cells established from foetal E16 and postnatal Pl, P3, and P6 developmental
ages. MOR and DOR intensity of expression in cell culture lysates reflected what was
observed in brainstem lysates. The same two MOR and DOR immunoreactive bands were
seen' No differerrce in MOR and DOR inrmunoreactivities was seen between cells after 4 and
7 days in culture at any developmental age tested.
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MOR staining of cell culture lysates from El6 rats after 4 and 7 days in culture shoued a
single band at 50 kD (Figure 6.10A). All postnatal cultures showed two immunoreactive
bands, one at 50 kD and another at 70 kD. These were the same molecular weights as the
bands observed in SH-SY5Y cells (Figure 6.28) and postnatal and adult brainstem t,ssue
lysates (Figure 6.5). Foetal (E16) cell culture lysates and foetal (E16) tissue lysates showed
one MOR immunoreactive band at 
-50 kD (Figure 6.10A and Figure 6.5). The postnatai cell
culture lysates and tissue lysates showed two immunoreactive bands at 50 kD and 70 kD
(Figure 6.10A and Figure 6.5).
DOR expression in brainstem cell cultures from El6, Pl, P3, and P6 animals showed two
immunoreactive bands at 30 kD and 60 kD (Figure 6.108). These proteins were the ;ame
molecular weights as seen in SH-SY5Y cells (Figure 6.2A) and brainstem tissue lysates
(Figure 6.lA). DOR expression was higher in foetal and early postnatal (Pl) cell culture
lysates than in lysates of cultured postnatal (P3 and P6) cells. The expression level observed
in cultured cells was similar to that seen in brainstem tissue lysate samples, in which foetal
tissue had greater DOR expression than postnatal tissue (Figure 6.108 and Figure 6.8).
Although trends in MOR and DOR expression could be observed in samples prepared from
cell culture lysates, a large amount of variation between samples collected fronr different cell
culture preparations was seen. For these reasons results were difficult to interpret, ar,d no
statistically significant differences were observed, due to the small sample size used (tr = 3
preparations at each developmental age).
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DOR Western Blot
C=60
kn
Figure 6,8
Western Blot Showing Developmental Expression of DOR
Western blo6 showing that DOR (rabbit anti-DOR, Chemicon) expres$ion levels are highest
in foeAl tissue (El6) and progrestively decrease with increased age. There are two DOR
immunoreacrive bands, one at 30 kD and the other at 60 kD. 20 pg of protein was loaded
into each lane. Western blot is from sample 3.
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Figure 6.9
Combined Sample Data of DOR Expression During Development
DOR Western blot staining intensity pattern during developnrent, using pooled results fror'r
3 separate preparations for the (A) 30 kD band and the (B) 60 kD band. Results are
presented as intensity I SEM. (C) Total DOR prorein expression levels in the rat brainstenr
during development showing higher DOR protein expression in the late foetal and early
postnatal developmental periods. This figure represents the sum otthe 30 kD and 60 kD
immunoreactive bands + SEM (n-3 separate brainstem preparations with individuat
preparation values averaged fiom duplicate gels).
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Figure 6.10
MOR and DOR Expression in Cells Cultured from the Rat Brainstem
(A) MOR (guinea pig anti-MOR, Chenricon) and (B) DOR (rabbit anti-DOR. Chemicon)
protein expression in rat brainstem cells cultured fiom P6. P3. Pl and El6 developmental
ages. after 4 (C4) and 7 (C7) days in culture. (A) MOR labelling of E I6 cells cultured for 4
and 7 days (lane 9 and 8 respectively) shows a 50 kD band. whereas postnatal cultures show
both 50 kD and 70 kD bands. sirnilar to the band staining seen in tissue lysates (l'igure 6.5).
Staining intensity is highest in li l6 and P6 cultures. (B) DOR- labelled (rabbit anti-DOR.
Chemicon) bands tiom cell cultures at all developmental ages show two immunoreactive
bands ar 30 kD and 60 kD. Note the higher intensity of band staining in the cultures isolated
from younger brainstems. similar to thc intensity seen in brain tissue lysates (Figure 6.8).
There are no changes in band sizes or staining intensities of bands between 4 andT days in
culture in any MOR or DOR labclled samples. (40 pS of protein per lane).
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6.4.5 MOR AND DOR DISTRIBUTION DI]RING DEVELOPMENT OF RAT
BRAINSTBM /N WVO
The regions of adult brainstem coronal sections taken for immunostaining are shown in Figure
6.11. Staining patterns were very similar lbr both MOR and DOR (Figure 6.12). The regions
showing the most intense staining for MOR and DOR included the nucleus of the solitary tract
(NTS). nucleus ambiguus (NA). inferior olive (IO), the spinal trigeminal nuclei and tracts
(STT), area postrema (AP). hypoglossal nuclei (10), and the dorsal motor nucleus of the vrgus
(12). Other areas that also showed staining included the raphe nuclei and VRG surrounding
the NA. High power images show staining of these regions in more detail (Figure 6.l3).
Figure 6.11
Regions of brainstem used for immunolabelling of MOR and DOR in Figure 6.12
c&t)
198
Figure 6.12 DOR and MOR Distribution in the Adult Rat Brainstem
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Figure 6.12
Distribution of DOR and IVIOR immunoreactivity in the Adult Rat Brainstem
Distribution of DOR (A, C" E, & G) (rabbit anti-DOR. Chemicon) and MOR @, D,
F, & H) (guinea pig anti-MOl.. Chemicon) irRnunoreastivity in matched seetions sf
the adult rat brainstem. Specific brainstem regions and nuclei are highligfols6 in th.
MOR. sections. NoIe the identical staining pattems for both MOR and DOR in the
NTS, NAe IO and $pind STT. Scale bar = 3.5 rnm. Abbreviations: nucleus of the
solitary uaet (NTS); nucleus ambiguus (NA); intrbrior olive (IO); spinal uigeminal
tract and nucleus (S'fD: medial longitudinal fasciculus (mlf); rosbo venfolateral
retieular nucleuo (RVL); gracile nucleus (Gr); lateral reticular nucleus (LR);
hypoglossal nucleus(I2)= dorsal motor nucleus of the vagus (10); extemal cuneate
nucleus (ECu); medial vestibular nucleus (MVe); r4phe nuclei (R! areapostrema
(AF); linear nucleus (Li),
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Fig 6.13
High Power Images of Adult DOR and MOR Immunoreactivity in the Brainstem
High-power images of DOR ( A.C. E, & G) (rabbit anti-DOR. Chemicon) and MOR (8, D, F, & H)
(guinea pig anti-MOR. Chemicon) imnrunoreactive regions of the brainstem including the inferior
olive (lO), nucleus ambiguus (NA), nucleus of the solitary tract (NTS), area postrema (AP),
dorsalmotor nucleus of the vagus ( l0), and hypoglossal nucleus (12) . Scale bar: 100 pm.
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In F6 rat pups, the distributions of MO.R and DOR in brainstem areas (Figure 6-14) were vcry
sinrlilar to the expression patterns seen in the adult (Figure 6.12). Infense staining was soen in
the NA, trO, STT, and the NTS, High power images of t'hese areas (Figure 6.15) s'how this
staining in more detail.
In 816 foetal animals,, I\4OR and DOR tabelling gave a much more diff,use staining partern
eonnpared with P6 oradult anirnals (Figure 6 16), Sraining cou-ld be seen in the dorsal motor
nucleus of the vagus (I0) and h;rp'oglossal nueleus (12), as well as the areas of the N[TS, $TT,
and NA., Higher power images show elearer shining of these regions, paniculady the [,IOR
and DOR staining seen in the NA (Figure 6.17).
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Figure 6.14
DOR and MOR Labelling in the Postnatal Rat Brainstem
DOR (A. C. E. G) (rabbit anti-DOR. Chemicon) and MOR (8, D. F, H) (guinea pig anti-MOR, Che:nicon)
labelled P6 rat brainstem sections showing staining of the NTS. NA. IO, mlf'. and S'fT. The region-' taken
fbr sectioning are similar to thosc shown for the adult (Figure 6.12) and are displayed from rostral (.\ & B) to
caudal (G & H). Scale bar:2.5 mm.
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High llower lmages of l)ostnatal DOII and MOR labelled Brainstem Regit ns
llighposcrrrragniiicatiorrrrl'l)()l{lr\.t &l:)(rabbitunti-tX)R.('hcnricon)irncl l\'1OR(ll. l).&Ii)
(guirrel pig arrti-N,lOl{. ('hen.ricorr)ilh,:ilins ol'l)(r nrt braittslcrtt shorrinrl stainirrg ot'thc N.,\ (',' & ll).
Sl t ((' & l)). rruclcus 10. ll. rrrrd thc \ lS (l:& l:). Scalc bar 100 Lrnt.
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Figure 6.16
DOR and MOR Immunoreactivitv in the Foetal Brainstem
Diffuse DOR (A & C:) (rabbit anti-DOR. Chemicon) and MOR (B & D) (guinea pig anti-MOR,
Chemicon) immunoreactivity in the nucleus of the solitary tract (NTS). nucleus ambiguus (NA) .
inferior olive (lO), spinal trigeminal trigeminal tract (STT), medial longitudinal fasciculus (mlt).
dorsalmotor nucleus of the vagus ( | 0). and hypoglossal nucleus ( I 2). Sections are presented in rostral
(A & B) and caudal (C & D) brainstem regions. Scale bar = I mnr
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FOETAL BRAINSTEM (E16)
MOR
Figure 6.17
High Power Images of of DOR and MOR Labelled Brainstem Regions
I ligh power picturcs of E,l6 brainstenr stained for DOR (A & C) (rabbit anti-DOR. Chemicon)
and MOR (B & D) (guinca pig anti-MOl{. Chenricon). Staining is seen in thc region of the
nuclcus of the solitary tract (Nl-St(A & ll). dorsalmotor nuclcus of the vagus ( l0), hypoglossal
nucleus (12), and nucleus artrbiguus (NA) (C & D). Scale bars = 100 pm.
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6.5 DISCUSSION
6.5.1 METHODOLOGY
6.5.1.1 Western Blotting
Both MOR and DOR antibody staining were shown to be quantitative on Western-transferred
whole brain, brainstem, and spinal cord lysates. lncreased protein loading on the gel caused
the predicted increase in band intensity. Negative controls included the use of LLC-PKI cell
lysates, which showed no immunoreactivity for either MOR or DOR antibodies, as expected.
Positive controls included SH-SYSY cell lysates, which showed immunostained protein bands
of the expected sizes for MOR and DOR that were identical in size to those seen in whole
brain and brainstem lysates. From these control experiments, it is reasonable to conclude that
MOR- and DoR-specific antibodies were binding to their respective receptors and not binding
non-specifi cally to other proteins.
Several lysis buffer solutions were used in preliminary studies. The lysis buffer (Western
Sample Buffer) described in the Methods (Section: 6.3.1.1) was chosen because the buffer was
highly reducing and helped prevent the action of proteases from degrading proteins within the
samples. This enabled the samples to be stored at -20"C for several months and allowed
samples of different developmental ages to be collected and electrophoresed on the same SDS-
PAGE gel. Brainstem lysates had a higher concentration of proteins (lpglttL to l0ltglltL)
compared to cultured cell lysates (0.5 ltglttL to I lrglltL). Thus, cultured cell lysates needed
proportionally more lysis buffer to lyse the sample. This caused several problems when large
volumes of sample were Ioaded on the gel because salts in the lysis buffer interfered with the
running of the SDS-PAGE gel. This was overcome by precipitation of the proteins with
acetone and reconstitution in a small volume in order to remove the salts. This concentration
and de-salting procedure was carried out immediately prior to electrophoresis of the samples
on a gel.
In preliminary experiments, brainstem lysates from different developmental ages were dot-
blotted onto PVDF membrane at increasing protein concentrations and immunolabelled using
antibodies specific for MOR and DOR. Although these experiments provided some general
trends, the protein samples tended to wash off the membrane when the membrane was
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rehydrated in methanol. The PVDF membrane also became saturated if too much sample was
added, making it difficult to accurately determine increases in OpR expression. Other types of
membranes such as nitrocellulose could not be used because of their non-specific binding
properties. When lysates were run on SDS-PAGE gels and transferred to nitrocellulose
membranes, multiple, non-specific bands were observed. Hence, all quantification was carried
out on Western blots from SDS-PAGE. Unfortunately, the large amount of brainstem material
required, and the high cost of the procedure due to the amount of primary antibody needed to
cover the membranes for immunostaining, limited the sample size to a maximum of 3 in these
experiments.
There are many complex variables involved when quantitating the expression levels of
proteins using Western blotting. Both the PVDF membrane and the exposure of the film can
become saturated, with increased protein loading and increased exposure times giving rise to
non-linear density changes. For these reasons all Western blots were normalised to a single
age group (P3) in all experiments, reducing the error in film exposure between samples run on
separate gels. Preliminary experiments determined the concentration of protein that could be
loaded onto gels, giving a useful range of OpR expression levels that could be detected in
most samples.
6.5.1.2 Immunohistochemistry
No IHC quantitation was attempted in this study because of the difficulty in making
quantitative comparisons between samples of different ages. Differences between samples can
arise from several factors, including fixative penetration differences between foetal and adult
tissue, which has been shown to affect both antibody binding and antibody penetration
(Harlow and Lane, 1999). Large variations in staining intensity also occur when experiments
are performed on different days. In some experiments with fainter staining, 0.37o nickel was
used to enhance the DAB colour development reaction. Nickel was not used in all
experiments since over-development with nickel can cause tissue sections to become very
brjttle, causing the sections to disintegrate. The use of an enzyme substrate such as DAB also
makes accurate quantitation difficult (Harlow and Lane, 1999).
208
6.5.2 OPIOD RECEPTOR EXPRESSION DURING BRAINSTEM DEVELOPMENT
6.5.2.1 MOR Expression During Development
Two MOR antibodies specific for the MOR-I protein were used in the pilot experiments
(guinea pig anti-MOR and rabbit anti-MOR, both from Chemicon). Both gave the same
MOR-positive bands at 50 kD and 70 kD. Both antibodies also gave the same staining
intensity patterns during development, suggesting that the staining patterns reflected true
MOR expression in the tissues. The presence of two immunoreactive bands of different MW
is not due to non-specific antibody binding. All samples analysed in this chapter were
peformed using the guinea pig anti-MOR antibody (Chemicon). The presence of two
immunoreactive bands for MOR in the present study (50 kD and 70 kD) is consistent with the
literature findings. For example, Abbadie et al. (2000), have described two MOR bands at (46
kD and 66 kD) (Abbadie et al., 2000a). MOR-I cDNA predicts a protein with a mass of 45
kD. Other reports in the literature describe a MOR protein band between 67-72 k'D
(Arvidsson et al., 1995b). Studies by Kaneko et al. (1995) showed MOR proteins bands at 50
kD, 65 kD and 94 kD (Kaneko et al., 1995). Further evidence suggests that the difference in
size of MOR protein bands is a result of posrfianscriptional modification of the receptor by
glycosylation (Eppler et al., 1993; Garz6n et al., 1995; Kaneko et al., 1995; Abbadie et al.,
2000a). The N-terminal of MOR has 5 potential sites for N-linked glycosylation (Chapter l:
Figure I.l) (Minami and M., 1995). Some deglycosylation experiments of brainstem lysates
were performed using the method of Garzon et al. (1995) who reported deglycosylation of the
MOR protein from mouse brain homogenates (Garz6n et al., 1995). In the present study,
endoglycosydase F enzyme (Sigma) was used to treat SH-SY5Y cell lysates and rat brain
homogenates, but deglycosylation was not observed, even when higher concentrations of
enzyme were used (data not presented). It is possible that the deglycosylation enzyme used
was inactive. These experiments were not pursued further due to the high cost of the enzyme.
In the present study, MOR protein expression during development of rat brainstem showed
that there was a progressive decline in the amount of the 50 kD MOR protein with increasing
age; whereas, fhere was a progressive increase in the amount of the 70 kD MOR protein. The
functional implications of differences in MOR glycosylation during development remain to be
elucidated. It is possible that the different states of MOR glycosylation reflect different
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binding properties for opioid ligands. If this is true, the OpR glycosylation state may explain
differences in binding affinity of opioid ligands to receptors that occurs during development
(Spain et al., 1985). These possibilities, along with alterations in OpR expression levels that
have been shown to occur during development (Coyle and Pert, 1976; Pasternak et al., 1980;
ftslie et al., 1982;Tsang et al., 1982; Wohltmann et al., 1982; Spain et al., 1985; Tavani et al.,
1985; Kornblum et al., 1987;Petrillo et al., 1987; Attali et al., 1990; Bem et al., 1991; Xia and
Haddad, 1991; Barg et al., 1992; Murphey and Olsen, 1995;Zha et al., 1998; Tong et al.,
2000; Beland and Fitzgerald, 2001) provide possible mechanisms for the differences seen in
opioid sensitivities during development (Grunstein and Grunstein, 1982; Moss et al', 1993a;
Murphey and Olsen, 1994; Greer et al., 1995; Colman and Miller,200l). This information
will be useful when considering the link between opioids and developmentally-related
diseases such as SIDS (Chavez et al., 1979: McMillen, 1986; Coqueral et al., 1992; Storm et
al., 1994).
Total MOR protein expression levels increased in the present study approximately 5-fold with
developmental age from E16 to P6. The increase in total MOR expression during development
has also been described in the literature, based on binding studies in whole brain and spinal
cord lysates (Coyle and Pert, 1976; Pasternak et al., 1980; kslie et al., 1982; Tsang et al.,
1982; Wohltmann et al., 1982; Spain et al., 1985; Tavani et al., 1985; Kornblum et al., 1987;
Petrillo et al., 1987; Attali et al., 1990; Kitchen et al., 1990; Bem et al., 1991; Barg et al.,
Igg2), as well as in the brainstem of several species (Xia and Haddad, I 991 ; Murphey and
Olsen, 1995). In guinea pig brainstem, there was a 42 7o increase in MOR binding between
the P3 and P? age groups (Murphey and Olsen, 1995); however, results from other species
such as guinea pig need to be interpreted with caution. For example, the guinea pig is more
developmentally advanced than the rat at birth. In the present study of the rat brainstem, an
approximate 3OVo increase was seen between P3 and P6, with a 5OVo inctease between P3 and
P15 (Figure 6.6), and these results support the studies in guinea pig brainstem. Other studies
have shown that MOR expression increases in different brain regions at different
developmental ages. For example, MOR in the brainstem appears at an earlier age than MOR
expression in the cortex (Xia and Haddad, l99l). In some brain regions, for example, the
olfactory bulb, MOR expression increases during late foetal and early postnatal development,
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and then decreases to adult levels (Kent et al., 1982). In the brainstem, however, MOR
expression remains highest in the adult, especially in the brainstem regions involved in
cardiorespiratory function (Xia and Haddad, I99l). The present study, is the first to describe
developmental OpR expression in the rat lower brainstem using antibody labelling.
6.5.2.2 DOR Expression During Development
DOR immunoreactive proteins on Western-transferred SDS-PAGE gels consisted of two
bands, one at 30 kD and the other at 60 kD. This pattern is consistent with the findings of Carr
et al. (1987) who showed DOR bands at 58 kD and 30 kD in rat brain lysates (Can et a1.,
1987). Other studies have reported a single 29 UD band (Harada et al., 1992). DOR-
transfected Cos-7 cells gave bands berween I l0 to 135 kD and between 65 to 80 kD (Cahill et
al., 2001b), whereas spinal cord preparations from the rat gave three bands of 65 kD, 52 kD
and 125 kD, corresponding to different forms of DOR (Cahill et al., 2001b). The 125 kD
DOR band was most likely a result of dimer formation (George et al., 2000; Ramsay et al.,
2002) and could be seen in the samples of the present study if the X-ray film was exposed for
longer periods. DOR protein sizes differed in various studies depending on the types of cell
sample and the methods used, including the lysis buffers, the species, percentage acrylarnide,
and electrophoretic running conditions. The predicted size of DOR based on its amino acid
content is 39 kD, although it is known to exist in multiple glycosylation states (Petijl-Repo et
al., 2001). DOR is synthesized as a core-glycosylated 45 kD precursor that is converted to the
fully mature 55 kD glycosylated receptor within the golgi apparatus (Petlja-Repo et al., 2000).
The low molecular weight form of DOR reported in the present study (30 kD) is consistent
with the findings of Belcheva et al ( 1996), who reported a 26 V,D DOR band that proved to be
a truncated, internalised form of DOR associated with the nuclear matrix (Belcheva et al.,
1996). The existence of a truncated, internalised DOR may explain why high levels of DOR
were found in early development in the present study. Others, however, report little DOR
ligand binding during development. Perhaps the differences between these studies can be
attributed to the differences between total DOR detection (including functional and non-
functional receptors) and detection of functional receptors only. The decrease in total DOR
protein levels during development in the present study is supported by a study on rat dorsal
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root ganglion (Beland and Fitzgerald, 2001). In this study, greater DOR immunoreactivity
was found at P0 than at P2l. A down-regulation with age was found mainly in the non-
nociceptive neurofilament-200 positive, large diameter sensory neurons. Most other studies
using binding in whole brain lysates report an increase of DOR during the late foetal and early
postnatal period that rises to maximum levels in the adult (Kent et al., 1982; Petrillo et al.,
1987; Attali et al., 1990). Others report little change in expression of DOR during
development in hindbrain lysates when DADL, in the presence of DAMGO, was used to
specifically label DOR (Spain et al., 1985).
6.5.2.3 MOR And DOR Expression In Cells Cultured From The Rat Brainstem During
Development
There were no differences observed in the staining intensity of MOR and DOR protein bands
in lysates prepared from cells cultured from rat brainstems with increased time in culture.
This suggests that OpR levels are maintained in culture and that the developmental changes
that occur in vivo do not occur in vito. This is probably due to the absence of cell signalling
(neurotransmitter or trophic support) that is required for developmentally programmed
changes in receptor expression. This property of cell culture suggests that the developmental
stage the cells were isolated at is maintained when cells are cultured for up to 7 days. The
present study, thus, provides a stable culture system with which to study factors affecting OpR
expression. Unfortunately, a large amount of variation was seen between cultures prepared
from animals of the same developmental stage in different experiments. This variation made
analysis difficult, given the small sample size used in this study (n = 3 preparations from each
developmental age). Interpretation of the data was also complicated due to the heterogeneity
of cells present in primary cultures. For example, neuron survival decreases with increased
developmental age from which cultures are established, and certain populations of cells
present at El6 may not be present in P6 cultures.
6.5.2.4 Comparisons With Literature Findings
Total OpR binding increases with increasing developmental age (Clendeninn et al., 1976;
Coyle and Peft, 1976), and differences between MOR, DOR and KOR expression levels
during development have been reported (I-eslie et al., 1982; Tsang et al., 1982; Tavani et al.,
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l9S5). These studies looked at whole brain preparations (usually with the cerebellum
removed) and often used non-specific, or poorly selective, opioid receptor ligands such as
naloxone or enkephalin (Kent et al., 1982). Other studies have shown that binding affinity of
the receptor for certain ligands also changes during development. For example, DOR binding
by DADL decreases 14 fold from Pl to adult (Spain et al., 1985). For these reasons, the
results from these experiments cannot be accurately extrapolated to the present findings for the
lower brainstem, using antibodies that specifically label MOR and DOR proteins. Binding
studies often use tissue lysates, usually of membrane fractions, that do not take into account
the internalised OpRs present in endosomes. In binding studies, only functional protein
expression is being assessed, and ligand binding or cAMP responses to agonist may be
affected by a number of factors, including post-translational modifications and the state of
receptor phosphorylation. These factors play a major role in regulating opioid receptor
activity (Law et al., 1983; Haynes, 1988; Kieffer et al., 1992; Chan et al., 1995; Monteillet-
Agius et al., 1996; tefkowitz, 1998; Law and Loh, 1999; Liu et al., 1999; Belcheva et al.,
2000; Kraus et a1.,2001; Tsao et a1.,2001; Sun,2002). Ligand binding studies during
development were also investigated before different splice-variants of the opioid receptors
were discovered. In the present study, the MOR-I receptor was specifically labelled by an
antibody; whereas, the studies described in the literature looked at binding to all MOR
proteins, including the splice variants that have the same binding site as MOR-1. In addition,
differences have been shown to occur in the binding studies described, depending on whether
binding is expressed as a measure of binding per brain, or per mg of protein. When results are
expressed as a measure of total protein, the differences that occur during development are
much less obvious (Barg et al., 1992). This is probably due to changes in protein
concentration during development and changes in functional OpR densities at the cell surface.
A study by Petrillo et al. (1987) showed that there was an increase in protein concentration in
the brain from 25 mg/g brain at P3 to 56 mg/g brain at P21 (Petrillo et al., 1987). These
findings complicate data interpretation because a decrease in specific content (OpR/mg
protein) may not reflect a decrease in the total amount of OpR present (OpR/g brain).
Comparisons between different studies that present their data in different ways must be taken
into account.
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6.5.2.5 Implications of Developmental Changes in Opioid Receptor Expression
Differences in opioid receptor levels during development have implications for the use of
opioids as labour analgesics during childbirth (Mardirosoff et al., 2002) and for analgesia in
newborns. In the rat spinal cord, binding studies have shown that there is little DOR binding
at birth and that DOR analgesia is not functional at birth (Rahman et al., 1998). Changes in
the distribution of opioid receptors during early postnatal development have implications for
respiration control. Timing of developmentally-related OpR expression may play a role in
sudden infant death syndrome, since abnormal opioid function has been implicated in this
disease (Chavez et al., 1979; McMillen, 1986; Storm et al., 1994). The role of opioids in
SIDS has been described in detail in Chapter I (Section 1.4. I . I ).
6.5.3 MOR AND DOR DISTRIBUTION IN TIIE ADI.JLT RAT BRAIN
Earlier studies into opioid receptor distributions in the late 1970's and 1980's used ligand-
binding techniques, which have several limitations, including the non-specificity of the ligands
and poor sensitivity. Mansour et al. (1988) used autoradiographic ligand binding techniques
to compare the distribution of MOR and DOR in the rat. Results of their study showed no
DOR binding in the STT or lateral reticular nucleus (LR), areas shown by others to have DOR
(Arvidsson et al., 1995a; Cahill et al., 2001b). Mansour et al. (1988) also showed low DOR
staining levels in the NTS (Mansour et d., 1988). an area that has high levels of MOR and
DOR binding (Delay-Goyet, 1990; Arvidsson et al., 1995a). These differences have been
attributed to differences in sensitivity between the methods
A breakthrough in opioid receptor distribution in the brain came in 1993 with the cloning of
the OpR. It then became possible to make specific antibodies to each receptor and to look at
the mRNA expression patterns by ISH. A review in 1995 on OpR expression in the rat using
mRNA probes showed that DOR mRNA was present in the STT, LR and NA but was absent
in rhe NTS, IO, and hypoglossal nuclei (10) (Mansour et al., 1994). These results differ from
the present study and the study of Arvidson et al. (1995) who found that the DOR was present
in the IO and NTS (Awidsson et al., 1995a). Most ISH studies use radioactive mRNA probes
that do not label axons and dendrites where the opioid receptor proteins reside; therefore, their
distribution patterns are expected to be slightly different from protein localisation studies. The
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discovery of multiple isoforms of MOR has also made it possible to subdivide MOR
expression into unique isoform distributions within the brain (Schulz et al., 1998; Pan et al.,
1999; Abbadie et al., 2000b; Abbadie et al., 2000a). For example, MOR-IN, M, and L are
only present in the spinal cord, but not other brain regions. MOR-I is present in the mouse
brainstem; however, the splice-variant isoforms MOR-l-G, H, I, J, K, L, M, and N were not
(Pan et al., 1999). MOR-I and MOR-IC were present in the same brainstem regions in the
rat, but MOR-lC was absent in several brain regions, including most thalamic nuclei and the
dendate gyrus, areas expressing high levels of MOR-I (Abbadie et al., 2000a). Because
ligands and antibodies may bind to several splice variants of MOR, the significance of the
distributions described is not clear.
6.5.3.1 DOR Distribution in the Adult Rat Brainstem
DOR distribution patterns in lower brainstem nuclei have been determined by ICC by
Arvidsson et al. (1995), who reported staining in the locus coeruleus, NA, NTS, pontine
reticular nucleus, gigantocellular nucleus, facial motor nucleus, raphe nuclei, STT,
hypoglossal nuclei (12), vagal nuclei (10), IO, and the medial and lateral reticular nuclei
(Arvidsson et al., 1995a). Another study showed DOR localised to the brainstem regions of
the spinal trigeminal nucleus (STT), the reticular nuclei (LR), RVLM, and olivary nuclei
(Cahill et al., 2001b); however, the lower brainstem €ueas, including the NTS and NA, were
not mentioned in this study. The staining of these other brainstem regions is consistent with
the staining patterns described in the present study.
6.5.3.2 MOR Distribution in the Adult Rat Brainstem
The MOR distribution found in the adult rat brain in the present study closely resembles the
distribution pattern reported in the literature using MOR-l antibodies (Ding et al., 1996b) and
includes positive MOR immunoreactivity in the NA, NTS, IO, and STT of the brainstem.
Studies using mRNA probes in the rat brain have found some differences in MOR distribution
in the rat brain, including an absence of signal in the IO, area postrema, and external cuneate
nucleus (Delfs et al., 1994), regions that were positively labelled for MOR protein. The
external cuneate nucleus also stained positive for MOR-1 receptor in an IHC study by Abbadie
et al. (2000) (Abbadie et al., 2000b). All other regions labelled by mRNA probes were also
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stained in the present study. As previously stated, differences in staining that were observed
were probably due to differences in sensitivity between the techniques, as well as differences
between mRNA and protein distributions at the cellular level.
6.5.4 DEVELOPMENTAL DISTRIBUTION OF MOR AND DOR RECEPTORS IN
TIIE RAT BRAINSTEM
Few differences were seen between MOR and DOR staining in the rat brainstem between late
foetal (Et6), postnatal (P6), and adult. In the adult brainstem there was intense staining in the
dorsal respiratory areas of the NTS, and the ventral respiratory areas in and around the NA, as
well as the hypoglossal nuclei (10), the dorsal motor nucleus of the vagus (12), IO, and STT.
These same areas were also stained in the P6 rat brainstem. The brainstem regions of P6 rats
were anatomically similar to the adult rat, although proportionally smaller; however, in foetal
(El6) brainstem, the nuclei were not fully developed, and staining was much more diffuse.
This may be due to the immaturity of the boundaries between brainstem nuclei at this early
developmental age (Lidov and Molliver, 1982). The brainstem nuclei of interest (NA, NTS,
STT, and nuclei l0 and 12) were proportionally larger in the foetal (E16) brainstem than the
older postnatal and adult brainstems (Paxinos and Watson, 1986; Paxinos et al, 1994).
Similar MOR protein patterns were found in the present study to mRNA distributions during
development reported in other brain areas. For example, in foetal (E17.5) mouse embryos, the
MOR expression pattern was characteristic of the adult brain, although the pattern was more
homogeneous and the nuclei were less discretely labelled. [n the striatum, the characteristic
patchJike patterns seen in the adult appeared diffuse in the foetus (Zhu et al., 1998). This
difference was attributed to the absence of cellular differentiation within the striatum at this
early stage of development.
Few studies have looked at or commented on the intracellular distribution of opioid receptors
during development (Kornblum et al., 1987;Zhu et al., 1998; Tong et al., 2000), and only one
study investigated the lower brainstem region in the rat (Xia and Haddad, l99l). Some
developmental studies on opioid receptor distributions in the brainstem have been carried out
on other species (Murphey and Olsen, 1995:Zhu et al., 1998; Moss and Laferridre, 2002). For
example, in the piglet, the distribution patterns are linked to acquisition of respiratory function
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during development, including the attenuated response to hypoxia caused by an increase in
MOR levels in respiratory-related brainstem areas during development (Moss and Laferridre,
2002). ln the present study MOR and DOR immunoreactivities were usually colocalised
within the same brainstem nuclei at all stages of development, although the relative density of
staining could not be compared in tissue sections when different antibodies were used. In
some individual sections, if signal amplification was low, some poorly expressing MOR and
DOR nuclei were not always co-labelled. Others have also reported colocalisation for MOR
and DOR in the adult rat brainstem (Goodman et al., 1980).
6.6 STJMMARY AND CONCLUSIONS
The expression levels of MOR and DOR change during development. MOR is expressed at
low levels during foetal (E16) development and progressively increases during postnatal
development to reach adult expression levels. These findings are supported by the findings of
others (Zhu et al., 1998; Laferridre et al.. 1999). DOR is expressed at high levels in early
development (El6) and progtessively decreases during postnatal development to reach adult
levels. In previous studies of whole brain homogenates from the rat (Spain et al., 1985;
Petrillo et al., 1987) and mouse (Tavani et al., 1985) DOR was found to increase, although
another study on the brainstem of piglets showed that DOR levels did not change in postnatal
development (P2 to P2l) (Laferridre et al., 1999). Both MOR and DOR are colocalised in
specific brainstem regions during embryonic, postnatal, and adult development. The areas of
highest expression were in the NTS, NA, STT, and IO, a distribution pattern consistent with
FISH experiments on mRNA expression (Eli Mrkusich and Dr Darren Day, personal
communication).
The'presence of two immunoreactive bands for MOR and DOR is consistent with what others
have found for MOR (Abbadie et al., 2000a) and DOR (Carr et al., 1987). The difference in
size of the bands is probably a result of receptor glycosylation and, in some cases, homodimer
(or heterodimer) formation. The present study is the first to investigate developmental changes
in expression levels of these individual protein bands. The results suggest that MOR and DOR
are colocalised to the same brainstem regions but are regulated differently during
development.
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Chapter 7
7 Discussion
7.1 General Discussion and Conclusions
One aim of the present study was to develop a primary culture system in which opioid
receptor expression could be monitored in isolated cells from late foetal and early postnatal
animals. It is well known that opioids play an important role in many physiologrcal
processes within the body (Olson et al., 1997; Yaccarino et al., 1999; Vaccarino and
Kastin, 2001). Opioid receptors are particularly important in the brainstem where they are
involved in the control of pain (Fields and Heinricher, 1985; Gutstein et al., 1998;
Commons et al., 2001) and in the modulation of respiratory activity (Pfeiffer et al., 1984;
Punnen and Sapuru, 1986; Yeadon and Kitchen, 1989; Shook et al., 1990; Pokela, 1993;
Rutherfurd and Gundlach, 1993; Kato, 1998; Colman and Miller, 2001; Morin-Surun et al.,
2001; Sarton et al., 2001) and cardiovascular function (Hassen et al., 1982: Pfeiffer et al.,
1984; Punnen and Sapuru, 1986; Schultz and Gross, 2001). Previous studies have reported
high densities of OpRs in the brainstem regions of the nucleus of the solitary tract (NTS),
nucleus ambiguus (NA), spinal trigeminal nuclei and tract (STT), dorsal motor nuclei of
the vagus, and hypoglossal nuclei (Mansour et al., 1988; Delfs et al., 1994; Mansour et al.,
1994; Arvidsson et al., 1995a; Bausch et al., 1995a; Ding et al., 1996b; Moriwaki et al.,
1996; Diaz et al., 2000). These staining patterns were confirmed in the present study.
Each different study, however, has presented slightly different levels of expression,
primarily due to differences in sensitivity between experimental techniques. The present
investigation, using highly specific MOR and DOR antibodies and a TSA amplification
method, is the first to show MOR and DOR distributions specifically in the rat brainstem
during development. It is also the first study to show DOR immunoreactivity in the rat
foetus. One interesting result was that MOR and DOR during late foetal (El6), postnatal
(P6), and adult development are generally colocalised within the same brainstem nuclei.
Most previous studies have looked at OpR expression within the whole brain, often using
non-selective ligands in receptor binding assays (Coyle and Pert, 1976; Pasternak et al.,
1980; L,eslie et al., 1982; Tsang et al., 1982; Wohltmann et al., 1982; Spain et al., 1985;
Kornblum et al., 1987; Petrillo et al., 1987; Attali et al., 1990; Kitchen et al., 1990; Bem et
al., 1991). The expression of OpRs within the brain is developmentally regulated as shown
by the results of this study and also the work of others. Both MOR and DOR expression
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levels change during development in a consistent way (Liu et al., 1999; Beland and
Fitzgerald, 2001; Ko et al.,2OO2). The role opioids play during development, however, is
not clearly understood. A primary culture method developed in the present study allows
brainstem cells to be investigated later in postnatal developmental than has previously been
possible. This method uses a defined, serum-free culture medium that would be ideal for
studying the effects of growth factors on neuronal development and differentiation (Kivell
et al., 2000, 2001). OpR expression was determined in cells cultured from different
developmental ages, and expression levels in culture were compared to normal
development in vivo. MOR, in primary culture, down-regulates from the membrane to
lysosomes on exposure to DAMGO, a MOR agonist. This down-regulation occurs in a
similar way to cloned MOR when it is expressed in cell lines, suggesting that cultured
neurons from the rat brainstem retain OpR functions. Thus, the culture system provides a
valuable in vitro model for determining brainstem OpR function.
Detailed aspects of this study have been discussed previously in each chapter. This chapter
aims to explore some of the remaining issues that were not discussed earlier, and to draw
some conclusions based on the overall results of the studv.
7.I.I PRIMARY CELL CULTI.JRE
OpR expression was investigated using a unique serum-free primary culture method that
allows brainstem cells to be cultured from late foetal to early postnatal development, up to
six days postpartum (Kivell et al., 2000, 2001). The types of cells present in culture were
monitored over time and in cultures from different developmental ages and the cell types at
each developmental age compared. More bipolar neurons were present in developmentally
younger cultures; whereas, older postnatal cultures had proportionally more multipolar
neurons (Chapter 2 Section 2.4.4). Cultured cells seemed to retain their differentiated
characteristics over time in culture. For example, the proportion of glial cells, bipolar, and
multipolar neurons was the same between 4, 7, and 9 days in culture for each
developmental age. Lysates from cells cultured from the rat brainstem also showed the
same amounts of MOR and DOR protein at 4 and 7 days in culture from each
developmental age tested (Chapter 6: Section 6.4.4). MOR and DOR expression in culture
was also measured by immunocytochemistry. No changes in intensity of staining were
seen when foetal (E16) and postnatal (P6) brainstems were cultured for 4, 7, and 12 days.
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This finding suggests that brainstem cells in culture remain in the developmental state in
which they were isolated. No up- or down-regulation of OpR expression was seen with
time in culture. One advantage of this stability of the culture system would be to allow
more flexible experimental timing in which to study OpR regulation. If expression rapidly
changed with time in culture, experiments would need to be carried out immediately after
isolation and attachment of the cells.
Cell culture provides a simplified system for studying cellular functions. OpR regulation
has been extensively examined in neural cell lines and in cells transfected with the OpR
(Prathert et al., 1994: Capeyrou et al., 1997; Gaudriault et al., 1997; Gies et al., 1997;
Yabaluri and Medzihradsky, 1997; Koch et al., 1998; Kramer and Simon, 1999;
Arttamangkul et al., 2000; Remmers et al., 2000; Tsao and von Zastro, 2000; Gray et al.,
2001; lrvac et al., 2001; Shapira et al., 2001; Jenab and Inturrisi, 2OO2; Wallington et al.,
2002). OpR regulation, however, has not been studied during brainstem development.
The present study shows for the first time in cultured brainstem cells internalisation of
MOR on exposure to the OpR agonist DAMGO. This result indicates that the process of
down-regulation occurs in the same way as seen in transfected cells and non-transfected
SH-SYSY cells, with rapid (within I hr) internalisation of receptors. It remains to be
determined, however, if the same pathways of internalisation are occurring in these
different cellular systems. It is possible that OpR regulation may be modified by the
developmental expression of other proteins involved in down-regulation, for example p-
arrestin and various isoforms of G-proteins and adenylyl cyclase. Immunocytochemistry
and Western blotting of cell lysates with antibodies against regulatory proteins could be
used if this proves to be the case. In vitro culture also provides a method for examining the
interaction between neurons and glial cells and the effects of their interactions on OpR
expression.
In some brain regions MOR is reported to be colocalised with K* channels (Bausch et al.,
1995b) where it acts on postsynaptic sites to inhibit neuronal firing by opening the K+
channels; however, the brainstem was not reported on in these studies. Primary cultures of
brainstem neurons could be doubled-labelled with an antibody specific for the K* channel
to help determine if OpRs and K" channels are colocalised within the brainstem. If this is
the case, properties of OpR inhibition of neuronal firing could be monitored. Membrane
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potentials with and without opioids, changes in potassium permeability, and Kn-channel
blockers could be used to study OpR regulation specifically in cultured brainstem neurons.
MOR is also colocalised with glutamate receptors in the NTS where it may be involved in
the decrease in arterial blood pressure and heart rate seen on exposure to opioid ligands
(Miyawaki et al., 2002). MOR acts as a general brake on numerous systems by inhibiting
adenylyl cyclase, decreasing cAMP levels, increasing potassium conductance, and
decreasing the conductance of voltage-gated calcium channels, as described in detail in
Chapter I (Section L.2.3). The specific localisation of opioid receptors to particular
neurons helps elucidate their diverse functions in distinct brain regions. In the preBOtC
and NTS brainstem regions involved in respiratory modulation, MOR is colocalised with
neurokinin I receptors (NKlr) (Gray et al., 1999; Laferridre et al., 2003). In the preBtitC,
rhythmogenic typel neurons are depolarised by substance P (acting on the NKlr) a peptide
that increases respiratory frequency and hyperpolarised by MOR agonist DAMGO, a
peptide that causes respiratory depression (Gray et al., 1999). Both NKlr and OpRs are G-
protein coupled receptors, although NKlr is excitatory and MOR inhibitory. In the dorsal
horn of the spinal cord, substance P, acting on the NKlr is involved in pain transmission
Marvis6n et al., 1997); whereas, activation of MOR by opioids inhibits the transmission of
pain (Fields and Heinricher, 1985; Tershner and Helmstetter, 2000). Substance P and
opioids are involved in the con[ol of breathing, with opioids having inhibitory (Shook et
al., 1990; Yeadon and Kitchen, 1990; Freye et al., 1992: Greer et al., 1995; Takita et al.,
1997; Gray et al., 1999; Colman and Miller, 2001) and substance P excitatory effects
(Chen et al., 1990; Gray et al., 1999). In a recent paper by Laferriere et al. (2003) NKlr in
the adult rat NTS showed receptor down-regulation after short-term intermittent (6x 5 min
interval) exposure to hypoxia (depleted oxygen); whereas MOR receptors remained the
same (Laferridre et al., 2003). Results suggest that down-regulation of the NKlr on
exposure to short-term intermittent hypoxia results in relatively more available MORs to
opioid peptides resulting in attenuated respiratory depression. The culture system
described, if shown to express NKI receptors, could be used to study the function of these
specialised cells, which have been suggested to be the preBtltC neurons responsible for
generating respiratory rhythm.
The process of internalisation of opioid receptors on exposure to opioid ligands has been
linked to the ability of opioid drugs to induce tolerance (Keith et al., 1998). This
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association is supported by the fact that different opioid drugs cause different
internalisation kinetics and responses. For example, methadone and morphine differ in
their abilities to induce both internalisation and addiction (Zhang et al., 1998; Whistler et
al., 1999), and mice lacking p-arrestin, a protein required for receptor internalisation, show
a reduced tolerance to morphine (Bohn et al., 2000). It remains a mystery why morphine
does not lead to OpR internalisation. One possibility is that morphine does not induce the
conformational change in the receptor required for phosphorylation, and phosphorylation
of the C-terminal of MOR and DOR is a requirement for endocytosis (Dohlman, 1991;
Koch et al., 1998; El Kouhen et al., 1999; El Kouhen et al., 2000; El Kouhen et al., 2001).
The study of OpR regulation in primary culture is a new field, and the present study is the
first to measure MOR regulation in brainstem neurons at the single cell level. A recent
study by tre et al. (20O2) has described OpR regulation in primary cultures of rat cortex.
This study used the OpR ligands dermorphin and deltorphin to label MOR and DOR,
respectively. Although these ligands have high affinities for their targeted receptors,
binding to other receptors is still possible. In addition, this technique does not take into
account different splice variants of the OpRs that have been shown to be regulated
differently (Koch et al., 1998; Koch et al., 2001). This study by tre et al. (2002) is unique
in that it uses confocal microscopy to examine OpR expression at high levels of resolution
similar to that used in the present study.
Primary cell culture models may provide simplified systems in which to study cell function
and regulation in a manner that more closely resembles the in vivo state compared to use of
established cell lines. Cell culture models are helpful for identifying individual
components involved in OpR regulation in vitro system before more complex OpR
regulatory pathways can be elucidated in vivo. Primary cultures however, have
disadvantages and limitations, as described previously in Chapter 2. Briefly, cultured
brainstem cells do not necessarily function in the same way as the same cells in vivo.
Alterations in gene expression and differential cell survival in different brainstem nuclei
may occur once the cells are dissociated for culture. It is possible that some neuronal
populations within the brainstem do not survive in culture at all the developmental ages
tested. Therefore, if this primary culture system is to be used to study receptors in vitro, it
may be necessary to first determine if the population of cells has been substantially
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modified from the in vivo population at each developmental age. Despite these limiting
factors, primary cell culture provides a useful approach in the process of understanding
complex cellular functions, despite the fact that extrapolation of findings to the in vivo
situation must be made with caution.
7.I.2 OPIOID RECEPTOR DISTRIBUTION AND EXPRESSION DURING
BRAINSTEM DEVELOPMENT
Immunohistochemical labelling of OpRs by specific antibodies and TSA amplification
techniques was used to determine OpR distributions in coronal and sagittal sections of rat
brainstem during development. In the foetal brainstem, DOR was found in the same
brainstem regions as in postnatal (P6) and adult animals. Earlier studies of DOR
expression in the developing brainstem used radioligand binding, which was unable to
detect significant levels of DOR in Pl rats, and the labelling that was seen at this age was
very diffuse (Xia and Haddad, 1991). Earlier studies of MOR expression also showed
binding of MOR ligand in the brainstem nuclei of the NTS, NA and STT (Xia and Haddad,
1991). Similar distributions were found in the present study (Chapter 6: Section 6.4.5).
Autoradiographic techniques have been used to measure OpR expression and to localise
the expression to particular brainstem regions. One study used DALDE to label DOR;
however, this OpR ligand has only slight selectivity for DOR over other OpRs (Gacel et
al., 1980). Autoradiography also does not have the resolution or the sensitivity
characteristic of highly selective antibody techniques and cannot take into account the
changes in OpR binding affinity that occur during development (Spain et al., 1985).
Ligand binding in whole brain homogenates of the rat (Spain et al., 1985; Tavani et al.,
1985; Petrillo et al., 1987) and mouse (Zhu et al., 1998) indicate that DOR is expressed at
low levels during late foetal and early postnatal development. The present study, however,
found that DOR was expressed at its highest levels in brainstem lysates of foetal rats, with
a subsequent decrease in expression to adult levels (Chapter 6: Section 6.4.3\. This finding
has several possible implications. One is that DORs are expressed early in development;
however, their binding properties are different in the foetus, not binding to the ligand, and
change later in development to a form that does interact with the ligand. This possibility is
supported by reports that there is an increase in binding affinity of DOR ligands during
postnatal development (Spain et al., 1985). Another possibility is that the brainstem region
has different expression levels during development compared to other brain regions.
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Therefore, when whole brain lysates are measured for OpR binding, the lower expression
levels in other brain regions dilute out the high expression levels found in the brainstem.
IHC results from the present study, however, provided a different picture to the brainstem
lysate immunoblot results. There was no difference in DOR expression in cells cultured
from foetal (El6) and postnatal (P6) brainstems (Chapter 3: Section 3.4.4). It is
conceivable that changes in expression occured that were not statistically significant due
to the small sample size used and the minimum level of change required for detection
using this technique.
The significance of different molecular weight forms of DOR seen in Western blots is
unknown. The 30 kD band is believed to be a truncated form of DOR that is unlikely to
reside in the plasma membrane and is therefore likely to be non-functional, although OpR
binding experiments will need to be undertaken to determine this. The detection of this
protein along with the complete 70 kD form may explain why higher expression of DOR
was seen during early development using IHC than that reported from ligand binding
srudies that only measure complete protein with functional binding sites. It is also possible
that the 30 kD DOR protein is a splice variant. DOR splice variants have been described
(Gav6riaux-Ruff et al., 1997), and one of these splice variants encodes a truncated DOR
protein with a single transmembrane domain. The DOR antibody used in the present study
was specific for the N-terminal region of DOR, and therefore is likely to recognise the N-
terminal of the truncated DOR receptor; whereas, an antibody specific for the C+erminal
region would not. In future, development of antibodies and mRNA probes specific for
each subtype of OpR will be able to determine if the truncated DOR is specifically found
in a particular cell type or if both molecular weight forms are present in all DOR-positive
cells. Opioid receptor splice variants are known to have different spatial distributions in
the brain @an et al., 1999; Abbadie et al., 2000b; Abbadie et al., 2000a), and their
regulatory properties differ (Abbadie and Pasternak, 2001; Koch et al., 2001). In one study
of mouse splice variants in transfected cells showed MOR-I and MOR-IC exhibit
phosphorylation and internalisation in response to DAMGO but not morphine exposure.
MOR-ID and MOR-IE, however, exhibit phosphorylation and internalisation in response
to both morphine and DAMGO (Koch et al., 2001). In another study of the mouse splice
variants in vivo MOR-IC showed internalisation with morphine exposure; whereas, MOR-
I did not (Abbadie and Pastemak, 2001). Splice variants are also likely to bind OpR
ligands with varying affinities, and this may account for some of the different
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pharmacological opioid receptor subtypes described in the literature (Lutz and Pfister,
1992; Satoh and Minami, 1995; Dhawan et al., 1996).
The expression of MOR during late foetal and early postnatal development resembled the
expression levels described by others in vtvo. MOR is expressed at low levels in the
brainstem during early development, and expression levels increase through later stages to
adultlevels(Spainetal., 1985;Petrilloetal., 1987;Zhuetal., 1998). Severalmolecular
weight MOR protein bands have been described and the size differences attributed to
different glycosylation states of MOR (Garz6n et al., 1995). The MOR-1 cDNA predicts a
protein with a mass of 45 kD, so it is likely that both MOR bands seen in the present study
have some glycosylation.
The present study is the first to describe changes in the expression level of different forms
of MOR during brainstem development (Chapter 6: Section 6.4.3). The 70 kD band is
found predominantly in the adult, with decreasing levels seen earlier in brainstem
development. The 50 kD band, however, is present at its highest levels in the foetal (El6)
brainstem, with decreasing levels seen at later ages. The two bands were also seen in
Western blots of lysates prepared from primary brainstem cell cultures, and the same
developmental trends for the two bands were seen. The functional significance of these
developmental changes in the glycosylation state of MOR remains to be deterrnined.
Glycosylation may change ligand binding properties or the mechanisms of receptor
regulation, thus, like DOR, contributing to the multiple pharmacological receptor subtypes
that have been described.
MOR agonists appear to cause a reduction in respiratory frequency via mu1 receptors and a
decrease in tidal volume via mu2 receptors (Colman and Miller, 2001; Colman and Miller,
2002). Different MOR agonists also cause respiratory depression via either ffiul or rlu2
activation (Ling et al., 1985; Paakkari et al., 1990; Chen et al., 1996). One theory that
could be put forward is that the pharmacological and physiological uniqueness of different
MOR agonists could be due to the glycosylated receptors having different binding
affinities for their ligands. For example, mu1 may be glycosylated at one site or sites and
mu2 at another or other sites. These different glycosylation forms of MOR may have
unique spatial distributions within the brain, which would also cause different
physiological responses to agonist exposure. Changes in expression of the glycosylated
225
receptors during development may therefore account for the variation in sensitivity
reported for young neonates to opioid agonists and antagonists compared to older neonates
and adult animals. For example, in a study of neonatal piglets, administration of OpR
agonist naloxone raised respiratory output, an effect that decreased with age (Long and
Lawson, 1983). Administration of the MOR agonists dermorphin and fentanyl caused a
decrease in respiratory output in neonatal and adult rats. This decrease in respiratory
output was greater in younger pups (Colman and Miller, 2001).
MOR and DOR were found to be distributed in the same brainstem regions. In addition,
cultured cells from brainstem showed MOR and DOR colocalisation in the same neurons,
suggesting that MOR and DOR have closely related or overlapping functions or that they
interact with each other, possibly by formation of heterodimers with unique binding
properties and signal transduction pathways. The extent of colocalisation of MOR and
DOR in cultured brain cells is only beginning to be investigated. A recent study in
cultured cortical neurons by tre et al. (2002) reported binding of fluorescent ligands to
MOR and DOR in the same cells, although the exact proportions were not determined in
their study ([re et a].,2002). This recent study by [,ee et al. is the first to show fluorescent
OpR localisation in primary brain cultures. The present study shows colocalisation of
MOR and DOR in cultures of brainstem cells and within brainstem nuclei indicating that
MOR and DOR colocalisation may be more prevalent than anticipated. It remains to be
determined if MOR and DOR form heterodimers in vivo.
7.2 FI.JTTJRE EXPERIMENTS
7.2.I CELL CTJLTURE
A significant advance would be to establish cell cultures from more defined regions of the
brainstem. For example, a specific brainstem region, such as the NTS or NA, could be
micropunched from thick coronal sections and cultured in microplates. The disadvantage
of using this technique is the small number of cells available for further analysis; however,
it would be ideal for studying the properties of single neuronal cells during development
using ICC or electrophysiology.
The use of primary cultures of individual brain regions would be essential for
understanding OpR regulation in those regions. Different neuronal populations have
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different neurotransmitters, receptors, and isoforms of regulatory proteins such G-proteins
(Harrison et al., 1998; Connor and Christie, 1999) or adenylyl cyclase isoforms (Standifer
and Pasternak, 1997). A review by Law and Loh (1999) suggested a model for OpR
regulation that involves the receptor complex changing conformation upon agonist
binding, with each opioid agonist inducing a different conformational change in the OpR
and thereby altering the receptor's other regulatory properties (Law and l,oh, 1999). A
model involving a static OpR does not account for all the known effects of the receptors
and their ligands. If this is the case, the interaction of the OpR complex with other proteins
such as B-arrestin, calmodulin and different isoforms of adenylyl cyclase is an important
area for future research.
7.2.1.L Molecular Biolory
Another interesting area of research is to study the ability of different OpR splice variants
to be phosphorylated (Koch et al., 1998), an important feature of agonist-induced
desensitisation. Spatial localisation of splice variants (Pan et al., 1998; Abbadie et al.,
2000b; Abbadie et al., 2000a), along with differences in their ability to be phosphorylated
(Koch et al., 1998), are interesting areas that may help investigators design splice variant-
specific opioid peptides. Splice variants that are resistant to desensitisation offer the
opportunity to provide pain relief without the need for increasing the doses of opiates. It is
also possible that opioid drugs without unwanted side effects could be developed.
Opioid receptor down-regulation involves phosphorylation of the opioid receptor.
Antibodies could be made against phosphorylated MOR or DOR, and Western blots could
be used to directly determine receptor phosphorytation on exposure to opioid agonists,
such as DAMGO (MOR) and DPDPE (DOR) or antagonists such p-FNA (MOR) and
natrindole (DOR). Immunogold electron microscopy could help determine if internalised
OpRs are actually in endosomes. Double-labelling of cells in culture could also help
determine if MOR and DOR share the same endocytotic pathways, or whether they are in
separate endocytotic vesicles, as has been previously studied in OpR transfected cells
(Gaudriault et al., L997).
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7 .2.1.2 Electrophysiology
The cell culture model described in this study (Chapter 2) provides an ideal system to
study firing of brainstem neurons. Previous studies by Rigatto et al. (1992 and 1994) using
a cell culture method described by Fitzgerald et al. (1992) (Fitzgerald et al., 1992) have
described spontaneous neuronal firing in foetal rat neurons cultured from the brainstem
regions of the NTS and NA (Rigatto et al., 1992; Rigatto et al., 1994). These spontaneous
action potentials may originate from the preBOtC neurons that are postulated to be
responsible for generating respiratory rhythm in vivo (Smith et al., L99l; Rekling and
Feldman, 1998). Some of the cultured neurons in the study by Rigatto et al. (1994) acted
like pacemaker cells with regular or single bursting activities. These neurons also had
chemosensitive properties. For example, when these cells were exposed to pulses of COz
or low pH, an increase in frequency and a decrease in amplitude of action potentials were
seen. Inegularly firing cells and silent cells showed no response to COz or low pH
(Rigatto et al., 1994). The firing properties of these cells, however, have not been studied
during postnatal developmental because of the limitations of culture methods for older
postnatal brainstem cells. The culture method described in this thesis opens the door to
further investigation of COz- and pH-responsive brainstem neurons in postnatal animals.
Cell culture is an ideal method to study the electrical activity and receptor properties of
individual neurons. It may be possible to study the effects of opioid agonists and
antagonists on the electrophysiological properties of these neurons, and the same cells
could then be isolated and their OpR expression profiles determined. Novel methods have
been developed for examining mRNA expression in single cells using PCR techniques
(Phillips and Lipski, 2000).
7.2.1.3 MOR and DOR Colocalisation
MOR and DOR colocalisation was often seen in primary culture of brainstem cells
(Chapter 3: Section 3.4.6), although not all regions of individual cells expressing one or
other receptor showed colocalisation. MOR and DOR were also colocalised within
brainstem nuclei in vivo, although the localisation of MOR and DOR to the same cell was
not determined. Future experiments using double-labelling techniques or immunogold
electron microscopy would be able to assess whether MOR and DOR are colocalised in the
same cells in vivo. Labelling of mRNA by fluorescence in siru hybridisation (FISH) could
also be used to determine if the message and protein are found within the same cells.
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Preliminary FISH studies carried out by Eli Mrkusich and Dr Darren Day (Victoria
University of Wellington, personal communication) show similar staining patterns to IHC
antibody labelling presented in this study. A preliminary experiment using double FISH
labelling of MOR and DOR mRNA showed that MOR and DOR mRNA are present in the
same cells in most brainstem regions. Labelling with FISH and IHC, however, is yet to be
performed on the same sections cut from the same rat brain. It seems likely that at least
some MOR and DOR protein will be colocalised to the same neurons in vivo. Quantitative
FISH techniques currently being developed make it possible to determine the relative
distributions in brain regions.
It is unknown if MOR and DOR form heterodimers in vivo in the same way as have been
found in cotransfected cells. Heterodimer formation could be assessed through the use of
time resolved fluorescence resonance energy transfer (FRET), bioluminescence resonance
energy transfer (BRET), or immunoprecipitation. Immunoprecipitation experiments have
already been carried out on MOR- and DoR-transfected cells by George et al. (2000)
(George et al., 2000), and homodimer formation has been examined by McVey (2001) in
DOR transfected cells (McVey et al., 2001).
Knockout models of OpRs have been generated and studied (Matthes et al., 1996; Kieffer,
1999; Chen et al., 2000; Kieffer and Gav6riaux-Ruff, 2O02); however, the development of
conditional knockout mice in which OpR or peptide genes are inactivated in a regional-
specific manner may help elucidate opioid function in specific brain regions during
development. The effects of opioids on respiration have also not been determined in all
OpR knockout mice. Studies on respiratory function in the triple MOR, DOR, and KOR
knockout mouse may help investigators further elucidate the role played by opioids in
respiration.
7.2.1.4 Opioids and Cerebellar function
The present study is the first to demonstrate MOR localisation in Purkinje cells in the rat
cerebellum (Chapter5). A clear determination of the roles played by opioids in cerebellar
development and function would help determine the significance of the receptor
distributions described in the present study. Quantitative assessment of the differences in
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expression levels between species, using both functional activation of opioid receptors and
protein expression by Western blotting, would be helpful in this regard'
7.3 OVERALLCONCLUSIONS
Primary cultures of brainstem cells of the rat can be established up to postnatal day 6.
Cells in brainstem cultures of late foetal and early postnatal development express both
MOR and DOR, with some colocalisation of receptors seen. MOR in cultured cells is
functionally down-regulated on exposure to the MOR agonist DAMGO in a similar way as
has been described for SH-SYSY cells and MOR-transfected cells (Arden et al., 1995; Law
and [,oh, 1999; Law et a1.,2000c; Afify, 2O02); thus, providing a suitable model to study
OpR regulation in culture. Brainstem cultures have advantages over use of established cell
lines in that the cell populations express receptors at endogenous expression levels, unlike
the over-expression seen in transfected cells. Thus, cells in primary culture are more likely
to resemble the in vivo cell population in which the cells were isolated from.
Opioid receptor expression is developmentally and spatially regulated. MOR and DOR
were found in the same brainstem regions in foetal, postnatal and adult rats with DOR seen
for the first time in foetal rat brainstem coronal sections. Several different molecular
weight forms of both MOR and DOR were seen in Western blots. This study shows for the
first time developmental changes in the molecular weight forms of MOR and DOR. The
developmental changes are likely to be due to differences in receptor glycosylation and/or
splice-vari ant expressi on.
Changes in the developmental expression and distribution of opioid receptors is likely to
play a key role in the growth, differentiation and physiological activity of brainstem
neurons involved in respiration and cardiovascular function
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Appendix L Hibernate Medium Composition
The only difference between Hibernate E and Hibernate A medium is the NaCl
concentration which alters osmolalitv.
Hybernate E
mo/L
Hybernate A
mo/L
INORGANIC SALTS
CaC12
Fe (NOg) 3.9H2O
KCI
MgClz
NaCl
NaHzPOa.HzO
NaHCO3
ZnSOr.THzO
AMINO ACIDS
L-Alanine
L-Arginine HCI
L- Asparagine.HzO
L-Cysteine
Glycine
L-Histeine HCIHzO
L-lsoleucine
L-Leucine
L-Lysine
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
OTHER COMPONENTS
D-Glucose
MOPS
PhenolBed Solution
Sodium Pyruvate
VITAMTNS
Choline Chloride
D-Ca-Pantothenate
Folic Acid
l-lnositol
Niacinamide
PyrodoxalHCl
Bibollavin
Thiamine HCI
Vitamin 812 Solution
2.000
84.000
0.830
31_ . 500
30.000
42.000
r_05.000
105.000
1_46.000
30.000
66.000
7.760
42 .000
95.000
l_5.000
?2.000
94.000
4500.000
209.000
8.100
25.000
200.000
0. r-00
400.000
77 .300
3000.000
125.000
74.000
0.l_90
4.000
4.000
4.000
7 .200
4.000
4.000
0.400
4.000
0.007
200.000
0.100
400.000
77 .300
4000.000
L25.000
74.000
0.l-90
2.000
84.000
0.830
31.500
30.000
42.OOO
r_05.000
105.000
r_46.000
30.000
66.000
7.760
42.000
95.000
16.000
72.000
94.000
4s00.000
209.000
8.r..000
2s.000
4.000
4.000
4.000
7 .200
4.000
4.000
0 .400
4.000
0.007
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Appendix 2
Solutions, Buffers and Miscellaneous Methods
I BALANCED SALT SOLUTTON (BSS)
148.0 mM
5.0 mM
1.3 mM
4.2mM
0.9 mM
0.3 mM
0.4 mM
2 PHOSPHATE BUFFERED SALII{E (PBS) 0.15M PH7.4
g/L
NaCl 0.80 g
KCI 0.2o g
NazFIPOa 1.15 g
KFIPO+ O.2O g
PBS was made by dissolving the salts in ddH2O.
concentrated HCL or NaOH.
The pH was adjusted to 7.4 using
3 REMOVAL OF PEROXIDASE ACTIVITY
Samples are incubated in hydrogen peroxide solution for 15 minutes
Hydroqen Peroxide Solution
NaCl
KCI
CaClZ
NaHCO3
MgS04
Na2HPO4
KH2P04.
Methanol
30VoHzOz
dHzO
5.000 mL
0.333 pL
4.660nI-
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DAB was dissolved in dHzO and the phosphate buffer added. Immediately prior to use
HzOz was added and the samples incubated for l-20 min until the desired brown colour
was reached. For increased staining I mL of l7o Nickel sulphate was added to the mixture
above to produce intense black staining.
5 0.4 M PHOSPHATE BUFFER
s/L
11 1.3 g
9.1 g
Salts were dissolved in ddH2O, and the pH adjusted to pH 7.4 before making to the final
volume.
4 DAB SOLUTION
DAB
dH2o
0.4M PO+ buffer
lVoHzOz
NazHPO+'12H20
NaHzPO+
6 GLYCERINJELLY
Gelatin
dHzO
Pure glycerin
Phenol Crystals
12.50 mg
18.75 mL
6.25 n[-
9.00 pL
5.00 g
60.00 mL
70.00 mL
0.25 g
Gelatin was dissolved in dHzO in a beaker, in a waterbath. When gelatin was dissolved
glycerin and phenol were added and melted in a hot waterbath or oven.
7 ANTIFADE MOI.JNTING MEDIUM
Antifade reagent, A.2 g of 1,4-diazabicyclo[2.2.2foctane (DABCO) was added to 9 mL
glycerol and heated to 50oC until dissolved. When dissolved, I mL of 0.2 M Tris buffer
containing O.02To sodium azide was added.
233
8 DEPC TREATED WATER
One mL of diethyl-pyro carbonate (DEPC) was added to I L of d HzO and shaken
vigously. The treated water is placed in a fume hood overnight. The next day the DEPC
treated water is autoclaved for 30 min.
9 LB MEDIT]M
To make I L
The following reagents are mixed together until they have dissolved. The pH adjusted to
pH 7 with NaOH and made up to the final volume of I L, then the mixture sterilised by
autoclaving.
10 LB-AGAR
LB agar plates were made by adding agar (15 /L) to LB medium before pH adjustment.
After autoclaving the media was cooled and antibiotics added. For LB-amp plates 50
p/ml- of ampicillin, and for LB-kan plates sOpg/ml- of kanamycin was added. The LB
Agar is then poured into l0 cm diameter petri dishes and stored at 4" until required.
Bacto-tryptone
Bacto-yeast extract
NaCl
dH20
11 SOC MEDIUM
950 ml
bacto-tryptone
bacto-yeast extract
NaCl
log
5g
log
950 mL
dHzO
20.0 g
5og
0.5 g
The reagents listed above are added together and shaken until all the solutes were
dissolved. Ten mL of KCI (250 mM) was added and the pH adjusted to pH 7 with NaOH.
The solution is made up to 975 mL with dHzO, and the mixture sterilised by autoclaving.
Following sterilisation 5 mL of sterile MgCl (2M) and 20 mL of I M, filter sterilised
glucose solution was added.
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12 SEQUENCING PI.JRIFICATION SPIN COLUMN
G50 Stock: Ten g of Sephadex-G5O (Pharmacia, Uppsala, Sweden) was added to 100 mL
of sterile dHzO and allowed to hydrate for 30 min. Water was decanted from the beads,
them more water was added. This step was repeated 3 times and the beads stored at 4oC
until required.
Spin column preparation: Clean reusable microfuge tube columns were washed 5 times in
dH2O and once in 70Vo ethanol and the column allowed to air dry. To the bottom of the
column 0.75 mL of G50 stock was added and centrifuged (2000 rpm for I min). After
centrifugation 200 pL of d HzO was added to the middle of the column centrifuged as
above. Prepared columns were sealed and stored at 4 "C for up to I week. Before use, the
column was washed by addition of 50 pL of sterile dHzO to the centre of the column and
centrifuged.
13 SDS-POLYACRYLAMIDE GEL ELECTROPHORBSIS
Gel plates and combs were cleaned with 7O7o ethanol, allowed to dry, and assembled onto
gel casting apparatus (BioRad).
Stock Solutions
1.5 M Tris pH 8.9
0.5 M Tris pH 6.8
l07o SDS
Water saturated butanol
87o Separating Gel
(2 gels 1.5 mm thick)
Acryl amide lbis (3OVo stock)
I.5 M Tris pH 8.8
ddHzO
107o SDS in ItO
TEMED
I 07o ammonium persulfate
(1S.2 g Tris/ 100 ml dHzO, pH with HCL)
(6 g Tris base/100 ml dHzO, pH with HCL)
(10 g SDS/ 100 ml dH2O)
5.32 mL
5.00 mL
9.38 mL
200.00 pL
10.00 pL
100.00 pL
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The solutions were added in the order shown. TEMED and l07o ammonium persulphate
were added last to initiate polymerisation. The gel solution was added to the casting
apparatus and overlayed with water-saturated butanol. The gel was left to polymerise for
30 min. The butanol was removed from the gel and the gel rinsed with ddllzO. The
stacking gel was then made and cast on top of the washed separating gel.
The stacking gel reagents were combined, mixed and overlayed on top of the separating
gel. A comb was added to form well for the samples and the gel was allowed to
polymerise for approximately 15 min. The comb was removed and the gel placed in the
electrophoresis tank with running buffer. Samples were added to the wells and
electrophoresed at l50V for lhour.
14 5X RI]NNING BUFFER (TRIS-GLYCINE PH 8.3)
AVo Stack'tng Gel
Acrylamid elbis (307o stock)
0.5 M Tris pH 6.8
107o SDS
ddH2o
TEMED
I 07o Ammonium persulfate
(Stored frozen)
Total
600 mL
Tris base
Glycine
SDS
glycerol
SDS
1.33 mL
2.50 mL
0.10 mL
6.10 mL
10.00 pL
50.00 pL
l0 00 mL
9.0 g
43.2 g
3.0 g
5.62 mL
1.15 g
The reagents listed above were added together with 500 mL of ddHzO, mixed, and made
up to 600 mL and stored at 4'C until required.
15 PROTEIN GEL LOADING BUFFER 5 X (10 ML)
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bromophenol blue 5 mg
0.5 M Tris-HCl pH 6.8 4.38 mL
The following reagents were added, mixed and stored at -20 until use. Immediately before
e use l0 pI of 2-mercaptoethanol per 0.1 mL gel loading buffer was added.
16 WESTERN TRANSFER BUFImR (3 L)
Tris 9.09 g
glycine 43.2 g
SDS 39
methanol 600 mL
The following reagents are combined and the volume made up to 3 L with ddH2O.
I7 TABLE 1: ARRANGEMENT OF WESTERN TRANSFER APPARATUS
Table Appendix 2 Arrangement of western transfer apparatus
Bottom I Grey Side of Cassette
I Fibre Fad
I| 3MM PaPer
I Electronhoresed Gel
I PVDF Membrane
| 3MM PaPer
I Fibre PadTop I Clear Side of Cassette
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Appendix 3
Statistical Analysis
MIJLTIPLE COMPARISONS (BASED OF KRUSKAL.WALLIS TEST)
The statistical significance of differences between pairs of values was determined using
Mann Whitney (2 groups) or Kruskal-Wallis (3 or more groups) for each developmental
age group or treatment, followed by Multiple comparisons test (Hollander and Wolfe,
1973a) (Hollander and Wolfe, 1973a))
For unequal sample sizes a significant difference was analysed using the following
equation.
Results are significant when
(R"-R")ttz1a4kt' r N(N+l) -, vz t | + I r' vz
,)r k- LT I (N" N" )
Ro, Ru = Mean ranks of samples u, v
z = Upper quartile of normal distribution N(O,lXstatistical table)
cL = Acceptable experimental error rate (0.001)
N = Mean rank
k = Number of groups
Nu, Nu = Total number in group u, v
N =Total number of samples
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Appendix 4 Cloning and Sequencing of MOR
Vector properties
pGEM-T
pGEltP-T
Uedor
{3000bp) 55
62
62
73
75
82
94
103
112
t26
1 start
l4
2A
26
*:l
37
46
Spe I
ruo, I
BstZlftrl
Sal I
Nttel
Sac I
BstX I
IVsi I
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